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Inositol, produced in vivo by the biosynthetic enzyme inositol-3-
phosphate synthase (Ino1), is an essential component of inositol phosphates 
and phosphoinositides that are involved in important cell signalling pathways. 
Dysregulation of inositol signalling has been implicated in various diseases, 
including bipolar disorder, Alzheimer’s disease, and diabetes. Research 
relating to inositol regulation in cells has primarily focused on the molecular 
and cellular effects of inositol depletion without considering the effects of 
altered Ino1 levels. This PhD study employed a simple eukaryote, 
Dictyostelium discoideum, to investigate the distinct effects of the loss of Ino1 
and inositol depletion. Ablation of ino1 in this model produced an inositol 
auxotrophy phenotype and affected development, with the former being only 
partially restored by an exogenous inositol supply. The removal of exogenous 
inositol from the ino1- mutant resulted in a 56% decrease in intracellular 
inositol levels within 12 hours, a reduction in cytokinesis and substrate 
adhesion, and an accumulation of autophagosomes. Inositol depletion also 
triggered a decrease in phosphoinositide levels. Intriguingly, the absence of 
the Ino1 protein and inositol depletion cause distinct metabolic changes, with 
the greatest changes seen following Ino1 loss. These data suggest a role for 
the Ino1 protein beyond inositol biosynthesis. To investigate this role, an 
immunoprecipitation approach was used, where an Ino1 binding partner, 
Q54IX5, was identified. Q54IX5 is likely to function as a macromolecular 
adaptor protein. Thus, this study has identified distinct cellular and metabolic 
effects for both inositol depletion and loss of Ino1, with implications for our 
understanding of human diseases.  
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Chapter I  
Introduction 
1.1 Inositol and its derivatives 
Myo-inositol, hereafter referred to as inositol, is the most widely 
occurring stereoisomer of inositol (Clements and Darnell, 1980) (Figure 1.1). 
It is a six carbon cyclic polyalcohol, which is present in a variety of cell types, 
including neurons. Cells can obtain inositol from three major sources. It can 
be synthesized de novo from glucose-6-phosphate by inositol-1-phosphate 
synthase (Ino1, EC5.5.1.4), recycled in the phosphatidylinositol cycle by a 
number of enzymes including inositol monophosphatase (IMPase), or 
transported from extracellular space by inositol specific transporters (Daniel 
et al., 2009; Deranieh and Greenberg, 2009) (Figure 1.2).  
Inositol is synthesised de novo from D-glucose-6-phosphate by an 
isomerase 1-L-myo-Inositol-1-phosphate synthase (Ino1) (Stein and Geiger, 
2002). The proposed biochemical process involves oxidation, enolisation, 
intramolecular aldol cyclisation, and reduction steps, with nicotinamide 
adenine dinucleotide (NAD+) used as a cofactor (Stein and Geiger, 2002). 
Inositol in turn regulates the transcription of the Ino1 encoding gene, where 
increased levels of inositol inhibit ino1 transcription (Hirsch and Henry, 1986). 
The biosynthesis of inositol is an evolutionarily conserved pathway, and the 
Ino1 protein, together with the gene encoding it, have been regarded as 
ancient in origin (Majumder et al., 2003). Inositol has also been shown to be 
necessary for cell survival in a variety of organisms, including 
Saccharomyces cerevisiae, Dictyostelium discoideum, Arabidopsis thaliana, 
and a parasite Trypanosoma brucei (Culbertson and Henry, 1975; Fischbach 
et al., 2006; Henry et al., 1977; Lester and Gross, 1959; Martin and Smith, 
2006; Meng et al., 2009).  




Inositol constitutes part of two important families of molecules: 
phosphoinositides and inositol phosphates (Deranieh and Greenberg, 2009) 
(Figure 1.1). These molecules are critically involved in a range of cellular 
functions, including phospholipid synthesis, the unfolded protein response 
(UPR) and protein secretion (Deranieh and Greenberg, 2009). 
 
Figure 1.1 The chemical structures of inositol, inositol phosphate and 
phosphoinositide. Inositol is a cyclic polyalcohol. Inositol phosphate, shown here as 1,4,5-
inositol trisphosphate, is a phosphorylated inositol, and phosphoinositide, shown here as 
phosphatidylinositol 4,5-bisphosphate, is a lipid containing a phosphorylated inositol head 
group and two fatty acid tails linked by a glycerol backbone. 
Phosphoinositides form part of cell membranes and play role in cell 
motility and intracellular membrane trafficking (Corvera et al., 1999). 
Phosphoinositides are formed by phosphorylation of an inositol ring in a 
phosphatidylinositol molecule. Phosphatidylinositol (PI) comprises of a 
glycerol backbone linked to two fatty acid tails and a phosphate group 
attached to an inositol ring (Figure 1.1). PI is synthesised from the precursor 




cytidine diphosphate diacylglycerol (CDP-DAG) by reaction with inositol, 
which is catalysed by the enzyme CDP-diacylglycerol inositol 
phosphatidyltransferase, also known as phosphatidylinositol synthase (PIS 
EC 2.7.8.11) (Figure 1.2). PIS is located in the endoplasmic reticulum, 
although it is also present in the plasma membrane in yeast (Tanaka et al., 
1996). PI is then transferred to membranes either in vesicles or by specific 
transfer proteins (Krauss and Haucke, 2007). Phosphoinositides are 
maintained at steady state levels in the inner leaflet of the plasma membrane 
by a continuous and sequential series of phosphorylation and 
dephosphorylation reactions by specific kinases, phosphatases and 
phospholipase C enzymes (Kurnasov et al., 2013) (Figure 1.2).   
Figure 1.2 Inositol uptake, 
de novo biosynthesis, and 
recycling. Inositol is 
produced from glucose 6-
phosphate (G6P), which is 
converted by an isomerase 
Ino1 to inositol 1-phosphate 
(IP), which is subsequently 
dephosphorylated by inositol 
monophosphatase (IMPase) 
to inositol. Inositol can be 
phosphorylated to form 
phosphoinositides (PI, PIP, 
PIP2, PIP3), or it can form 
part of inositol phosphates. 
Phosphatidic acid (PA) is 
produced from diacylglycerol 
(DAG) by diacylglycerol kinase (DGKA), and is a precursor to phosphatidylinositol. Inositol 
phosphates are produced by the cleavage of PIP2 by phospholipase C (PLC). Inositol 1,4,5-
triphosphate (IP3) is an example of a second messenger that initiates separate intracellular 
signalling cascades, leading to the release of intracellular calcium (Ca
2+
) that can lead to a 
modulation in gene transcription. The recycling of inositol is completed by sequential 
dephosphorylation of inositol phosphates with the help of inositol polyphosphate 
phosphatase (IPP). Inositol can be also transported from extracellular sources into the 
cytosol by specialised transporters located at the plasma membrane. Abbreviations: PIS, 
phosphatidylinositol synthase; IMPase, inositol monophosphatase; Ino1, inositol-1-
phosphate synthase; IPPase, inositol polyphosphate phosphatase; IP, inositol phosphate; 
IP2, inositol bisphosphate; IP3, inositol trisphosphate; CDP-DAG, cytidine diphosphate-
diacylglycerol; DAG, diacylglycerol; DgkA, diacylglycerol kinase; PLC, phospholipase C; 
PI4K, phosphatidylinositol 4-kinase; PI, phosphatidylinositol; PIP, phosphatidylinositol 
phosphate; PIP2, phosphatidylinositol bisphosphate; PIP3, phosphatidylinositol 
trisphosphate. 




Inositol phosphates consist of another group of inositol-containing 
molecules. Inositol phosphates originate from the cleavage of 
phosphatidylinositol 4,5-bisphosphate (PIP2) by phospholipase C (PLC) to 
produce inositol 1,4,5-triphosphate (IP3) and DAG (Burton et al., 2009) 
(Figure 1.2). The central role of IP3 is to trigger the release of intracellular 
calcium but it can also be phosphorylated to form inositol phosphates (IP4, 
IP5, IP6) or inositol pyrophosphates (IP7 and IP8) (Bennett et al., 2006; 
Burton et al., 2009), which are involved in the regulation of gene expression 
and in post-translational protein modifications (Shen et al.,  2003; Steger et 
al., 2003). 
1.2 Inositol metabolism in disease 
Inositol is naturally present in many fruits, vegetables, grains and 
meat, and a diet restrictive in inositol reduces its levels in the brain 
(Shaldubina et al., 2006). Magnetic resonance spectroscopy (MRS) studies 
showed that inositol is present in the human brain at 3.93 +/- 1.13 mM in 
young subjects and 4.69 +/- 0.69 mM in older subjects (Kaiser et al., 2005). 
Altered inositol metabolism has been implicated in various human diseases, 
including metabolic, cardiovascular, neurodegenerative and neuropsychiatric 
diseases (Cocco et al., 2004; Croze et al., 2013; Deranieh and Greenberg, 
2009; McLaurin et al., 1998; Moore et al., 1999; Scioscia et al., 2007; 
Shimohama et al., 1998; Teo et al., 2009; Thakkar et al., 1990; Toker and 
Agam, 2014; Trushina et al., 2012). Inositol has also been shown to prevent 
the onset of gestational diabetes, and chronic supplementation with inositol 
has improved insulin sensitivity and reduced fat accretion in mice (Croze and 
Soulage, 2013; Croze et al., 2015, 2013; Kennington et al., 1990; Murphy et 
al., 2015; Santamaria et al., 2015; Scioscia et al., 2007; Thakkar et al., 1990; 
Zheng et al., 2015). Additionally, increased glucose has been demonstrated 
to competitively inhibit inositol uptake by cells (Coady et al., 2002). Inositol 
has been also shown to be therapeutic in patients with bulimia and binge 
eating disorder (Manji et al., 1996), and to increase plasmalogens in serum 
and decrease low density lipoprotein C (LDL-C) in cardiovascular health 
(Maeba et al., 2008).  




Figure 1.3 The 
structure of valproic 
acid (VPA) 
Inositol imbalance has also been linked to neurodegenerative 
diseases and neuropsychiatric disorders. In Alzheimer’s disease, scyllo-
inositol and myo-inositol isomers have been shown in vitro to inhibit the 
formation of Aβ42 fibrils (Fenili et al., 2007; McLaurin et al., 2000, 1998). 
Furthermore, Ino1 protein activity and levels are higher in the brains of 
Alzheimer’s disease patients, as measured post-mortem (Shimohama et al., 
1998). Additionally, inositol is used as a therapeutic in bipolar disorder 
treatment, a neuropsychiatric condition characterised by recurring mood 
swings (Chengappa et al., 2000; Nierenberg et al., 2006), and has been 
tested as a therapy for depression and panic disorders (Palatnik et al., 2001). 
Inositol has been also found to reduce anxiety in a rat model during the maze 
behavioural test (Cohen et al., 1997). In humans, clinical studies have shown 
that 10 out of 15 patients experienced reduced severity in bipolar disorder 
when inositol intake was reduced (Shaldubina et al., 2006). Furthermore, in 
humans, diacylglycerol kinase eta (DGKH) has been one of the prominent 
genes associated with bipolar disorder (Baum et al., 2008). DGKH 
(Dictyostelium DgkA), an enzyme that phosphorylates diacylglycerol (DAG) 
to generate phosphatidic acid (PA) (Figure 1.2),, is involved in inositol 
signalling and plays a key role in promoting cell growth (Topham and Epand, 
2009).  
1.3 Inositol depletion theory and inositol depleting drugs 
Inositol imbalance has been implicated in the aetiology of bipolar 
disorder, where a decrease in inositol levels has been reported in the brains 
of bipolar disorder patients undergoing drug therapy (Belmaker et al., 2002; 
Davanzo et al., 2001; Moore et al., 1999). Furthermore, 
inositol depletion has been demonstrated as a 
common effect of three structurally different bipolar 
disorder treatments, valproic acid (VPA) (Figure 1.3), 
lithium, and carbamazepine, in cultured rat sensory 
neurons and in the simple biomedical model organism 
Dictyostelium discoideum (Williams et al., 2002). VPA, 




lithium, and carbamazepine also prevented the collapse and increased the 
spread area of the growth cones of rat sensory neurons (Williams et al., 
2002). These effects were reversed by the addition of inositol to the culture 
medium, suggesting that these treatments act via inositol depletion (Williams 
et al., 2002) and corroborating the inositol depletion theory, which states that 
mood stabilising drugs such as lithium act via lowering inositol levels 
(Berridge et al., 1989). 
 VPA (2-propylpentanoic or 2-propylvaleric acid) is a branched short-
chain fatty acid used as a first-choice treatment for acute mania (Terbach et 
al., 2011). It is also a widely used medication in the treatment of bipolar 
disorder, epilepsy, migraine, and more recently has been suggested for use 
in cancer or Alzheimer’s disease (Terbach and Williams, 2009). Although 
VPA has been suggested to target inositol signalling in cells and indirectly 
inhibit inositol-1-phosphate synthase, the mechanism of VPA action in bipolar 
disorder therapy remains unknown (Ju et al., 2004; Shaltiel et al., 2004; 
Vaden et al., 2001). 
Lithium is another inositol depleting drug prescribed for bipolar 
disorder therapy  (Ketter et al., 2016). Lithium inhibits inositol polyphosphate 
1-phosphatase (IPPase) and inositol monophosphatase (IMPase), which are 
both involved in inositol recycling (Berridge et al., 1989; Parthasarathy et al., 
2003; Serretti et al., 2009). This inhibition causes a depletion of inositol in 
cells, an increase in inositol monophosphate levels (the substrate of IMPase), 
and a downregulation of the phosphoinositide cycle. Lithium has been also 
shown to suppress phosphatidylinositol (3,4,5)-trisphosphate (PIP3) 
signalling in Dictyostelium and in human cells (King et al., 2009). Thus, 
numerous studies have suggested that both VPA and lithium decrease 
inositol level through either the inhibition of phosphatidylinositol recycling or 
via inhibition of de novo inositol biosynthesis. Since inositol depletion is a 
common mechanism of action of bipolar disorder therapies, and inositol 
levels are lowered in bipolar disorder patients, the effect of inositol depletion 
may be used as a molecular indicator in identifying improved bipolar disorder 
treatments. 




1.4 Glycolysis and inositol signalling 
Research into the pathology of inositol metabolism led to the 
identification of a number of signalling pathways and molecular targets linked 
to inositol signalling. Glycolysis is one of the pathways linked to inositol 
metabolism (Shi et al., 2005). Previous studies have shown that 
Saccharomyces cerevisiae glycolysis mutants (lacking triose phosphate 
isomerase Tpi1, or phosphoglycerate kinase Pgk1) are inositol-auxotrophs. 
The tpi1 and pgk1 mutants accumulate cellular dihydroxyacetone phosphate 
(DHAP) 30-fold over the basal level (Shi et al., 2005). DHAP is a product of 
fructose 1,6-bisphosphate breakdown, and upon its production it is rapidly 
and reversibly isomerised to glyceraldehyde 3-phosphate (Figure 1.4) (Shi et 
al., 2005). DHAP was shown to competitively inhibit yeast Ino1 in vitro (Shi et 
al., 2005). In the tpi1 yeast mutant, the level of ino1 expression was not 
changed, suggesting that the inositol auxotrophy phenotype was due to the 
inhibitory activity of DHAP on Ino1. Similarly, another S.cerevisiae glycolysis 
mutant, pgk1, defective in the conversion of 3-phosphoglyceroyl phosphate 
to 3-phosphoglycerate, also accumulated DHAP and was unable to survive 
without exogenous inositol supply to the growth media (Shi et al., 2005). 
Additionally, in vitro studies have shown that carbohydrate metabolites, 
glyceraldehyde 3-phosphate (G3P) in the glycolytic pathway and 
oxaloacetate (OAA) (fatty acid degradation), inhibit the activity of human and 
yeast Ino1 proteins (Shi et al., 2005). Finally, in Dictyostelium, the ablation of 
ino1 led to an accumulation of a glycolytic intermediate, 2,3-
bisphosphoglycerate (2,3-BPG) (Fischbach et al., 2006). Overall, these data 
suggest a cross-talk between glycolysis and inositol signalling.  
 
 












Figure 1.4 Dihydroxyacetone phosphate (DHAP) in the glycolysis pathway. DHAP is 
produced during the fourth step of glycolysis when aldolase splits fructose 1,6 bisphosphate 
into DHAP and glyceraldehyde 3-phosphate. In the fifth step of glycolysis DHAP, is rapidly 
isomerised by triosephosphate isomerase into glyceraldehyde 3-phosphate.  
1.5 SUMO regulation of the inositol synthesis pathway 
Sumoylation is another cellular process that has been associated with 
inositol metabolism. Sumoylation is a post-translational protein modification 
by highly conserved small ubiquitin-related modifier (SUMO) proteins (Henley 
et al., 2014; Wang and Dasso, 2009). Sumoylation can influence the 
localisation, stability or interactions of the modified proteins by, for example, 
directing the assembly and disassembly of dimeric and multimeric protein 
complexes (Kerscher, 2007) and thus dysregulation of sumoylation has 
pathological consequences. Indeed, dysfunction of a number of proteins 
regulated by sumoylation was implicated in human diseases including 
cancer, Huntington's, Alzheimer's disease (also linked to impaired inositol 
metabolism), and Parkinson's disease, as well as spinocerebellar ataxia 1 
and amyotrophic lateral sclerosis (Cho et al., 2015; Henley et al., 2014; 
Sarge and Park-Sarge, 2009).  




Figure 1.5 SUMO pathway regulation of inositol production. Schematic of the function of 
the endoplasmic reticulum (ER) type II integral membrane protein Scs2 in inositol synthesis 
in the yeast Saccharomyces cerevisiae. In the presence of inositol, the Scs2 protein remains 
at the ER membrane and a transcriptional repressor Opi1 is bound to Ino2/Ino4 regulators at 
the inositol-sensitive upstream activation sequence (UASINO1) in the promoter site, thus 
inhibiting the transcription of the ino1 gene. When inositol levels decrease, Scs2 sequesters 
the Opi1 repressor, and thus enables Ino2/Ino4 regulators to initiate ino1 transcription. 
Adapted from Felberbaum et al. (2012). 
Although the mechanism under which sumoylation operates is not yet 
fully understood, in S.cerevisiae it has been linked to inositol regulation. In 
this model, mutations in the SUMO proteases Ulp1 and Ulp2 decrease ino1 
gene transcription, causing impaired cell growth in the absence of inositol, 
and leading to an accumulation of the sumoylated proteins in vivo 
(Felberbaum et al., 2012). One of the identified proteins was Scs2, a type II 
integral membrane protein in the endoplasmic reticulum (ER) and a member 
of the vesicle-associated (VAP) family proteins, which regulates 
phosphatidylinositol synthesis and lipid trafficking, and when deleted results 
in inositol auxotrophy (Felberbaum et al., 2012). Thus, an interdependence 
between SUMO and inositol has been proposed, where protein sumoylation 
regulates inositol production and inositol modulates SUMO protein 
conjugation in cells (Figure 1.5). Furthermore, inositol starvation both 
increased the global sumoylation level and at the same time led to 
desumoylation of some specific proteins (Felberbaum et al., 2012). Finally, in 
the phosphoinositol pathway, sumoylation also regulates the class III 
phosphatidylinositol 3-kinase (PI3K-III) complex (and its product 
phosphatidylinositol 3-phosphate, PIP), which is involved in the control of 
autophagy, endocytosis or cytokinesis (Reidick et al., 2014).  




1.6 Dictyostelium discoideum as a biomedical model 
Investigation into the molecular mechanism of the regulation of inositol 
signalling has been previously conducted using mammalian tissue culture as 
well as simple model organisms, such as Dictyostelium discoideum or 
S.cerevisiae. The use of simple model organisms provides some advantages 
over more complex models such as neuronal culture, due to the challenges 
in handling mammalian cells for experimental purposes. Simple model 
organisms offer easy genetic manipulation and maintenance in a laboratory 
environment. Dictyostelium is an established simple biomedical model 
organism that is used in cell biology and molecular pharmacology research 
(Annesley and Fisher, 2009; Escalante and Vicente, 2000; Francione et al., 
2011; King et al., 2010; Nichols et al., 2015; Stephens et al., 2008; Williams, 
2005). Compared to mammalian model organisms, Dictyostelium cells are 
relatively easy to genetically manipulate and observe phenotypic changes 
(King and Insall, 2009; Manstein et al., 1989; Montagnes et al., 2012; 
Williams, 2005). The genome of Dictyostelium has been fully sequenced and 
contains a number of human disease-related orthologues (Eichinger et al., 
2005). Examples of research related to human diseases where Dictyostelium 
has previously been used as a model organism, include studies to 
characterise the molecular mechanism of drug action in bipolar disorder and 
epilepsy treatment (Boeckeler et al., 2006; Eickholt et al., 2005; Ludtmann et 
al., 2011; Teo et al., 2009; Williams et al., 1999, 2002; Xu et al., 2007), 
research into the molecular mechanism of Alzheimer’s disease (Ludtmann et 
al., 2014; McMains et al., 2010), research into taste perception and to assess 
emetic liability (Cocorocchio et al., 2015; Robery et al., 2013, 2011), as a 
model for human mitochondrial diseases (Francione et al., 2011), and in 
studies of cell growth and differentiation (Escalante and Vicente, 2000; 
Maeda, 2005). 
Changes in inositol levels can be studied in Dictyostelium or yeast 
(S.cerevisiae), where the expression of the ino1 gene is regulated by the 
intracellular level of inositol (Shaltiel et al., 2004; Shetty and Lopes, 2010; 
Steger et al., 2003; Williams et al., 2002). In such experiments, mutagenesis 




can also be applied to study inositol depletion. For instance, a library of 
random mutants can be created in Dictyostelium by restriction enzyme 
mediated mutagenesis (REMI), where an insertional cassette is introduced 
into cells and is integrated into the genome at frequently occurring restriction 
enzyme sites, and  mutants are selected based on the antibiotic resistance 
present in the cassette (Kuspa and Loomis, 1994). Genes identified using 
such techniques can be further examined for their role in inositol signalling 
and the inositol depleting effects produced by drug treatment. A reduction of 
cellular inositol in Dictyostelium cells can be reversed by the addition of 
inositol to the growth medium, since cells are able to take up inositol from 
extracellular sources (Fischbach et al., 2006). Discoveries into the mode of 
action of inositol depleting drugs have been made using these methods in 
Dictyostelium, thus validating this organism as a suitable biomedical model 
for the research into inositol depletion effects on a cell (Williams, 2009; 
Williams et al., 2002).  
1.7 Dictyostelium development 
In addition to a role as a basic biomedical model, Dictyostelium is also 
widely used to study multicellular development. In the wild, Dictyostelium 
undergoes development following starvation (Eichinger et al., 2005) (Figure 
1.6). In the presence of a food source, Dictyostelium lives as a single-celled 
amoeba. During an onset of environmentally unfavourable conditions, such 
as a lack of nutrients, cells start to release pulses of the extracellular 
chemical cyclic adenosine monophosphate (cAMP), which is sensed by 
neighbouring cells (Chisholm and Firtel, 2004). The cAMP signal is then 
propagated by cells and initiates intracellular events that lead to chemotactic 
cell movement. Cells chemotax towards each other to form aggregates that 
via a number of developmental stages differentiate into a multicellular 
structure called a fruiting body. The fruiting body is a multicellular organism 
that contains spores held aloft by dead, vacuolated stalk cells (Loomis, 
2014). When conditions are favourable, spores germinate to release the 
single–celled amoebae (Eichinger et al., 2005). 




This developmental process is completed within 24 hours, and is 
sensitive to intracellular inositol changes (Fischbach et al., 2006), as well as 
exposure to inositol-depleting drugs (Williams et al., 2002). This process can 
be artificially stimulated in the laboratory by plating the cells onto a substrate 
without nutrients, like agar plates or nitrocellulose filters. Thus, this makes 
Dictyostelium a simple eukaryotic model organism that can be used to study 
cell and developmental biology (Adley et al., 2006).  
Figure 1.6 Multicellular development of Dictyostelium discoideum. Depletion of 
nutrients triggers the developmental program, where starving Dictyostelium cells aggregate 
to form mounds, and then differentiate into fruiting bodies. In the aggregation stage, cells 
interact forming streams that migrate toward an aggregation centre to form aggregates (8-10 
hours). The aggregates elongate to form structures called first fingers (12-13 hours). At this 
stage of development, cells differentiate into anterior prestalk and posterior prespore cells in 
a motile multicellular slug. The slugs further differentiate into structures called culminants 
and then into a fruiting body (Chisholm and Firtel, 2004). This process takes 24 hours, and 
the mature fruiting body comprises a basal disk, a stalk and a sorus (the spore head), which 
contains spores that can be dispersed. Upon germination, amoebae emerge to resume a 
single-celled existence. 
Inositol signalling is involved in a number of cellular processes that 
can be investigated using Dictyostelium as a model organism. The following 
paragraphs describe an involvement of inositol derivatives, phosphoinositides 
and inositol phosphates, in cell motility (chemotaxis), cell polarity, cell 




adhesion, cytokinesis, and autophagy processes, which can be assayed in 
Dictyostelium.  
1.8 Chemotaxis 
Chemotaxis is an essential part of the early phase of Dictyostelium 
development, when cells deprived of nutrients release cAMP, thus 
stimulating surrounding cells to migrate towards the aggregation centre, 
which is a point source from where this chemical is being released. To 
efficiently chemotax, cells must be able to sense the chemoattractant and 
relay the signal within the cell to trigger the events that lead to cytoskeletal 
rearrangement, allowing for cell orientation and movement towards the 
source of the chemoattractant. Important aspects of chemotaxis thus include 
initiating morphological changes to induce cell polarity and the maintenance 
of the directionality of movement.  
Detection of a cAMP signal initiates intracellular signalling via the 
activation of cyclic AMP receptor 1 (cAR1), a G-protein coupled receptor, 
which then transmits the signal to downstream effectors initiating forward 
movement (Stephens et al., 2008). Stimulation of cAR1 activates 
phosphatidylinositol-3-kinase (PI3K), target of rapamycin complex 2 (TORC2) 
and phospholipase A2 (PLA2) (Figure 1.7). Activated PI3K phosphorylates 
PIP2 into PIP3, while phosphatase and tensin homologue (PTEN) 
dephosphorylates PIP3 back into PIP2. PTEN is located at the rear end of 
the cell leading to a decrease in the level of PIP3 in the posterior end of the 
cell to create a PIP3 gradient (Stephens et al., 2008). The accumulation of 
PIP3 at the leading edge of migrating cells initiates a translocation of a family 
of pleckstrin homology (PH) domain-containing proteins which act as 
effectors of PIP3 and play important roles in chemotaxis (Stephens et al., 
2008). These proteins include PhdA (PH-domain containing protein A), which 
is involved in the initiation of F-actin polymerisation, and cytosolic regulator of 
adenylate cyclase (CRAC) and PkbA (PKB-related) proteins, which 
propagate the release of intracellular cAMP via the activation of adenylate 
cyclase (AC) (Huang et al., 2003; Insall et al., 1994; Lilly and Devreotes, 




1995). Dictyostelium cells also chemotax in the absence of PIP3 gradients 
(when a strong gradient of chemoattractant was used) suggesting that there 
are other mechanisms of cell directionality during chemotaxis, which may 
involve sensing TORC2 and PLA2 (Hoeller and Kay, 2007). TORC2 is 
involved in F-actin polymerisation at the leading edge of the cell during 
PKB/RasG signalling (Charest et al., 2010; Kamimura et al., 2008; King and 
Insall, 2008). PLA2 has been shown to regulate chemotaxis by elevating 
calcium levels in cells via the conversion of membrane phospholipids to 
lysophospholipids and arachidonic acid, leading to calcium release (King and 
Insall, 2009).  
Figure 1.7 Regulation of chemotaxis in Dictyostelium. In Dictyostelium, chemotaxis is 
controlled by extracellular cAMP binding to the cAR1 receptor, and the partially redundant 
pathways involving PI3K, TORC2 and PLA2. The PI3K pathway is regulated by PLC via 
PIP2 and PTEN. The TORC2 pathway activates F-actin polymerisation via RasG signalling. 
The PLA2 pathway is dependent on fatty acid release triggering increased calcium levels. In 
steep chemoattractant gradients, these pathways are dispensable, however, in shallow 
chemoattractant gradients, the PI3K pathway is crucial for efficient chemotaxis. Red arrows 
indicate enzymatic reactions. Abbreviations: PL, phospholipids; Lyso-PL, lyso-phospholipids; 
PLA2, phospholipase A2; Gαβγ, heterotrimeric G protein; cAR1, cAMP receptor 1; PI3K, 
phosphatidylinositol-3-kinase; TORC2, target of rapamycin complex 2; PTEN, phosphatase 
and tensin homologue; PLC, phospholipase C; IP3, inositol trisphosphate; PIP2, 
phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate. After 
Kölsch et al. (2008). 
 
 




1.9 Phosphoinositides in cell polarity and cell adhesion 
Phosphoinositides are important for cellular processes determining 
cell polarity and adhesion. Multiple signalling pathways have been proposed 
to control patterns of cell polarity through a feedback loop mechanism (King 
and Insall, 2009). In Dictyostelium, Ras proteins present at the leading edge 
of cells can be rapidly activated by cAMP binding to cAR1, driving the 
polarisation of PIP3 distribution (Sasaki et al., 2004). However, in 
Dictyostelium cells, polarised PI3K signalling and subsequent morphological 
changes in the absence of G-proteins have also been shown, suggesting that 
cellular polarity can be maintained independently of cAR1/heterotrimeric G 
protein signalling (Sasaki et al., 2004). Regardless, PIP3 remains an 
important molecule in Dictyostelium chemotaxis, and although it does not 
exclusively dictate directionality of movement, it’s functional importance 
highlights the importance of its precursor, inositol, in the events leading to 
cell movement. 
Reorganization of the actin cytoskeleton is crucial for cell motility, 
chemotaxis, and adhesion. Actin-binding proteins and membrane lipids, 
especially PIP2 and PIP3, are involved in this process, where some actin-
binding proteins interact with, or are regulated by, phosphoinositides (Wu et 
al., 2014). For example, PIP2 activates Talin, a protein that binds to β-
integrins to enhance cell adhesion (Figure 1.8). PIP2 also activates WASp 
family proteins, which in turn activate the Arp2/3 complex proteins that are 
involved in actin filament assembly during chemotaxis (Pollitt and Insall, 
2009; Wu et al., 2014), and the actin-depolymerizing factor (ADF)/cofilins, 
which coordinate organization of actin filament assembly and disassembly 
(Bamburg and Bernstein, 2010). PIP3 activates various guanine nucleotide 
exchange factor proteins that regulate small GTP-binding proteins such as 
Rho, Rac, Ras and Cdc42 (Wu et al., 2014). In neutrophils, PIP3 has been 
associated with actin polymerisation via Rho GTPases (Figure 1.9). PIP3 has 
been also implicated in determining cell polarity during movement (King and 
Insall, 2009). Together PIP2 and PIP3 play important roles in actin 
cytoskeleton organisation, including cell movement, adhesion and 




cytokinesis, and alterations of phosphoinositol levels have been linked to 
diseases related to cell migration, like cancer (Wu et al., 2014). 
 
Figure 1.8 Regulation of actin binding proteins by PIP2. PIP2 regulates cell function via 
actin-binding proteins such as ERM proteins, Talin, SCAR/WAVE/WASP and ADF/cofilin. (A) 
The presence of PIP2 and phosphorylation of ERM (Ezrin-Radixin-Moesin) membrane–actin-
tethering proteins lead to an activation of the ERM complex. The activated ERM proteins 
bind to F-actin filaments. In Dictyostelium, a protein called enlazin, which is a natural fusion 
of an ERM family protein and the actin cross-linker fimbrin, contributes to cell adhesion and 
cortical mechanics (Octtaviani et al., 2006). (B) Integrin proteins bind to Talin, which in turn 
binds to actin, increasing cell adhesion events. (C) PIP2 activates the WASp proteins 
SCAR/WAVE, leading to Arp2/3 complex activation and actin branch formation on the inside 
of the cell membrane (Pollitt and Insall, 2009). (D) The actin-depolymerising factor 
(ADF)/cofilins integrate transmembrane signals to coordinate the spatial and temporal 
organization of actin filament assembly/disassembly (Bamburg and Bernstein, 2010). 
Inactive cofilin remains bound to PIP2 at the plasma membrane. Dissociation of cofilin from 
PIP2 increases severing of actin filaments. Adapted from Wu et al. (2014). 




Figure 1.9 Activation of actin filament assembly by PIP3. Activation of actin filament 
assembly occurs by transient production of PIP3, activating Rho GTPase, a member of the 
family of guanine nucleotide exchange factors (GEFs). The pathway starts with PI3K 
activation, which leads to the accumulation of activated Rac (Rac-GTP). Adapted from Wu et 
al. (2014). 
1.10 Cytokinesis 
Phosphoinositides also play role in processes leading to cell 
cytokinesis, an essential cellular function enabling cells to divide into two 
daughter cells. Cytokinesis is a sequential process occurring in three stages: 
assembly of the cytokinetic apparatus, furrow progression and fission 
(scission) of the newly-formed daughter cells (Uyeda and Nagasaki, 2004) 
(Figure 1.10). In Dictyostelium, the first step involves microtubules of the 
mitotic spindle initiating the position of a division plane where the cleavage 
furrow will form. The next step involves the ingression and severing of the 
cleavage furrow. The process of ingression involves accumulation of myosin 
II in the furrow and the constriction of an equatorial actomyosin ring, where 
an increased level of PIP2 is necessary for furrow stability (Brill et al., 2011a; 
D’Avino et al., 2005). Dictyostelium also uses other myosin II-independent 
methods to induce the furrowing of the equatorial ring. These alternative 
cytokinesis events occur when cells are adhered to a substrate, and one of 
these is cell-cycle coupled (Knecht and Loomis, 1987; Nagasaki et al., 2002; 
Uyeda and Nagasaki, 2004; Zang et al., 1997). Mechanistically, these two 
cytokinesis processes are different. During myosin II-dependent cytokinesis, 




cells detach from the substrate and become more round with a V-shaped 
contractile ring. By contrast, during myosin II-independent cell division, cells 
are flat and remain attached to a substrate throughout the cleavage furrow 
separation and have a U-shaped contractile ring. Ingression of the equatorial 
ring occurs as a result of two opposing traction forces generated by the two 
polar leading edges of an adherent cell (Uyeda and Nagasaki, 2004). Wild-
type cells utilise both methods of cytokinesis during normal growth on a solid 
substrate, where cells initially detach forming the V-shaped contractile ring, 
re-spread and attach to a substrate to complete the division (Uyeda and 
Nagasaki, 2004). The third form of cytokinesis is also linked to a cell-
substrate interaction, and relies on an extension of the part of the cell where 
the leading edge pulls away from the centre of a cell, leaving a long tail of 
cytoplasm behind that eventually leads to cell separation (Hibi et al., 2004). 
Thus, myosin and actin contractile ring are required to provide the force 
necessary for the separation of a dividing cell, and the disruption of either 
actin or myosin components has a severe impact on cytokinesis. 
Dictyostelium myosin II mutants are however still able to separate when cells 
are attached to a substrate. 




Figure 1.10 Cytokinesis in Dictyostelium. Three forms of cell division are presented here. 
(A) Myosin II-dependent cell division relies on myosin accumulation in the cleavage furrow, 
initiating the constriction of the actin contractile ring. (B) Myosin II-independent cell division 
relying on the opposite polar traction forces to separate the cleavage furrow. This type of cell 
division was observed in myosin II null cells, and can only occur on a substrate but not in 
suspension. (C) Another form of myosin II-independent cell division where the leading edge 
of a cell is pull away from the centre of the cell, tearing the cell apart. Adapted from Uyeda 
and Nagasaki (2004).  
1.11 Autophagy 
Inositol metabolism has been associated with macroautophagy (Criollo 
et al., 2007; Sarkar et al., 2005; Toker and Agam, 2014; Vicencio et al., 
2009). Macroautophagy (hereafter referred to as autophagy) is a process 
triggered by stress conditions, for example nutrient starvation, to promote cell 
survival; however, it can sometimes lead to cell death (Denton et al., 2012). 
Although autophagy is not usually associated with programmed cell death, it 
is typically involved in the death of cells during development of an organism 
(Denton et al., 2012).  During autophagy cells digest cellular components via 
the activity of enzymes that originate in lysosomes. It is a highly regulated 
catabolic process that comprises a number of steps: induction, 




autophagosome nucleation, expansion and completion, lysosome fusion, 
degradation and recycling (Figure 1.11).  
Figure 1.11 Autophagosome formation in eukaryotic cells. The induction of 
autophagosome formation starts with Atg1 that localises to the membrane sac generated 
from the pre-autophagosomal structure (isolation membrane). An autophagy-specific Vps34 
PI3-kinase complex I assists in the nucleation of the forming autophagosome. The complex 
is essential for the recruitment of the Atg8-phosphatidylehanolamine (Atg8-PE) conjugate 
and the Atg12-Atg5 conjugate to the pre-autophagosomal structure. Atg8-PE remains at the 
autophagosome membrane even after autophagosome maturation. Autophagosome 
maturation involves elongation, completion and fusion with endosome structures. These 
steps are essential for the subsequent fusion with lysosomes. The final steps of autophagy 
involve degradation and recycling of the engulfed cellular material. 
The autophagy-related gene-1 (Atg1) complex is responsible for the 
activation of autophagy. The nucleation of newly-formed vesicles happens 
upon the activation of class-III phosphatidylinositol-3-kinase (Vps34), Beclin-
1/Atg6, and several other proteins, which recruit lipids and proteins for the 
formation of autophagosomes (Chen and Klionsky, 2011; Denton et al., 2012; 
Mizushima et al., 2002). Following nucleation, the vesicles are elongated and 
completed by the ubiquitin-like proteins that modulate conjugation of the Atg8 
protein to the lipid phosphatidylethanolamine (PE), and assembly of an 
Atg12/Atg5 complex, which then assists in the binding of Atg8-PE to the 
autophagosome membrane (Chang and Neufeld, 2010; Chen and Klionsky, 
2011; Yang and Klionsky, 2010). The Atg12/Atg5 complex is highly 




conserved among eukaryotes, and the conjugation of Atg12 to Atg5 
resembles ubiquitination reactions, where the C-terminal glycine of Atg12 is 
covalently attached by an isopeptide bond to lysine 130 of Atg5 (Mizushima 
et al., 2002). Atg8 is present on the elongating vesicle membrane and 
remains on the autophagosomal membrane after autophagosome formation 
is completed (Mizushima et al., 2002). The final step of autophagosome 
formation is the fusion of autophagosomes with lysosomes. Proper function 
of microtubules, an acidification of autophagosomes, and the fusion with 
endosomes are essential steps allowing for the fusion with lysosomes 
(Kovács et al., 1982; Yamamoto et al., 1998). The significance of the 
endosome fusion events remains unclear; however, it has been shown that a 
perturbation of endosome function leads to an accumulation of 
autophagosomes that cannot fuse with lysosomes (Nara et al., 2002). 
Dictyostelium cells rely on autophagy during starvation conditions and 
development (Giusti et al., 2009; Kosta et al., 2004; Luciani et al., 2011; Otto 
et al., 2004, 2003). Nutrient starvation and cAMP induce autophagy in 
Dictyostelium, while the presence of the differentiation factor DIF-1, acting as 
a secondary signal, triggers programmed cell death; a process that is 
essential for proper development of this organism (Luciani et al., 2011).  
An increased number of autophagosomes has been found in many 
human diseases, including degenerative diseases of the muscle and the 
nervous system like amyotrophic lateral sclerosis (ALS), Alzheimer's disease, 
Parkinson's disease, and Huntington's disease (Wong and Holzbaur, 2015). 
These diseases are characterised by an accumulation of misfolded proteins 
that failed to be degraded via the ubiquitin-proteasome system (Mizushima et 
al., 2002).  
1.12 Aims of this work 
 Inositol signalling plays vital role in cell homeostasis and its 
dysregulation has been implicated in various diseases, including 
neurodegenerative and metabolic diseases. Cellular processes such as 
development, cell movement, cytokinesis and autophagy relate to inositol 




regulation and are the subject of current research. Various yeast mutants 
impaired in inositol production have been demonstrated to rely on exogenous 
inositol for survival. In Dictyostelium, inositol depletion has been shown to 
decrease cell growth and to inhibit development (via the action of inositol 
depleting drugs). Molecular targets affected by a change in inositol levels are 
however still not fully identified. 
 This thesis investigates the mechanism and the consequences of 
inositol depletion in Dictyostelium cells with the use of molecular biology, lipid 
analysis, metabolomic and proteomic approaches. I also examine the 
characteristics and cellular functions of Ino1 protein and inositol depletion 
using the following strategies: 
 Identification and characterisation of the potential homologue of 
inositol biosynthetic enzyme, Ino1, in Dictyostelium  
 Genetic manipulation of the ino1 gene in Dictyostelium and the 
generation of the ino1 knock-out mutant 
 Analysis of the effects of inositol depletion and the Ino1 loss on cell 
function in Dictyostelium 
 Characterisation of cellular roles of the Ino1 protein, including growth 
effects resulting from a mutation in the enzyme catalytic core, the 
effects of inositol depleting drugs on the development of Dictyostelium 
ino1 mutants, and identification of the Ino1 protein-protein interaction






Chapter 2  
Materials and Methods 
  




Chapter II  
Materials and Methods 
2.1 Materials 
2.1.1 Reagents obtained from Sigma-Aldrich Ltd (Poole, England) 
2-Propanol, 4′,6-Diamidino-2-phenylindole 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (DAPI), acrylamide (30% solution), ammonium persulfate 
(APS), bacteriological agar, β-mercaptoethanol, caffeine, cyclic adenosine 
monophosphate (cAMP), dithiothreitol (DTT), ethylenediaminetetraacetic acid 
(EDTA), ethylene glycol tetraacetic acid (EGTA), Fluorescein Diacetate 
(FDA), Fluoromount Aqueous Mounting Medium, horse serum, sodium 
dodecyl sulphate (SDS), Luria-broth (LB) tablets, magnesium chloride, 
Nonidet-P40 (NP40), Tween 20, phenylmethylsulfonyl fluoride (PMSF), 
potassium chloride, sucrose, phosphatase inhibitor tablets (PhosStop, 
Roche), propidium iodide (PI), protease Inhibitor Cocktail Tablets (cOmplete 
ULTRA Tablets, Mini, Roche), sodium chloride, sodium dihydrogen 
phosphate (NaH2PO4), sodium fluoride, sodium orthovanadate, sodium 
phosphate dibasic (Na2HPO4), N,N,N′,N′-Tetramethylethylenediamine 
(TEMED), trizma base; Triton-100, TruPAGE Precast Gels, TruPAGE LDS 
Sample Buffer.  
2.1.2 Reagents obtained from other suppliers 
Agarose, deoxynucleotide trisphosphates (dNTPs) (Bioline, London, 
England); Ethidium bromide (Bio-Rad Laboratories, Hemel Hampstead, 
England); Axenic (Ax) medium, SM medium, LoFlo medium (ForMedium, 
Hunstanton, England); Imperial Protein Stain with Coomassie dye R-250, 
6xLoading dye (Fermentas); NuPage MOPS buffer, NuPage Transfer buffer, 
NuPage SDS-polyacrylamide gel (Invitrogen), Tris-borate-EDTA (TBE), 10x 
glycine buffer (ThermoFisher Scientific, Loughborough, England); ethanol, 
dipotassium hydrogen phosphate (K2HPO4), glycerol, acetic acid, acetone, 




bromophenol blue, chloroform, dimethyl sulfoxide (DMSO), glucose, 
hydrochloric acid, isopropyl β-D-1-thiogalactopyranoside (IPTG), methanol, 
paraformaldehyde (PFA), potassium dihydrogen phosphate (KH2PO4), 
sodium hydroxide (VWR International Ltd., Lutterworth, England). 
2.1.3 Antibiotics 
Ampicillin (Sigma-Aldrich Co. Ltd., Poole, England); Blasticidin, 
penicillin/streptomycin (Pen/Strep) solution x100 (PAA Laboratories Ltd. 
Yeovil); Hygromycin, Geneticin (G418) (Invitrogen, part of ThermoFisher 
Scientific, Loughborough, England). 
2.1.4 Molecular weight standards 
GeneRuler 100 bp and 1 kb DNA Ladder (0.1 µg/µl); PageRuler Plus pre-
stained protein ladder (ThermoFisher Scientific, Loughborough, England). 
2.1.5 Restriction enzymes 
All restriction enzymes were obtained from ThermoFisher Scientific 
(Loughborough, England) and New England Biolabs (UK) Ltd. (Hitchin, 
England). 
2.1.6 Other enzymes 
RNase A, DNase (Sigma-Aldrich Co. Ltd., Poole, England); BIOTaq 
polymerase (Bioline, London, England); Q5 High-Fidelity PCR polymerase 
(New England Biolabs (UK) Ltd., Hitchin, England); Phusion High-Fidelity 
PCR polymerase (ThermoFisher Scientific, Loughborough, England); Calf 
Alkaline Phosphatase (CIAP) (Promega UK, Southampton, England). 
2.1.7 Antibodies 
GFP rat [3H9] monoclonal antibody, GFP Trap agarose beads, RFP mouse 
[6G6] monoclonal antibody, RFP rat [5F8] monoclonal antibody, RFP Trap 
agarose beads (ChromoTek GmbH, Germany); IRDye 800 Goat Anti-Rat, 
IRDye 800 Goat Anti-Mouse (Licor Bioscience Ltd., Nebraska, USA); mouse 
monoclonal anti-FLAG M2 antibody (Sigma-Aldrich Ltd., Poole, England). 
 





QIAfilter Plasmid Maxi Kit and MiniElute PCR purification kit (QIAgen Ltd, 
Crawley, West Sussex, UK); GenElute HP Plasmid Midiprep and Maxiprep 
kit, GenElute PCR Clean-Up Kit (Sigma-Aldrich Co. Ltd., Poole, England); 
High Pure RNA Isolation kit (Roche, West Sussex, England); DNase treated 
with DNA-free kit (Ambion supplied by Invitrogen, part of ThermoFisher 
Scientific, Loughborough, England); First Strand cDNA Synthesis kit, Pierce 
BCA Protein Assay Kit, TOPO® TA Cloning kit (ThermoFisher Scientific, 
Loughborough, England); β-Galactosidase Enzyme Assay System with 
Reporter Lysis Buffer (Promega UK, Southampton, England). 
2.1.9 Bacterial strains 
TOP10 chemically-competent E.coli, chemically-competent JM107 E.coli 
(Invitrogen, part of ThermoFisher Scientific, Loughborough, England); 10β-
competent cells (New England Biolabs (UK) Ltd., Hitchin, England); 
Raoultella planticola (lab-made stock). 
2.1.10 Primers (Table S1, supplementary material) 
Custom-made oligonucleotides were purchased from MWG-Biotech AG 
(Eurofins) (Germany) or Sigma-Aldrich Co. Ltd. (Poole, England). 
2.1.11 Equipment 
Bio-Rad gel casting system, Bio-Rad wide mini-sub cell electrophoresis 
system, Gel Doc XR system, GenePulser Xcell electoporator (Bio-Rad 
Laboratories, Hemel Hempstead, England); GeneFlash gel documentation 
system (Syngene Bio-Imaging); 505Di peristaltic pump (Watson Marlow); 
centrifuge (Biofuge 13, Jencons); microcentrifuge (ThermoFisher Scientific, 
Loughborough, England); PeqSTAR 2x thermocycler, PeqSTAR 96 Universal 
thermocycler, 4mm EP cuvettes (PEQLAB Ltd. Portsmouth, England); 
Odyssey Infrared Imaging System (Li-cor Biosciences, Nebraska, USA); 
Olympus IX71 microscope (U-RFL-T laser, 482nm emission, Olympus 
UPlanFL 60x oil immersion objective with NA 1.25) with an QImaging 
RetigaExi Fast1394 digital camera. 





2.2.1 Bioinformatic analysis 
Dictyostelium Ino1 protein homologues were identified in other species 
by performing the Basic Local Alignment Search Tool (BLAST) using the 
engine from the National Centre for Biotechnology Information site (NCBI). 
The BLAST search options were optimised for more dissimilar sequences 
(discontinuous megablast). The search parameters were as follows: program 
= BLASTP 2.2.25; matrix = blosum62; threshold = 0.01. The BLAST search 
was performed within the ‘non-redundant’ (‘nr’) database of nucleic acid 
collection, which allowed for any given sequence within this database to 
appear only once, thus minimising possible duplications. Discontinuous 
megablast option allowed for cross-species comparisons. 
Phylogenetic analysis and evolutionary history were acquired with the 
MEGA program, version 5, using the neighbour-joining method with 500 
bootstrap replicates (Tamura et al., 2011). The Phyre2 (Protein 
Homology/analogY Recognition Engine V 2.0) (Kelley et al., 2015) and the 
Conserved Domain Database (CDD) (NCBI) (Marchler-Bauer et al., 2014) 
engines were used to obtain the information regarding the structure and 
conserved functional domains in the human and Dictyostelium Ino1 and the 
Q54IX5 proteins. 
2.2.2 Dictyostelium discoideum methods  
2.2.2.1 Cell culture 
Dictyostelium discoideum cells were stored at -80ºC as spores in 1x 
sterilised phosphate buffer KK2 (16.2 mM KH2PO4, 4 mM K2HPO4) or as 
cells frozen in horse serum containing 7% DMSO. Every four weeks, 
Dictyostelium frozen stock cells were plated onto plates containing SM agar 
(Sigma) and 300 µl live Raoutella planticola, and incubated at 22 °C until 
visible plaques formed. Liquid plates were prepared with the cells collected 
from the growth zone of the SM agar plate and incubated in Ax medium 
(ForMedium), with 100 µg/ml penicillin and 100 µg/ml streptomycin at 22 °C. 




The ino1- mutant cells were grown in the presence of 10 µg/ml blasticidin S 
with 500 μM inositol. Cell lines transformed with extrachromosomal plasmids 
(389-2, pTX, pDdGal) were cultured in the presence of 50 µg/ml hygromycin 
(Invitrogen) or at least 10 µg/ml geneticin (G418) (Invitrogen).  Cells were 
maintained in tissue culture plates or shaking (120 rpm) at 22 °C and 
harvested in mid-log phase (4x106 cells/ml).   
2.2.2.2 Growth  
Dictyostelium cells that were grown in tissue culture dishes were washed 
twice with buffer KK2 (16.2 mM KH2PO4, 4 mM K2HPO4) and counted using 
haemocytometer. 1x105 cells per sample per repeat were incubated in 10 ml 
aliquots in a 150 ml conical flask. Cells were shaken at 22 °C for 5 to 7 days 
and cell density was calculated daily using haemocytometer counts at the 
same time of the day. 
2.2.2.3 Viability  
Fluorescein Diacetate (FDA) dye (Sigma) was used to stain live 
cells. FDA is a non-fluorescent compound that is cleaved by metabolically 
active cells into a green fluorophore. Adherent cells were washed once in 
KK2 (16.2 mM KH2PO4, 4 mM K2HPO4). FDA concentrated stock (10 mg/ml 
in acetone) was added to cells in KK2 to reach a final concentration of 0.05 
mg/ml. Cells were incubated in the dark for 10 minutes at room temperature. 
Following the incubation, the cells were washed twice in KK2 and viewed 
under the Olympus IX71 microscope (Zeiss filter set 09: BP 450-490, FT 510, 
LP 515) to observe green fluorescence. 
Propidium iodide (PI) dye (Sigma) was used to stain the nuclei of 
dead cells. PI dye reaches the nucleus by passing through the damaged 
plasma membrane of dead cells, and intercalates in the DNA double helix of 
the cell. Adherent cells were washed once in KK2 (16.2 mM KH2PO4, 4 mM 
K2HPO4). PI was added to cells in KK2 to a final concentration of 4 µM. Cells 
were incubated in the dark for 10 minutes at room temperature. Following the 
incubation, the cells were washed twice in KK2 and viewed under the 




Olympus IX71 microscope (Zeiss filter set 09: BP 450-490, FT 510, LP 515) 
to observe red fluorescence. 
2.2.2.4 Development  
Dictyostelium developmental phenotypes were analysed using filter 
assays (Boeckeler et al., 2006; Williams et al., 2002). Cells growing in 
shaking suspension (120 rpm) in Ax medium (ForMedium) were counted 
using a haemocytometer, and 1x107 cells were harvested. Cells were 
washed twice in KK2 (16.2 mM KH2PO4, 4 mM K2HPO4) and evenly 
distributed on a 47 mm nitrocellulose filter soaked in KK2 (Millipore, USA), 
which was then placed on an absorbent pad saturated with KK2 or KK2 
mixed with a drug. The filter was incubated for 24 hours at 22 °C in a moist 
environment. Development images were captured with the use of a 
dissection microscope (Leica) and a QImaging RetigaExi Fast1394 digital 
camera. 
2.2.2.5 Chemotaxis 
Dictyostelium chemotaxis was analysed using a Dunn chamber 
(Hawksley, Sussex, UK) assay (Zicha et al., 1991). Dictyostelium cells 
growing in shaking suspension (120 rpm) in Ax media (ForMedium) were 
counted using a haemocytometer and 1x107 cells were harvested. Cells were 
washed twice in KK2 (16.2 mM KH2PO4, 4 mM K2HPO4), centrifuged, re-
suspended in 6 ml KK2 and placed in a 100 ml conical flask at 22 ºC to be 
pulsed for 5 hours with cAMP (90 ml KK2 + 3 µl 200 mM cAMP). Following 
that, cells were centrifuged, washed twice in KK2, re-suspended in 1 ml KK2 
(1x107 cells/ml), and placed on ice. 25 µl of cells were transferred to a cover 
slip and allowed to adhere for 5-10 minutes. 22 µl of KK2 was placed to the 
inner well and 36 µl to the outer well of a cleaned and dried Dunn chamber, 
ensuring that KK2 surrounded the whole cell. The coverslip with cells was 
inverted and placed on top of the Dunn chamber, ensuring that no bubbles 
were present in the inner well of the Dunn chamber. KK2 buffer was drained 
from the outer well using 3MM absorbent paper cut into small triangles. The 
Dunn chamber was sealed in place with Vaseline. 70 µl of 5 µM cAMP (1 µl 
200 mM stock in a serial 1:40 and 1:1000 dilution) was added to the outer 




well of the Dunn chamber, and incubated in a moist chamber for 30 minutes. 
Following the incubation, images of chemotaxing cells were recorded every 
15 seconds over a 12-minute period, using Olympus IX71 microscope 
(objective 40x) with a QImaging RetigaExi Fast1394 digital camera. 
2.2.2.6 Cell adhesion 
Dictyostelium cells were grown in culture dish plates in Ax media 
(ForMedium). Cells were washed twice in KK2 (16.2 mM KH2PO4, 4 mM 
K2HPO4), counted using a haemocytometer and 1x10
5 cells/ml were plated 
into each well of 6-well plates containing 2 ml of growth medium. After 24 
hours the medium was gently removed with an aspirator, cells were re-
suspended using a pipette, and an aliquot of cells was immediately taken out 
and placed on ice. Cells were counted using a haemocytometer. The 
counting procedure was repeated every 24 hours for 7 days. 
2.2.2.7 Cytokinesis 
  A single round slide (stored in 80% ethanol) was placed into each well 
of a 12-well tissue culture plate. Each well was washed twice with 1 ml sterile 
distilled water. Approximately 5x106 cells re-suspended in 0.5 ml of KK2 (16.2 
mM KH2PO4, 4 mM K2HPO4) were placed into each well. Cells were left to 
adhere for 30 minutes, prior to being washed in KK2 with gentle aspiration to 
remove the liquid. Cells were fixed with 1 ml of ice cold methanol for 5 
minutes in the -20 °C freezer. Each well was washed once with KK2 and 
DAPI (Sigma) was added (1:250 dilution of 2 µg/ml DAPI in KK2), and 
incubated for 5 minutes at room temperature in the dark. Following the 
incubation, DAPI was replaced with ddH2O and 12.5 µl of mounting medium 
(Fluoromount Aqueous Mounting Medium, Sigma) was placed onto a 
microscope slide. The coverslip with cells was placed onto the drop of 
mounting medium, and dried in the dark overnight at room temperature. DAPI 
fluorescence was visualised using an Olympus IX71 microscope (oil objective 
60x) with a QImaging RetigaExi Fast1394 digital camera. The number of 
cells having 1, 2, 3, or more nuclei was counted using ImageJ v1.46a 
software, and the percentage relative to the total number of cells for a given 




sample was counted. Three independent experiments were conducted. Over 
350 cells were counted per condition. 
2.2.2.8 Autophagy 
Autophagy was measured in ino1- cells transformed with the atg8-GFP 
construct (Otto et al., 2003) (dictybase.org). Cells were grown in Ax medium 
(ForMedium) with shaking (120 rpm) for 72 hours (- inositol condition had 
inositol removed for 24 hours prior to the experiment), with 16 hour 
incubation in LoFlo medium (ForMedium) to reduce the background 
autofluorescence. The cells were viewed using an Olympus IX71 microscope 
(60x objective with oil) with a QImaging RetigaExi Fast1394 digital camera to 
record green fluorescence. The number of autophagosomes was counted 
and the cell surface area was measured using ImageJ v1.46a software. 
Three independent experiments were conducted; between 117 and 180 cells 
were analysed per condition. 
2.2.3 Molecular biology methods 
2.2.3.1 Polymerase chain reaction (PCR) 
DNA was amplified by polymerase chain reaction (PCR) with the 
following conditions: 2 µl DNA, 2 µl 2 mM dNTPs, 2 µl NH4 BioTaq reaction 
buffer, 1 µl MgCl2, 0.5 µl BioTaq DNA polymerase (5 U/µl), 2 µl forward and 2 
µl reverse primer (10 pmol). PCR amplification with other DNA polymerases 
(Q5 and Phusion) was set up according manufacturer’s instructions. 
The PCR amplification was set up according to the following cycling 
conditions: initial denaturation at 95 °C for 10 minutes, 30 cycles of 
denaturation at 95 °C for 30 seconds, annealing at 56 °C (temperature 
depending on primer melting points) for 45 seconds, extension at 72 °C with 
the time dependent on the length of the product being amplified (one minute 
per 1,000 base pairs), followed by the final extension at 72°C for 10 minutes. 
DNA samples were then stored at 4°C for short-term or -20°C for long-term 
storage.   
 




2.2.3.2 Agarose gel electrophoresis 
Gel electrophoresis was used to separate and visualise DNA using 1% 
agarose gels containing 30 µg/ml ethidium bromide (Sigma) and TBE buffer 
(89 mM Tris base / 89 mM Borate/ 2 mM EDTA pH 8.3 ±0.1). 5 µl of DNA 
were mixed with 1x DNA loading dye. The gel was run for 40 minutes to 1 
hour at 100-110 V (depending on the size of the gel) and visualised using the 
GeneFlash gel documentation system (Syngene Bio Imaging). 
2.2.3.3 Bacterial transformation 
Chemically-competent cells (JM107 E.coli) were used for the 
transformations during DNA cloning procedures. Agar plates were prepared 
from sterile LB agar medium (according to Sigma’s protocol) with added 
ampicillin (Sigma) at a concentration 100 µg/µl. 30 ml of the agar media was 
poured into a 90 mm Petri dish and allowed to set. Bacteria were thawed on 
ice. 10 µl of DNA ligation reaction was added to 50 µl of competent cells. The 
cells were incubated with DNA on ice for 30 minutes, and then heat-shocked 
for 30-second at 42 °C (water bath or heat block), followed by immediate 
transfer to ice, where the cells remained for 2 minutes. 250 µl of room 
temperature LB medium was added to the cells and incubated at 37 °C for 1 
hour. After incubation, the cells were plated onto the agar plates and 
incubated at 37 °C overnight. 
2.2.3.4 Plasmid preparation 
Plasmids that were used for sequencing or cloning procedures were 
purified from bacterial transformants using the Qiagen QIAfilter or Sigma 
GenElute plasmid kits, according to manufacturer’s instructions. 
Plasmid minipreps that were not performed with commercial kits were 
prepared as follows: 2 ml of an overnight E.coli culture was harvested for 3 
minutes at 4,000 rpm. The pellet was re-suspended in 200 µl of buffer P1 (50 
mM Tris-Cl pH 8.0, 10 mM EDTA, 50 µg/ml RNase A), and lysed with 200 µl 
of buffer P2 (200 mM NaOH, 1% w/v SDS). Following 5-minute incubation at 
room temperature, 200 µl of buffer P3 (3M potassium acetate pH 5.5) was 
added, mixed with the sample by inversion, and incubated on ice for 5 




minutes. After the incubation, samples were centrifuged at 17,000 g for 10 
minutes to pellet the cell debris. The supernatant was transferred to a new 
1.5 ml microcentrifuge tube, and the plasmid DNA was precipitated with 0.7 
volumes of isopropanol, followed by centrifugation at 17,000 g for 10 
minutes. The pellet was washed with 600 µl of 70% ethanol, and centrifuged 
at 17,000 g for 5 minutes. The pellet was air dried to remove residual 
ethanol, and DNA was re-suspended in ddH2O. 
2.2.3.5 Construction of the knock-out vector (Figure 2.1 A) 
PCR was used to amplify two gene fragments inside the open reading 
frame of the ino1 gene using Ax2 genomic DNA as a template. PCR products 
were purified using the GenElute PCR Clean-Up Kit (Sigma) or QIAquick spin 
PCR purification kit (Qiagen) protocol. The pLPBLP vector used to construct 
the ino1 knock-out cassette contained the blasticidin-S deaminase gene 
conferring resistance to the blasticidin antibiotic (Faix et al., 2004). The 
pLPBLP vector and the gene fragments were double-digested with 
appropriate restriction enzymes before each fragment was separately cloned 
into the vector. Double digests were performed with BamHI/PstI for the 5’ 
fragment and NcoI/KpnI for the 3’ fragment for 2 hours at 37 °C. Prior to 
cloning each fragment in, the double-digested pLPBLP vector was treated 
with 1 µl of Calf Intestinal Alkaline Phosphatase (CIAP) (1 U/µl) and 
incubated for 1 hour at 37 °C. CIAP was inactivated at 65 °C for 20 minutes. 
Digested PCR products and pLPBLP vector were purified using GenElute 
PCR Clean-Up Kit (Sigma) or QIAquick spin PCR purification kit (Qiagen 
Ltd., UK), and ligated together using 1 µl T4 DNA ligase (1 U/µl) at different 
ratios of insert:vector (10:1 and 20:1). The ligation reactions were incubated 
at room temperature for 1 hour, and then the ligase was inactivated at 65 °C 
for 20 minutes. The constructs were transformed into chemically-competent 
JM107 E.coli cells and the DNA from the resultant colonies tested for the 
presence of an insert by a double-digest with restriction enzymes that were 
used in the cloning steps. The second fragment was inserted using the same 
methodology. Plasmid DNA with confirmed insertion of both gene fragments 
was processed with QIAfilter Plasmid Maxi prep kit (Qiagen) according to the 




manufacturer’s protocol. Correct sequence of the knock-out cassette was 
verified by gene sequencing. 
Figure 2.1 Schematic of the ino1 gene knock-out and screening procedure. (A) 5’ and 
3’ ino1 gene fragments were amplified from gDNA of wild-type cells (Ax2) using PCR and 
cloned into the knock-out vector (pLPBLP) at multiple cloning sites (MCS) 1 and 2 to create 
a knock-out cassette. The blasticidin resistance gene was oriented in the opposite direction 
to the cloned ino1 fragments (the orientation of the genes is indicated by the arrows). The 
knock-out cassette was excised from the knock-out vector and transformed into 
Dictyostelium Ax2 cells. Homologous recombination allowed for the creation of an ino1 
knock-out mutant with a disrupted ino1 gene. (B) Correct transformants were identified by a 
PCR screen. The primers used for the screening procedure are shown, where (G)enomic, 
(V)ector and (K)nock-(O)ut primer combinations were designed for the 5’ and 3’ sites of the 
ino1 gene to confirm the correct integration of the knock-out cassette into the Dictyostelium 
genome.   




2.2.3.6 Transformation of Dictyostelium by electroporation 
The knock-out fragment containing blasticidin resistance cassette was 
excised from the pLPBLP plasmid using 5 µl of KpnI (10 U/µl) and 5 µl of 
BamHI (10 U/µl) restriction enzymes. The digested construct (20 µg) was 
precipitated with isopropanol, and resuspended in sterile water at 1 μg/µl. 
1x107 Dictyostelium Ax2 cells were chilled on ice for 10 minutes followed by 
one wash with 10 ml KK2 buffer and two washes with 10 ml electroporation 
(EP) buffer (10 mM sodium phosphate buffer pH 6.1, 50 mM sucrose). The 
pellet was re-suspended in 700 μl EP buffer, transferred to a 0.4 cm cuvette 
together with 20 µl of previously digested DNA (1 μg/µl), and incubated on 
ice for 10 minutes. The cells were electroporated with a Bio-Rad GenePulser 
Xcell electroporator using 1 pulse, 850V, 25uF, resistance ∞ and incubated 
on ice for 10 minutes. After this incubation, 8μl of 100mM CaCl2 and 8μl of 
100mM MgCl2 were added to the cuvette, and further incubated at room 
temperature for 15 minutes, prior to the cells being transferred into 10 ml Ax 
medium (ForMedium) containing penicillin/streptomycin (100x). 100 μl of the 
culture was transferred into each well of a 96-well plate. After 24 hours, 100 
μl Ax medium (ForMedium) containing blasticidin was added to each well to a 
final concentration of 10 µg/ml. 
2.2.3.7 Overexpression of fluorescently-tagged proteins 
Overexpression plasmids containing N-terminal GFP and N-terminal 
FLAG (pTX) and pDXA-3H-Hyg were obtained from dictybase.org; the 
plasmid containing C-terminal RFP (389-2) was kindly provided by Dr 
Annette Müller-Taubenberger. The plasmids were transformed into JM107 
E.coli competent cells (Sigma) and prepared with QIAfilter Plasmid Maxi prep 
kit (Qiagen) according to manufacturer’s protocol. Ax2 genomic or 
complementary DNA was used as a template to PCR amplify (with Q5 High-
fidelity DNA polymerase, NEB Biolabs) the ino1, gpmA, secG, pefB and 
Q54IX5 genes. PCR products were purified using the GenElute PCR Clean-
Up Kit (Sigma) or QIAquick spin PCR purification kit (Qiagen), and digested 
with the following the restriction enzymes: ino1: EcoRI and BamHI to clone 
into 389-2 plasmid, BamHI and XbaI to clone into pTXGFP, SacI and XbaI to 
clone into pDXA-3H-Hyg (removing 3H sequence); gpmA: SacI and XhoI to 




clone into pTXGFP and pTXFLAG; secG: SacI and XbaI to clone into 
pTXGFP and pTXFLAG; pefB: BamHI and XbaI to clone into pTXGFP and 
pTXFLAG; Q54IX5 : BamHI and XbaI to clone into pTXGFP and pTXFLAG. 
Digested products were purified with GenElute PCR Clean-Up Kit (Sigma) or 
QIAquick spin PCR purification kit (Qiagen) and ligated to a selected plasmid 
using T4 DNA ligase (Fermentas) according to the supplier’s protocol. 
Correct sequences were verified by gene sequencing. 10-20 µg of the 
plasmid DNA was transformed by electroporation in Dictyostelium Ax2 or 
ino1- mutant cells. The transformants were selected with 10 µg/ml geneticin 
or 50 µg/ml hygromycin for approximately two weeks. Correct transformants 
were analysed using an Olympus IX81 microscope with FV1000 confocal 
laser (HeNe laser, 543 nm emission, Olympus UPLSAPO 60x oil immersion 
objective).  
2.2.3.8 DNA extraction from transformants 
Recombinants growing in 96 well plates in medium containing 
blasticidin were screened for homologous integration by genomic DNA 
extraction and PCR amplification. Genomic DNA was extracted as follows: 
200 µl of the cell suspension was collected from individual wells and 
transferred into a 1.2 ml PCR tube, centrifuged for 3 minutes at 1,500 g, and 
the cell pellet was re-suspended in 48 µl of the lysis buffer (50 mM KCl, 10 
mM Tris pH 8.3, 2.5 M MgCl2, 0.45% Nonidet P 40, 0.45% Tween 20) and 2 
μl Proteinase K (822 U/ml) (Fermentas). The samples were incubated for 5 
minutes at room temperature followed by 1 minute incubation at 95 °C. 5 µl 
of the extracted DNA was used in the PCR screening protocol. 
2.2.3.9 Screening for ino1- homologous recombinants 
Screening for ino1- homologous recombinants was performed using 
PCR with primers (Table S1) designed to detect whether the ino1 knock-out 
cassette was inserted correctly into the ino1 locus in the Dictyostelium 
genome. Three primer sets were used to screen for the knock-out cassette: 
knock-out construct, vector control and genomic control. The primer set for 
the knock-out construct included one primer outside the knock-out cassette, 
in the genomic DNA, and one primer in the blasticidin resistance cassette. 




The vector control primer set included one primer within the knock-out DNA 
fragment and the blasticidin resistance cassette. The genomic control primer 
set included one primer outside the knock-out cassette, in the genomic DNA, 
and one primer in the blasticidin resistance cassette (Figure 2.1 B). The 
correct transformants were serially diluted using 96-well plates to select for 
an isogenic cell line.  
2.2.3.10 RNA extraction and RT-PCR analysis 
1x107 cells were harvested and washed twice with KK2 (16.2 mM 
KH2PO4, 4 mM K2HPO4) buffer. RNA was extracted using High Pure RNA 
Isolation Kit (Roche Applied Science), DNase treated with DNA-free™ Kit 
(Ambion), and cDNA was synthesised with First Strand cDNA Synthesis Kit 
(Fermentas) using 1 µg of RNA and Oligo(dT)18 primers according to 
manufacturer’s instructions. 2 µl of the cDNA was used in the subsequent 
PCR amplification, as described in the polymerase chain reaction section 
above (2.2.3.1). 
2.2.4 Proteomics analysis 
2.2.4.1 SDS-PAGE  
(sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
Loading buffer (2X) was made according to the following recipe: 1.6 ml 
2 M Tris pH 6.8, 6 ml 80% glycerol, 10 ml 10% SDS, 2.5 ml β-
mercaptoethanol, ddH2O, bromophenol blue. Running buffer (10X) was made 
according to the following recipe: 75 g Tris base, 360 g glycine, 250 ml of 
10% SDS solution, made up to 2.5 l with ddH2O; 2M Tris pH 8.8; 2 M Tris pH 
6.8. 
TruPAGE Precast Gels (Sigma) or NuPage SDS-polyacrylamide gel 
(Invitrogen) were used for SDS-PAGE gel electrophoresis with the supplier’s 
recommended buffers. Gels used that were not from commercially available 
sources were prepared as follows: resolving gel (7%): 2.25 ml acrylamide, 
1.9 ml Tris pH 8.8, 5.65 ml ddH2O, 200 μl 10% SDS, 100 μl 10% ammonium 
persulphate (APS) in ddH2O, 10 μl tetramethylethylenediamine (TEMED); 




stacking gel: 2.55 ml acrylamide, 0.94 ml Tris pH 6.8, 11.25 ml ddH2O, 150 μl 
10% SDS, 150 μl 10% APS in ddH2O; 15 μl TEMED.  
Protein samples to analyse by gel electrophoresis were prepared by 
boiling cell pellets at 95°C (for standard protein detection 1x107 cells were 
used) for 10 minutes in 2X loading buffer. 5 μl of Page Ruler Plus Prestained 
Protein Ladder (Fermentas) per well was used as a molecular marker. The 
gel was run at 200 volts in running buffer for 1 -1.5 hours, or as specified by a 
manufacturer.   
2.2.4.2 Western blot analysis 
Proteins separated by SDS-PAGE were transferred to PVDF 
membrane (Immobilon-FL Transfer Membrane). PVDF membrane was 
activated by saturation in methanol. Blotting paper (3 MM), sponges and the 
activated membrane were soaked in transfer buffer (1 X ETB made fresh with 
100 ml 10 X ETB (75 g Tris base; 360 g glycine; 25 ml 10% SDS), 100 ml 
methanol and 800 ml ddH2O). The transfer block was prepared in a tank kept 
on ice, filled with the transfer buffer, and run at 400 mA for 1 hour.  
To visualise the proteins, the membranes were immunostained with 
appropriate antibodies. The membrane soaked in 5% milk in PBST (1X PBS, 
1% Tween 20) buffer was gently rocked for 1 hour at room temperature. 
Following the incubation, the primary antibody, mouse or rat anti-RFP 
monoclonal antibody, rat anti-GFP monoclonal antibody (ChromoTek) or anti-
FLAG M2 monoclonal antibody (Sigma), was added at a 1:1000 dilution in 
the milk buffer (5% milk in 1X PBS with 1% Tween 20) and incubated 
overnight at 4 °C with gentle rocking. The membrane was rinsed in 1X PBS 
(10X stock: 14.4 g Na2HPO4, 80 g NaCl, 2 g KCl, 2.4 g KH2PO4, made up to 
1l with ddH2O, pH 7.4) and the excess primary antibody was washed off with 
3 x 10 minute washes in PBST (PBS, 1% Tween 20). The secondary 
antibody, IRDye 800 goat anti-rat or goat anti-mouse  (Li-cor Biosciences), 
was added to the membrane at a 1:2000 dilution in 5% milk in PBST (1X 
PBS, 1% Tween 20) buffer, and incubated at room temperature for 1 hour 
with gentle rocking. The membrane was rinsed in PBS followed by with 3 x 




10 minute washes in PBST. The immunostaining was visualised with the 
Odyssey Infrared Imaging System (Li-cor Biosciences). 
2.2.4.3 Immunoprecipitation 
Aggregation-competent cells were washed with KK2 (16.2 mM 
KH2PO4, 4 mM K2HPO4), re-suspended at a density of 3-4 x10
8 cells/ml in 
KK2, and shaken for 20 minutes at 250 rpm with 2.5 mM caffeine. The cells 
were then centrifuged and the pellet was lysed (0.5 % NP40, 40 mM Tris-
HCl, 20mM NaCl, 5 mM EGTA, 5 mM EDTA, 10 mM DTT, 1 mM PMSF, 2X 
protease cocktail inhibitor and 2X phosphatase inhibitor (Roche)). Cell 
lysates were incubated with RFP-Trap or GFP-Trap agarose beads 
(ChromoTek) for 1 hour at 4°C with gentle agitation. The beads were 
collected and washed twice with the IP wash buffer (10 mM Tris-HCl, 150 
mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 2X protease cocktail inhibitor and 2X 
phosphatase inhibitor (Roche)). Immunocomplexes were dissociated from 
the beads by incubating samples at 95 °C for 10 minutes, followed by 
centrifugation to collect the beads. The immunoprecipitated proteins were 
separated by SDS-PAGE and analysed by Western blot analysis, or stained 
with Commassie blue (Pierce) stain and analysed by mass spectrometry 
(MS). MS analysis was conducted by S. Lilla and Prof R. Insall (Beatson 
Institute, Glasgow).  
2.2.5 Metabolomics analysis 
Dictyostelium discoideum Ax2 and ino1- strains were grown at 22 °C in 
shaking (120 rpm). Additional samples of Ax2 cells that were used as a 
control were grown in the presence of 500 µM myo-inositol. Ino1- cells were 
cultured in medium containing 500 µM myo-inositol and 10 µg/ml blasticidin. 
Inositol was removed from the growth medium for 12 and 24 hours, and the 
cells growing in inositol were washed twice in KK2 (16.2 mM KH2PO4, 4 mM 
K2HPO4), and re-suspended in medium without inositol. After 24 hours of 
inositol starvation, 500 µM myo-inositol was added to the growth medium. 
Samples for the nuclear magnetic resonance (NMR) spectroscopy analysis 
were prepared with 2 x 107 cells. The cells were washed twice in KK2 and 
the pellets were freeze-dried. 




NMR spectrometry (conducted by Dr S P Claus and C. Le Roy, 
University of Reading) was performed as follows: freeze-dried cell pellets 
were re-suspended in 1 ml of Water/Methanol (1:2) and vortexed for polar 
metabolite extraction. Samples were centrifuged at 2,400 g for 5 minutes and 
supernatants were dried in a vacuum concentrator for 4.5 hours at 45°C. 
Dried samples were re-suspended in 80 μl of phosphate buffer (in 90 % D2O 
and 0.05 % sodium 3-(tri-methylsilyl) propionate-2,2,3,3-d4 (TSP) as a 1H 
NMR reference). 50 μl of the solution was transferred into 1.7 mm capillary 
NMR tubes. Spectra were acquired at 300 ºK on a Bruker Avance DRX 700 
MHz NMR Spectrometer (Bruker Biopsin, Rheinstetten, Germany) operating 
at 700.19 MHz and equipped with a CryoProbe from the same manufacturer. 
All spectra were acquired using a 1-dimensional noesy pulse sequence 
[recycle delay – 90º - t1 – 90º - tm – 90º - acquire free induction decay (FID)] 
with water suppression applied during RD of 2 s, a mixing time (tm) of 100 
ms and a 90º pulse set at 7.70 μs. For each spectrum, 512 scans were 
accumulated over a spectral width of 9803.9 Hz, and all FIDs were multiplied 
by a broadening line function of 0.3 Hz prior to Fourier transformation. All 
spectra were manually phased, baseline-corrected and calibrated to the TSP 
standard at δ 0.000 using the software MestReNova (version 10.0.1, 
Mestrelab Research S.L., Spain). 
2.2.6 Lipid analysis 
Dictyostelium discoideum Ax2 and ino1- strains were grown at 22 °C in 
shaking culture (120 rpm). Additional samples of Ax2 cells that were used as 
a control were grown in the presence of 500 µM myo-inositol. Ino1- cells were 
cultured in medium containing 500 µM myo-inositol and 10 µg/ml blasticidin. 
Inositol was removed from the growth medium for 12 and 24 hours, and the 
cells growing in inositol were washed twice in KK2 (16.2 mM KH2PO4, 4 mM 
K2HPO4), and re-suspended in medium without inositol. After 24 hours of 
inositol starvation, 500 µM myo-inositol was added to the growth medium. 
Samples for the mass spectroscopy analysis were prepared with 1.7 x 106 
cells. The cells were washed twice in KK2 and the pellets were freeze-dried. 




Glycerophospholipid levels were analysed by mass spectroscopy, as 
previously described (Clark et al., 2014) (conducted by Dr J. Clark and Dr P. 
Hawkins, Babraham Institute, Cambridge). 
2.2.7 Fluorescence microscopy 
To analyse protein localisation, cells producing fluorescently-tagged 
proteins were cultured in Ax medium (or for ino1- cells in Ax2 medium 
containing 500 µM inositol and 10 µg/ml blasticidin), washed twice in KK2 
(16.2 mM KH2PO4, 4 mM K2HPO4), and allowed to adhere to a glass 
coverslip before being visualised with an Olympus IX71 microscope (U-RFL-
T laser, 482 nm emission, Olympus UPlanFL 60x oil immersion objective with 
NA 1.25) with an QImaging RetigaExi Fast1394 digital camera and 
ImagePro6.3 software.  
2.3 Software 
Phylogenetic analysis was performed using Mega, version 5 (Tamura 
et al., 2011). Statistical analysis was performed using Prism 5, version 5.02 
(GraphPad Software, Inc.). Microscopy images were captured and 
chemotaxis data was analysed using ImagePro Plus, version 6.3 (Media 
Cybernetics, Inc.). Number of nuclei, autophagosomes and cell size was 
analysed using ImageJ v1.46a (developed by Wayne Rasband, National 
Institutes of Health). Mass spectrometry data was analysed using Scaffold3 
(Proteome Software, Inc.). 
2.4 World-wide web references 
Dictyostelium gene and protein information: http://dictybase.org/  
       http://www.uniprot.org/  
BLAST: http://www.ncbi.nlm.nih.gov/BLAST/ 
http://dictybase.org/tools/blast  
Protein domain analysis: 
Phyre2: http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index  
CDD:  http://www.ncbi.nlm.nih.gov/cdd  
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Chapter III  
Bioinformatic analysis of Ino1 
3.1 Introduction 
Inositol-3-phosphate synthase (Ino1) UniProt ID Q54N49 is a key 
enzyme in the inositol and phosphoinositide synthesis pathway. Ino1 
catalyses the first and rate-limiting step in the biosynthesis of all inositol-
containing compounds, converting glucose 6-phosphate to inositol 3-
phosphate (Seelan et al., 2004) (Figure 3.1). The proposed biochemical 
process involves an oxidation, enolisation, intramolecular aldol cyclisation, 
and reduction steps (Jin et al., 2004). Nicotinamide adenine dinucleotide 
(NAD+) is used as a cofactor by Ino1.  
Figure 3.1 Inositol signalling. Ino1 enzyme converts glucose 6-phosphate to inositol 3-
phosphate, which is a rate-limiting step in inositol production.  
Ino1 has been cloned from and characterised in a variety of 
evolutionarily distinct organisms including yeast, plants, flies, humans, 
Archaebacteria, and bacteria (Majumder et al., 2003). The structure and 
catalytic activity of Ino1 was studied in yeast, humans, C.elegans and various 
bacterial species (Abreu and Aragão, 2007; Bachhawat and Mande, 1999; 
Dean-Johnson and Henry, 1989; Lohia et al., 1999; Majumder et al., 1997; 




Norman et al., 2002; Park et al., 2000; RayChaudhuri et al., 1997; Seelan et 
al., 2009a; Stein and Geiger, 2002). These studies showed that Ino1 forms 
homotetramers or trimers and its monomer is composed of a NAD-binding 
domain, a catalytic region, and N- and C-terminal domains (Stein and Geiger, 
2002). Amino acids located in the vicinity of the active site in the catalytic 
region are disordered in the unbound form of the Ino1 enzyme. The folding of 
this domain is nucleated upon substrate binding, leading to an encapsulation 
of the bound substrate (Stein and Geiger, 2002).  
The Ino1 protein and the gene encoding it are ancient in origin 
(Majumder et al., 2003). Comparing Ino1 proteins from distinct biological 
species revealed that prokaryotic and eukaryotic proteins group separately, 
and that Ino1 proteins from eukaryotes shared a high degree of similarity, 
with conserved stretches of amino acids (Majumder et al., 2003). Prokaryotic 
Ino1 proteins diverged from their eukaryotic counterparts early in evolution 
and became quite divergent, whereas eukaryotic Ino1 proteins remained 
quite stable during their evolution (Majumder et al., 2003). This study further 
revealed that plant Ino1 proteins were of monophyletic origin, and that the 
Ino1 proteins of fungi contained an extra stretch of amino acids at the N-
terminus that was specific to this group. Despite the difference between 
prokaryotic and eukaryotic Ino1 proteins, the Ino1 catalytic core has been 
remarkably evolutionarily conserved (Majumder et al., 2003). 
In this chapter, bioinformatic analysis of the inositol-3-phosphate 
synthase (Ino1) protein from Dictyostelium discoideum is described. To gain 
a more detailed understanding of the structural characteristics of Ino1 and its 
evolutionary conservation, BLAST analysis, sequence alignment to infer 
protein homology, and phylogenetic and domain structure analysis were 
performed and are discussed here. 
3.2 Domain and structure analysis of Dictyostelium Ino1 
 To better understand the function of the Dictyostelium Ino1 protein, the 
identity and evolutionary conservation of its domains were researched. The 
Phyre2 web portal (Kelley et al., 2015), and the Conserved Domain Database 




(CDD) (accessible from NCBI webpage) (Marchler-Bauer et al., 2014, 2002), 
were used to search for structural information about Dictyostelium Ino1 and 
to identify the conserved functional domains (CDs) within the protein. The 
CDD is a compilation of multiple sequence alignments representing protein 
domains that are conserved in molecular evolution (Marchler-Bauer et al., 
2002). The CDD tool operates by comparing protein sequences to models of 
protein families (as opposed to other single sequences) accessed from Pfam 
or SMART databases to investigate patterns of conservation and divergence 
in molecular evolution (Marchler-Bauer et al., 2002). A CDD search with the 
term “Ino1” showed that the protein belonged to a conserved NAD_binding_5 
domain superfamily (accession: cl00554; PSSM ID: 260495). Also, using the 
Conserved Domain Architecture Retrieval Tool (CDART) (Geer et al., 2002) 
with the query term: Q54N49 (Dictyostelium Ino1 UniProt ID), showed that 
Dictyostelium Ino1 belongs to a conserved NAD_binding_5 domain 
superfamily that is present in 4,553 proteins in cellular organisms. The 
Phyre2 web portal was used to perform structural analysis of Ino1. This 
search confirmed the presence of four domains in the Ino1 monomer: an 
NAD-binding domain, characterised by a Rossman fold typical of an 
oxidoreductase (Kleiger & Eisenberg, 2002), C-terminal and N-terminal 
domains, and an inositol synthase (catalytic) site (Figure 3.2). 





Figure 3.2 Domain positioning in the Dictyostelium Ino1 monomer. The structure of 
Dictyostelium Ino1 protein was modelled using Protein Homology/analogy Recognition 
Engine V2.0 (Phyre
2
), the NCBI protein database, and literature searches. Dictyostelium 
Ino1 (DDB_G0285505) contains 511 amino acids and the presence of the tetramerisation 
domain suggests that it forms multimers. (A) The structure of the Ino1 monomer with 
individual regions coloured as follows: green, the N-terminal region; purple, the NAD-binding 
domain; red, the catalytic or tetramerisation region; blue, the C-terminal region. The N- and 
C-termini, along with residues from the NAD-binding domain, form a close association. Upon 
binding of monomers to each other, the catalytic regions would be sequestered in the core of 
the protein multimer. (B) Domain positioning in Dictyostelium Ino1 protein along with 
approximate amino acid residue numbers. 
3.3 BLAST analysis 
 BLAST analysis of the Dictyostelium Ino1 protein (DDB_G0285505) 
against all sequenced genomes was performed using the NCBI PSI-BLAST 




engine. This analysis revealed the presence of potential homologues across 
various biological kingdoms. The top Ino1 homologues from a range of 
species are presented (Table 3.1), using a selection of proteins with >50% 
sequence identity, similar protein length, and an e-value <10-40, as previously 
suggested (Eichinger et al., 2005). BLAST analysis revealed that 
Dictyostelium Ino1 was homologous to Ino1 proteins from a large variety of 
species, including plants and brown algae (the highest identity was to 
common tobacco Ino1), vertebrates (the highest identity was to frog and 
salmon Ino1), insects, fungi, and bacteria (Table 3.1). This remarkable 
degree of evolutionary conservation illustrates the importance of inositol 







Q54N49 Dictyostelium discoideum (Social amoeba) 511 100 0 
Q9LW96 Nicotiana tabacum (Common tobacco) 510 67 0 
D8LQB3 Ectocarpus siliculosus (Brown alga) 533 66 0 
C4PW34 Arabidopsis thaliana (Mouse-ear cress) 511 66 0 
Q41107 Phaseolus vulgaris (Kidney bean) 511 65 0 
P42802 Citrus paradisi (Grapefruit) 507 64 0 
Q7ZXY0 Xenopus laevis (African clawed frog) 563 63 0 
B5X3P3 Salmo salar (Atlantic salmon) 551 62 0 
D6WV33 Tribolium castaneum (Red flour beetle) 526 62 0 
Q9JHU9 Mus musculus (Mouse) 557 59 1.00E-177 
O97477 Drosophila melanogaster (Fruit fly) 565 59 1.00E-175 
Q6AYK3 Rattus norvegicus (Rat) 557 59 1.00E-175 
Q9NPH2 Homo sapiens (Human) (isoform 1) 558 58 1.00E-176 
Q2NL29 Bos taurus (Bovine) 557 58 1.00E-174 
P90626 
Entamoeba histolytica (Anaerobic parasitic 
protozoan) 
508 56 1.00E-168 
P11986 Saccharomyces cerevisiae (Baker's yeast) 533 53 1.00E-153 
P42800 Candida albicans (Ascomycete fungus) 520 52 1.00E-152 
Table 3.1 Homology search results (BLAST analysis) identifying proteins related to 
Dictyostelium Ino1 (EC 5.5.1.4) in other species. The UniProt accession numbers are 
indicated. Protein length refers to the number of amino acid residues. The identity is given as 
a percentage relative to Dictyostelium discoideum Ino1. The E-value indicates statistical 
significance of a given pairwise alignment and is a reflection of the size of the database and 
the scoring system used. Lower E-values indicate greater significance of the homology. 
 




3.4 Phylogenetic analysis 
 A phylogenetic tree to show the evolutionary conservation of the Ino1 
proteins was constructed using the Molecular Evolutionary Genetics Analysis 
(MEGA) 5 software, with a neighbour-joining method and 500 bootstrap (the 
number of resampling analyses) replications to assess the reliability of the 
nodes (Tamura et al., 2011) (Figure 3.3). The tree also included human and 
A.thaliana peptidyl-prolyl isomerases as outgroups, to represent proteins that 
are outside the Ino1 protein family but that are still isomerases. The 
phylogenetic tree showed that all the Ino1 proteins from the group of species 
analysed were more closely related to each other than they were to the 
outgroup (Figure 3.3). The first node on the tree had a bootstrap value of 52, 
and it separated the Ino1 proteins of bacterial and eukaryotic origins. The 
second node had a bootstrap value of 100, and it showed that Ino1 proteins 
of fungal origin formed a distinct group to those of other eukaryotes. 
Dictyostelium discoideum Ino1 protein falls within the same group as that of 
brown algae, consistent with the close similarity of these proteins. 
Dictyostelium Ino1 was also present on the same node as Ino1 from other 
eukaryotic species, although it was separate from the higher animals (like 
human or frog Ino1) or plants (like maize or A.thaliana). Overall, this 
phylogenetic analysis showed that eukaryotic Ino1 proteins are distinct from 
Ino1 proteins present in prokaryotes, and that Dictyostelium Ino1 protein is 
more closely related to Ino1 proteins from higher organisms than it is to the 
fungal Ino1 proteins. 





Figure 3.3 Phylogenetic analysis of Ino1 proteins from different biological kingdoms. 
Bootstrap consensus tree showing the evolutionary relationship between the Ino1 proteins of 
Dictyostelium and other species. The tree was generated in the Molecular Evolutionary 
Genetics Analysis (MEGA) 5 program via the Neighbour-Joining method with 500 bootstrap 
replications applied to assess the reliability of the nodes. Numbers represent percentage of 
replicate trees in which the associated taxa clustered together. Human and A.thaliana 
peptidyl-prolyl isomerases (EC 5.2.1.8) denote the root of the tree. 
 3.5 Homology alignment 
 A portion of the catalytic region of Dictyostelium Ino1 (amino acids 
283-454) protein was aligned to the corresponding amino acid sequence of 
the Ino1 protein from other species (Figure 3.4). The alignment showed a 
high degree of amino acid conservation in this region, confirming the 
evolutionary relatedness of Dictyostelium Ino1 to other Ino1 proteins. Further 
homology analysis was performed with a comparison of Dictyostelium Ino1 
(Q54N49) to the three human Ino1 (Q9NPH2) isoforms, and this analysis 
again showed a high degree of similarity between the proteins (Figure 3.5). 
Human Ino1 isoform 3 lacks the N-terminal portion present in the other 
proteins in this alignment; otherwise, all three human Ino1 isoforms are 
nearly identical. Aligning human Ino1 isoform1 with Dictyostelium Ino1 




showed strong sequence homology, with 58% identity and 83% similarity 
(Figure 3.6). 
 
Figure 3.4 Conservation of the Ino1 catalytic region. Multiple sequence alignment of the 
putative active site regions of Ino1 proteins from different species show highly conserved 
amino acid residues that were considered to be important for Ino1 activity. The names of the 
species used in the alignment are indicated on the left, along with the amino acid position 
numbers. Identical amino acids are marked by an asterisk and highlighted in dark grey. The 
multiple sequence alignment was conducted using the UniProt website. 





Figure 3.5 Homology between human Ino1 isoforms and Dictyostelium Ino1. Multiple 
sequence alignment of the human and Dictyostelium Ino1 proteins showing similarity in the 
amino acid residues, from the top: human Ino1 isoform 2, isoform 3, isoform 1, Dictyostelium 
Ino1. Identical amino acids are marked by an asterisk and highlighted in dark grey; similar 
amino acids are marked by a colon. The multiple sequence alignment was conducted using 
the UniProt website. 






Figure 3.6 Homology between human and Dictyostelium Ino1 proteins. Sequence 
alignment of the human (isoform1) (top sequence) and Dictyostelium (bottom sequence) 
Ino1 proteins, showing similarity in the amino acid residues. Identical amino acids are 
marked by an asterisk and highlighted in dark grey; similar amino acids are marked by a 
colon. The proteins were 58% identical and 83% similar. The sequence alignment was 
conducted using the UniProt website. 
 The homology between human and Dictyostelium Ino1 isoform 1 
proteins was analysed in more detail, where Dictyostelium (Q54N49) and 
human (Q9NPH2-1) protein sequences were compared, in view of the amino 
acid conservation seen in the Ino1 proteins from other species (Figure 3.7). 
The proteins were of similar size (511 amino acids for Dictyostelium Ino1 and 
558 amino acids for human Ino1) and showed common conserved domains, 
including NAD-binding and catalytic domains. These conserved domains 
were also present in Ino1 proteins from a variety of biological species, 




suggesting a highly conserved catalytic role of Ino1 throughout evolution and 
supporting the use of Dictyostelium to analyse Ino1 function.  
 
Figure 3.7 Conservation of the Ino1 protein between Dictyostelium and humans. (A) 
Sequence homology between the human isoform 1 (Q9NPH2-1) and Dictyostelium 
(Q54N49) Ino1 is present throughout the proteins. Identical amino acids are represented as 
dark vertical lines. The NAD-binding (orange) and catalytic (red) domains are among the 
regions that are highly conserved in eukaryotic Ino1 proteins; the other regions are 
highlighted in blue, green and purple. The tetramerisation domain containing the putative 
catalytic region (with the conserved amino acid residues SYNHLGNNDG) is shown in red. 
The amino acids that were ablated in Dictyostelium Ino1 are marked by a dark horizontal bar 
( ). (B) Alignment of the conserved regions of Ino1 proteins from various species, 
where ‘*’ denotes identity, ‘:’ high conservation, ‘.’ low conservation.  
3.6 Discussion 
 Proteins are composed of domains, which are mobile units that define 
protein function and are subject to genetic modifications throughout 
molecular evolution. In Saccharomyces cerevisiae, the active Ino1 protein is 
a homotetramer (Stein and Geiger, 2002). The crystal structure of 
S.cerevisiae Ino1 shows that the N- and C-terminal portions of the Ino1 
monomer are in close proximity and make most of the contacts between the 
monomers (Stein and Geiger, 2002). Ino1 uses NAD+ as a co-factor 




(Majumder et al., 1997). The NAD-binding domain, positioned between the 
N-and C-terminal regions, also protrudes into the cleft between these 
regions. The active site of the enzyme is formed by substrate binding, which 
nucleates its own complete encapsulation (Stein and Geiger, 2002). The 
catalytic region additionally provides a tetramerisation interface during the 
assembly of multimers (Stein and Geiger, 2002). The presence of these 
domains in the Ino1 protein was previously reported in a number of distinct 
biological species (Majumder et al., 2003). Through the domain analysis, 
Dictyostelium Ino1 was shown to contain an evolutionarily conserved 
catalytic region, an NAD-binding domain, and N- and C-terminal domains that 
are structurally positioned as previously described (Stein and Geiger, 2002); 
these features are indicative of the same mechanism of action of the enzyme 
as in other species. 
 To establish the relatedness of Dictyostelium Ino1 with that of other 
species, the Basic Local Alignment Search Tool was used. This search 
identified a number of potential Ino1 homologues from a variety of species, 
including mammals (human, mouse, bovine), plants (Arabidopsis thaliana, 
maize, tobacco), frog (Xenopus laevis), fish (salmon), fly (Drosophila 
melanogaster), protozoa (Leishmania major) and yeast (Saccharomyces 
cerevisiae). The expectation value (E) threshold was used as a measure to 
verify whether the homology match is likely to be significant.  The e-value is 
the number of expected matches in a random database, where the lower the 
e-value, the more likely is the match to be significant. The top potential 
Dictyostelium Ino1 homologues, with the highest e-value (0), were the 
proteins from plants (tobacco, A.thaliana, kidney bean, and grapefruit), brown 
alga, frog (X.laevis) and salmon. All of these Ino1 homologues were over 
60% identical to Dictyostelium Ino1. Human Ino1 protein had an e-value of 
10-176 and was 58% identical to Dictyostelium Ino1, supporting the close 
homology of these two proteins.  
 The biosynthesis of inositol is an evolutionarily conserved pathway 
(Majumder et al., 2003), and since Ino1 is responsible for the biosynthesis of 
inositol, a phylogenetic tree was constructed to better understand the 




evolutionary relationship of the Dictyostelium Ino1 protein to that of other 
organisms. A phylogenetic tree shows the evolutionary relationship between 
groups of organisms called taxa. The ends on the tree branches represent 
groups of descendent taxa, which are often separate species, and the nodes 
on the tree are the common ancestors of the descendants. All the Ino1 
proteins grouped together, separately from the tree outgroup (peptidyl-prolyl 
isomerase), which is an enzyme from the same family of proteins (an 
isomerase), supporting the evolutionary relatedness of the Ino1 protein 
homologues from prokaryotes and eukaryotes. The grouping of Ino1 proteins 
separately from the outgroup was validated by the bootstrap value of 98. 
Bootstrapping is a resampling analysis that involves removing amino acids in 
the Ino1 protein at random from the analysis, rebuilding the tree, and testing 
if the same nodes are recovered. Dictyostelium discoideum Ino1 protein was 
found to group with the Ino1 protein homologues from higher organisms, 
including human. This finding is in agreement with the data obtained during 
the Ino1 BLAST analysis, validating the evolutionary conservation between 
Dictyostelium and other eukaryotic Ino1 proteins.  
 The evolutionary relatedness of Ino1 in archaeal (T.gammatolerans) 
and eukaryotic species (including Dictyostelium, yeast, plants and mammals) 
was not well supported by the phylogenetic analysis, as indicated by a low 
bootstrap value (52) (Hillis and Bull, 1993). Although Ino1 proteins from 
archaea, eubacteria and cyanobacteria most likely evolved independently 
from each other, and the Ino1 proteins are quite divergent in the prokaryotic 
species, a number of archaeal proteins remain similar to the eubacterial 
proteins (Majumder et al., 2003). Thus, despite the fact that the archaeal and 
eukaryotic Ino1 proteins are evolutionarily distinct, a higher homology in 
certain regions of the Ino1 proteins could have affected the poor split on the 
phylogenetic tree (Majumder et al., 2003). Also, the low homology observed 
between Dictyostelium and yeast Ino1 proteins is reflected in the 
phylogenetic tree, where the yeast Ino1 protein grouped separately from the 
Ino1 proteins from other eukaryotes, as previously reported (Majumder et al., 
2003).  




 Sequence homology was studied by aligning amino acids that 
constitute part of the putative catalytic region of the INO1 proteins. Potential 
homologues of Dictyostelium Ino1 from different taxa showed a remarkable 
conservation of the amino acids in the catalytic region, corroborating the 
notion that Ino1 is evolutionarily conserved (GhoshDastidar et al., 2006; 
Majumder et al., 2003; Stein and Geiger, 2002). Additionally, sequence 
alignments also showed high similarity between human (all three Ino1 
isoforms) and Dictyostelium Ino1 proteins. Compared to the Dictyostelium 
protein, human Ino1 contains an additional C-terminal domain that is 
considered specific to Ino1 proteins of animal origin, the function of which is 
unknown (Majumder et al., 2003). Further analysis of the domain structure of 
the human and Dictyostelium Ino1 proteins showed that the functional 
domains occupied the same relative amino acid positions and contained 
stretches of amino acids that were highly conserved, confirming the 
homology and indicating a similarity in function between the human and 
Dictyostelium Ino1 proteins. 
3.7 Summary 
  Study of the relatedness of Ino1 amino acid sequences from a variety 
of species, including the Dictyostelium Ino1 homologue, using domain 
conservation, BLAST, phylogenetic and sequence alignment analyses, 
showed a high degree of conservation of Ino1 throughout evolution. These 
data together support the notion that Dictyostelium can be used as a model 
to study the function of the Ino1 protein in relation to other eukaryotic 
species, and, in particular, human Ino1 protein. 
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Chapter IV  
Ino1 gene deletion and rescue 
4.1 Introduction 
This chapter describes the genetic manipulation of the ino1 gene in 
Dictyostelium, and the analysis of the growth and development of the ino1- 
mutant strains. Homologous recombination was the strategy used to 
generate the ino1 knock-out mutant in Dictyostelium. Homologous 
recombination is a process where nucleotide sequences are exchanged 
between two similar or identical molecules of DNA (Figure 4.1), and allows 
for gene alternations by the introduction of cloned sequences at exact 
locations (De Lozanne and Spudich, 1987). Gene alternations can include 
introduction of point mutations, addition of extra copies of the gene or the 
deletion of a gene. Homologous recombination has been previously used 
successfully in yeast and mammalian cells (Witke et al., 1987), and to 
generate gene deletions in Dictyostelium (De Lozanne and Spudich, 1987; 
Fischbach et al., 2006; Pakes et al., 2012; Witke et al., 1987). To 
complement for the loss of ino1 gene, extrachromosomal plasmids that 
expressed genes from a constitutive promoter were introduced into ino1- 
cells.  
The Dictyostelium discoideum ino1 gene (DDB0231710 dictybase.org) 
is located on chromosome 4, has a length of 1672 base pairs, and includes 
one intron at position 1389–1528. The gene encodes a protein of 511 amino 
acids. A single isoform of Ino1 exists in Dictyostelium. Similar to mammalian 
and yeast homologues, Dictyostelium Ino1 is responsible for de novo inositol 
biosynthesis (Majumder et al., 1997). A previous study of a Dictyostelium 
ino1 deletion mutant reported an inhibition of cell growth in liquid, an inability 
to phagocytose both on bacterial lawns and bacteria in suspension, 
developmental defects leading to multi-tipped aggregates with generally 
delayed development, a reduction in phosphoinositol levels, and an increase 




in the level of 2,3-BPG (glycolytic pathway product) (Fischbach et al., 2006). 
The ino1 mutant was completely unable to grow without an exogenous 
supply of inositol (minimum concentration of 100 μM) in the growth media. 
Cells lost viability when deprived of inositol for 24 hours, and did not resume 
growth when inositol was supplied. The work presented in this chapter 
reports a successful deletion of the portion of the Dictyostelium ino1 gene to 
allow for an analysis of the effects of inositol depletion and Ino1 loss. 
Figure 4.1 Homologous recombination. Schematic represents a process of homologous 
recombination, where a construct that contains DNA homologous to the targeted gene and a 
selection marker is introduced into cells. Upon homologous recombination and an exchange 
of DNA, the targeted gene is modified. The modified gene now contains the desired mutation 








4.2 Creating an ino1- mutant 
To investigate the role of Ino1 in Dictyostelium, the ino1 gene was 
partially removed through homologous integration of a knock-out cassette 
into the Dictyostelium (Ax2) genome. The cassette was designed with 540 
base pairs of the 5’ region of the ino1 gene, including the start codon, and 
477 base pairs at the 3’ region of the ino1 gene, excluding the stop codon, 
with these regions flanking a blasticidin resistance gene used as a selection 
marker for the transformation (Figure 4.2 A). The 5’ and 3’ regions of the ino1 
gene were amplified by PCR from Dictyostelium genomic DNA, and cloned 
into the knock-out vector pLPBLP (Faix et al., 2004). Restriction enzyme 
analysis was performed to verify the presence of the 5’ and 3’ ino1 gene 
fragments in the knock-out vector (Figure 4.2 B) Restriction digests of the 
knock-out plasmid with single enzymes were used to confirm that the 
enzymes cut the vector once, while digests with enzyme combinations were 
used to show the presence of the 5’ and 3’ ino1 fragments, as well as the 
entire knock-out cassette (Figure 4.2 B). Additionally, correct gene 
sequences present in the ino1 knock-out vector were confirmed by DNA 
sequencing. 
Wild-type Dictyostelium Ax2 was transformed by electroporation of the 
ino1 knock-out cassette previously digested with BamHI and KpnI enzymes 
(Figure 4.2 A). Transformed Dictyostelium cells were plated into 96-well 
dishes with added 500 µM inositol to supplement a possible lethal loss of 
endogenous inositol (Fischbach et al., 2006). Potential knock-out mutants 
were selected for cassette integration by survival in the presence of 









Figure 4.2 Construction and restriction digest analysis of the ino1 knock-out vector. 
The ino1 gene was partially removed using a homologous integration technique. (A) 
Schematic showing the construction of the ino1 knock-out cassette. 5’ and 3’ fragments of 
the ino1 gene were cloned into the pLPBLP plasmid that contained the blasticidin resistance 
cassette with a promoter positioned to ensure the blasticidin gene is transcribed in the 
opposite direction to the ino1 gene fragments. The ino1 5’ and 3’ fragments were cloned into 
the pLPBLP vector using unique restriction enzymes as follows: 5’ fragment, BamHI/PstI 
(540bp) and 3’ fragment, NcoI/KpnI (477bp). The whole knock-out cassette (used for 
transformation of Dictyostelium) was released by cutting with BamHI/KpnI (2603bp) 
restriction enzymes. The enzymes used for cloning, and the sizes of the DNA fragments are 
indicated on the diagram. The complete knock-out vector contained 5,526 base pairs. (B) 
Restriction digest analysis of the constructed ino1 knock-out vector. The undigested (uncut) 
knock-out vector was used as a control, and the single digest for each restriction enzyme 
that was used in the cloning was performed as an additional control reaction to confirm that 
the enzymes cut in a single place. 
4.2.1 PCR screening analysis of the ino1- mutant 
To isolate potential ino1 knock-out mutants, cells resistant to 
blasticidin were screened by PCR to identify strains showing homologous 
integration of the knock-out cassette, as previously described (Adley et al., 
2006) (Figure 4.3). In these screens, three primer combinations were used, 
providing diagnostic products for genomic (G) DNA, for vector (V) DNA, and 
to identify colonies showing homologous integration of the knock-out (K) 
cassette. These three products were screened at both the 5’ and 3’ regions 
of the gene. For the genomic controls, the primers were designed so that one 
primer would anneal to the genomic DNA in the region outside of the knock-
out cassette, and the other primer to the genomic DNA that formed part of 
the knock-out cassette. For the vector controls, the primers were designed to 




anneal to the genomic DNA region within the knock-out cassette and to a 
DNA sequence in the blasticidin resistance gene. A unique knock-out band to 
diagnose the homologous integration was obtained by amplifying the DNA 
region with two primers, one located in the genomic DNA region outside of 
the knock-out cassette and the other in the DNA sequence in the blasticidin 
resistance gene. These primer combinations were designed for the 5’ and 3’-
regions (corresponding to the 5’ and 3’ regions of the ino1 gene) of the ino1 
knock-out cassette (Figure 4.3). To identify potential ino1- cell lines, ~143 
blasticidin resistant colonies transformed with the knock-out construct were 
screened. From these screens, one positive integrant showed homologous 
integration at the 5’ and 3’ regions of the ino1 gene (Figure 4.3). 
Figure 4.3 PCR screening analysis of the ino1
-
 cells. Potential ino1
-
 mutants resistant to 
blasticidin were screened using PCR to identify successful homologous integration events on 
both 5’ and 3’ sites of the ino1 gene. (A) A schematic representation of the strategy used to 
generate and screen an ino1 knock-out mutant. PCR screening analysis was used to confirm 
cell transformants that were resistant to blasticidin. The schematic shows blasticidin (BSR), 
genomic (G) and vector (V) controls as well as the diagnostic knock-out band (KO), together 
with the indicated DNA sizes in base pairs (bp) for both 5’ (N-terminal) and 3’ (C-terminal) 
regions. (B) The PCR analysis of the transformed cells resistant to blasticidin and wild-type 
control to confirm the homologous recombination event on both 5’ and 3’ regions of the ino1 
gene. 




Identification of the homologous integration of the ino1 knock-out 
cassette into the 5’ and 3’ regions of the ino1 gene was indicative of the 
successful deletion of the central part of the gene. The identified positive 
colony was then serially diluted in media supplemented with 500 µM inositol 
to derive an isogenic cell line. 
4.2.2 Loss of ino1 gene transcription 
 Following the identification of the ino1 knock-out cell line, a reverse 
transcription PCR (RT-PCR) analysis was used to confirm the loss of gene 
transcription in these cells (Figure 4.4). cDNA was synthesised from ino1- 
cells and analysed for the absence of ino1 gene transcription. In this test, the 
primers for the PCR reaction were designed to anneal to the DNA region that 
was deleted in the knock-out cassette. The control reaction was performed 
using the same PCR conditions for the wild-type Dictyostelium strain that was 
used as a parent to create the ino1 knock-out cell line. The DNA fragment 
visible on an agarose gel as a 302 base pair band was indicative of 
expression of the ino1 gene. Mitochondrial large subunit rRNA (rnlA or Ig7) 
PCR product was used as an expression control (559 base pairs), as 
previously published (Sugden et al., 2010). The absence of the band from 
cDNA derived from the knock-out cell line was indicative of the loss of gene 
transcription resulting from successful ablation of the ino1 gene. This process 
confirmed that the isolated ino1- colony was isogenic, since a non-
homologous transformant would contain the wild-type ino1 gene fragment.  










 cells that showed resistance to blasticidin and were confirmed to integrate the 
knock-out cassette at 5’ and 3’ sites of the ino1 gene were analysed for gene expression 
using RT-PCR. (A) A schematic to show the position where the primers to screen ino1 loss 
of transcription anneal. (B) The RT-PCR analysis on the wild-type and ino1
-
 cells. RNA was 
extracted from both cell lines and converted to cDNA using reverse transcriptase. PCR was 
performed with ino1 primers located within the deleted region of the ino1 gene, which were 
only able to anneal to DNA of the wild-type to allow for amplification of a DNA fragment of 
302 base pairs. Ig7 gene (control) primers were used as a control to give a DNA product of 
559 base pairs.  
4.3 Creating ino1 genetic rescue 
4.3.1 Expressing the Dictyostelium ino1 gene in the ino1- mutant 
To allow for a verification of the ino1- phenotype, an ino1- mutant cell 
line was created that expressed the Dictyostelium ino1 gene fused to an RFP 
gene at the C-terminus under control of an actin 15 constitutive promoter 
(ino1-::dino1-RFP) (Figure 4.5). The Dictyostelium ino1 (dino1) gene was 
amplified using PCR with sequence-specific primers, and cloned into a 
plasmid containing mRFPmars (389-2, sourced from Dr Annette Müller-
Taubenberger). The presence of the correct ino1-RFP sequence was verified 
by DNA sequencing using sequence-specific primers. The ino1-RFP 
containing plasmid was electroporated into ino1- cells, and an isogenic cell 




line was selected by a growth on a bacterial plate. Ino1-RFP gene expression 
was confirmed by RT-PCR, and the presence of the Ino1-RFP protein was 
confirmed by Western Blot analysis (Figure 4.5 A, B). Live-cell imaging 
revealed a cytosolic distribution of the Ino1-RFP protein (Figure 4.5 C). The 
ino1- mutant expressing ino1-RFP was used in all the rescue experiments 
described in this thesis. 




cells were transformed with a plasmid containing dino1-RFP gene expressed 
from an actin15 promoter, and analysed for gene expression, and production and localisation 





RFP rescue cells, where RNA was extracted from the cells and converted to cDNA using 
reverse transcriptase. PCR was performed with dino1 primers located within the deleted 
region of the ino1 gene, and were only able to anneal to DNA of the wild-type Dictyostelium 
and ino1
-
 rescue strains to allow for the amplification of a DNA fragment of 302 base pairs. 
Ig7 gene (control) primers were used as a control to give a DNA product of 559 base pairs. 
(B) Western Blot analysis for the presence of Ino1-RFP protein (approx. 85kDa) using anti-
RFP antibody. (C) Dictyostelium Ino1-RFP protein shows cytosolic localization by live-cell 
imaging with a fluorescence microscopy. 
To examine the functionality of the Ino1 protein fused to a marker at 
the N-terminus, the Dictyostelium ino1 (dino1) gene was amplified by PCR 
using sequence specific primers and cloned into a GFP-containing plasmid  
(pTX-GFP (Levi et al., 2000)). The presence of the correct GFP-ino1 
sequence was verified by DNA sequencing using sequence-specific primers. 
The GFP-ino1 containing plasmid was electroporated into ino1- cells, and an 
isogenic cell line was selected by a growth on bacteria. Live cell imaging 
showed a cytosolic localisation of the GFP-Ino1 protein (Figure 4.6). The 




ino1-::GFP-dino1 mutant was able to 
grow and develop in the absence of 
inositol (data not quantified). 
 





cells were transformed with a 
plasmid containing GFP-dino1 gene expressed 
from an actin15 promoter, and analysed for the 
localisation of the GFP-Ino1 protein. GFP-Ino1 
protein shows cytosolic localization in live cells 
by fluorescence microscopy. 
 
4.3.2 Expressing the human ino1 gene in the Dictyostelium ino1- 
mutant 
Based on a high degree of evolutionary conservation of the 
Dictyostelium and human Ino1 proteins (see chapter 3), the human ino1 
(hino1) gene was expressed in Dictyostelium ino1- cells to test for functional 
complementation. DNA encoding the human ino1 gene optimised to 
Dictyostelium codon bias was synthesised with restriction sites to enable 
cloning into an N-terminal GFP fusion vector pDM317 (Veltman et al., 2009) 
(ino1-::GFP-hino1) and a C-terminal mRFPmars fusion vector 389-2 sourced 
from Dr Annette Müller-Taubenberger (ino1-::hino1-RFP). Live-cell imaging 
revealed a cytosolic localisation of both of the tagged human Ino1 proteins 
(Figure 4.7). Tagging the human Ino1 protein at the N-terminus enabled ino1- 
cells to grow in the absence of exogenous inositol; however, the slow growth 
of the overexpressing cells did not allow for growth quantification. Tagging 
the human Ino1 protein at the C-terminus did not rescue inositol auxotrophy 
of the ino1- cells. Slow growth of these strains did not allow for further 
experimental analysis. 
 









cells were transformed with a plasmid containing either GFP-hino1 or hino1-RFP gene 
expressed from an actin15 promoter, and analysed for the localisation of the human Ino1 
protein. Both GFP-Ino1 and Ino1-RFP showed cytosolic localization by fluorescence 
microscopy. 
4.4 Growth of the ino1- mutant 
Since Ino1 catalyses the first rate-limiting step in inositol production, 
the loss of the Ino1 protein would result in inositol depletion in the ino1- cells, 
with a potential impact on cell growth. Growth rate of the wild-type and ino1- 
mutant was assessed by incubating cells in growth medium supplemented 
with various concentrations of inositol at a starting density of 1x105 cells/ml, 
and were then counted daily until wild-type cells reached the stationary 
phase (1.88 x107 cells/ml) (Figure 4.8 A). Concentrations from 0 µM to 500 
µM of inositol were used in this experiment. Wild-type cells went through the 
logarithmic, exponential and stationary phases within 192 hours without the 
need for exogenous inositol supplementation. In contrast, ino1- cells were 
unable to grow in the absence of inositol supplementation. After 72 hours of 
inositol removal, the number of ino1- cells was seven-fold lower in 
comparison to the inositol-supplemented (500 µM) control and started to 
decrease over time, suggesting that the internalised inositol reserves were 
being depleted. Growth of the ino1- mutant was restored by adding 150 µM 
inositol to the growth media. There was no difference observed in the growth 
of the ino1- cells supplemented with 300 µM or 500 µM inositol, suggesting 
inositol saturation at 300 µM. Addition of inositol enabled the growth of the 




ino1- mutant in the liquid media; however, growth was not restored to the 
wild-type level even at higher inositol concentrations (Figure 4.8 A). Cell 
density of the wild-type cells grown in the liquid media was significantly 
higher than that of the ino1- cells, even with inositol supplementation. 
Doubling times were calculated for cultures growing in the logarithmic phase. 
Wild-type cells doubled every 18 hours while ino1- cells every 25 hours 
(when grown in the media with 300 µM inositol) or every 23 hours (when 
grown in the media with 500 µM inositol) indicating that the ino1- mutant 
supplemented with inositol exhibits a slower growth rate (approximately one 
third) compared to the wild-type under the tested conditions (Figure 4.8 A).  
 
Figure 4.8 Growth of the ino1
-
 mutant in liquid medium. Wild-type and ino1
- 
cells were 
grown in shaking suspension +/- inositol as indicated. Ino1
-
 cells were unable to grow without 
inositol below the tested concentration of 150 µM. Ino1-RFP expression restored the growth 
of ino1
- 
cells under no inositol conditions. Difference in cell density between wild-type and 
ino1
-
 cells (grown in the presence of 500 µM inositol) was observed to be variable (as shown 
in panel A and B), which might have arisen from the biological variability between different 
batches of the wild-type cells used. (A) Wild-type and ino1
- 
cells were counted every 24 
hours for 192 hours, starting from an initial cell density of 1x10
5






::dino1-RFP cells were counted every 24 hours for 192 hours starting from an initial 
cell density of 1x10
5
 cells/ml. Statistical analysis was performed using 2-way ANOVA with 
Bonferroni post-test and comparison were to the wild-type control, the significance values 
are presented in the tables below the graphs. (A) n= 3 technical repeats; 1 biological 
replicate, (B) n = 3 technical repeats; 1 biological replicate. 
Another growth experiment was conducted to test for the ability of 
Ino1-RFP to restore the growth of ino1- cells in media without inositol. Here, 




cell density and growth rate between wild-type and ino1- cells was observed 
to be similar (21 hours doubling time for wild-type and ino1- +500 µM inositol) 
(Figure 4.8 B). The difference in the cell density of the wild-type cultures 
presented in the graphs in figure 4.8 panel A and B might have arisen from 
the biological variability between different batches of the wild-type cells used 
for these experiments. Overexpressing Dictyostelium ino1-RFP rescued the 
growth of ino1- cells in liquid culture without the addition of exogenous inositol 
(Figure 4.8 B). Additionally, the doubling time for the ino1- cells expressing 
dino1-RFP decreased to 15 hours compared to 21 hours for the wild-type 
control, suggesting that overproduction of Ino1 protein in the ino1- cells 
increases their growth rate. These data suggest that ino1- mutant is an 
inositol auxotroph.  
 
Figure 4.9 Growth of ino1
- 
cells on bacteria. Wild-type and ino1
-
 cells were plated onto 
agar plates seeded with live bacteria (Raoultella planticola), except for the plates marked “+ 
inositol” where inositol (500 µM) was added to heat-killed R.planticola, and inoculated for 7 
days at 22°C. Wild-type cells formed plaques indicative of the ability to grown by consuming 
bacteria, whereas ino1
-
 cells did not form plaques regardless of inositol supplementation. 
Overexpressing dino1 tagged with RFP in the ino1
-
 cells rescued the inability of those cells 
to grow on bacteria without inositol supplementation. Size bar represents 1 cm. 
During the selection for the ino1 knock-out isogenic cell lines, the ino1- 
mutant was plated onto nutrient agar plates containing live bacteria 
(Raoultella planticola). Under these conditions, wild-type Dictyostelium Ax2 
cells are able to grow by consumption of bacteria (phagocytosis) (Cardelli, 
2001). Bacterial consumption is visible as formation of plaques of cleared 
bacteria (Figure 4.9). As these plaques enlarge, the bacteria are depleted in 
the centre of the plaque and the cells in this area begin to starve and 
undergo the developmental process to produce fruiting bodies. During the 
clonal selection, the ino1- cells were not able to grow and no plaques were 
seen to be formed (Figure 4.9). This loss was not corrected by adding inositol 
(500 µM/plate) to the growth medium (both in the agar and mixed with heat-




killed bacteria). Overexpressing dino1-RFP in the ino1- cells restored the 
growth on bacterial plates in the absence of inositol, suggesting a 
requirement for Ino1 protein to complete phagocytosis. 
Since the ino1- cells were unable to grow on agar plates seeded with 
bacteria, the mutant cells were analysed for their ability to phagocytose in 
liquid culture. For this purpose, a bacteria clearing assay was performed 
where wild-type and ino1- cells were incubated in shaking suspension in the 
presence of heat-killed R.planticola as a food source (Figure 4.10). For this 
experiment, ino1- cells were in the absence of inositol for a total of 25 hours 
(including 7 hours of the assay duration). Consumption of bacteria was 
determined by measuring the loss of light absorbance over time.  
Figure 4.10 Ino1
-





::dino1-RFP cells were inoculated with heat-killed bacteria (R.planticola) in the presence 
or absence of inositol and optical density was measured over a period of 7 hours. No 
significant differences were observed between the wild-type (control) and ino1
- 
strains in the 
ability to clear away bacteria from the suspension. n = 3 technical repeats; 1 biological 
replicate 
The wild-type cells cleared away 30% of bacteria, while the ino1- cells 
grown without inositol cleared away 28% of bacteria over 7 hours (Figure 
4.10). Also, the ino1- cells overexpressing Ino1 or incubated with inositol (500 
µM) cleared away 34% and 35% of bacteria, respectively. The optical density 
was also measured after 24 hours from the time when the cells were 
incubated with bacteria (Table 4.1). By that time, the wild-type cells cleared 
away 57% of bacteria, while the ino1- cells grown in absence of inositol or in 
the presence of inositol (500 µM) cleared away 61%, and 66% of bacteria, 




respectively; the ino1- cells overexpressing ino1-RFP cleared away 73% of 
bacteria. The ino1- mutant thus showed no significant difference in the ability 
to phagocytose when compared to wild-type. 
 Time (hours) 
 0 3 5 7 24 
Bacteria alone 100 100 100 100 96 
Wild-type 100 84 76 70 43 
ino1
-
 (- inositol) 100 89 80 72 39 
ino1
-
 (+ 500 µM inositol) 100 82 71 65 34 
ino1
-
::dino1-RFP 100 79 68 66 27 
 





 cells are able to phagocytose bacteria at the same rate as the wild-type 
strain. Statistical analysis between wild-type and ino1
-
 strains was performed using two-
tailed student’s t-test and compared to wild-type control. No significant difference was found. 
n = 3 technical repeats; 1 biological replicate 
4.5 Development 
When starved of nutrients, Dictyostelium cells aggregate to form 
fruiting bodies over a period of 24 hours. To investigate the effect of ino1 
ablation on this developmental process, the wild-type and the ino1- cells were 
starved on nitrocellulose membranes over a 24-hour period to induce 
development. In the wild-type cells, these conditions lead to the development 
of fruiting bodies containing a basal disk, stalk, and a round spore head 
(sorus) (Figure 4.11 A,B) (Schaap and Wang, 1986). In the ino1- mutant, the 
development into fruiting bodies was dependent upon inositol treatment prior 
to setting up the development assay. Ino1- cells were able to form fruiting 
bodies when the cells had been grown in the presence of exogenous inositol 
(500 µM) prior to the transfer onto nitrocellulose membranes. Ino1- cells were 
arrested in development when the cells were grown in the absence of 
exogenous inositol for a period of 24 hours before their transfer onto 
nitrocellulose membranes, although the cells were able to aggregate (Figure 
4.11 B). This analysis shows a requirement of inositol to complete 
development in Dictyostelium. Overexpressing ino1-RFP (ino1-::dino1-RFP) 
restored fruiting body formation in the ino1- cells grown in the absence of 
inositol which indicates that the developmental defect was due to the loss of 
ino1 gene.   

























Figure 4.11 The effect of ino1 ablation on Dictyostelium development. Wild-type and 
ino1
-
 mutant cells were developed on nitrocellulose membranes over 24-hour period. The 
ino1
-
 cells were grown in the presence (500 µM) or absence of inositol prior to the 
development assay. The wild-type cells formed mature fruiting bodies over 24 hours, while 
the ino1
-
 cells required the presence of inositol prior to the development assay to be able to 
complete differentiation into fruiting bodies. Overexpression of ino1-RFP rescued the 
impaired developmental phenotype of the ino1
-
 cells. Representative of 3 independent 
technical repeats. Size bars represent 0.5 mm. 





To investigate the role of the Ino1 protein in Dictyostelium, a cell line 
was created with 19% of the ino1 gene removed using the homologous 
recombination method. The loss of ino1 expression was confirmed by 
reverse transcription PCR. The created ino1- mutant was grown in the 
presence of inositol in the liquid media (500 µM) to avoid a potential lethality 
resulting from a lack of inositol, as previously demonstrated (Culbertson and 
Henry, 1975; Fischbach et al., 2006). Various expression constructs were 
also created to complement for the loss of ino1 in Dictyostelium.  
Dictyostelium Ino1 expressed with a GFP tag at the N-terminus or an 
RFP tag at the C-terminus restored the growth of the ino1- mutant without 
exogenous inositol supplementation. Human Ino1 expressed with a GFP tag 
at the N-terminus in the ino1- mutant resulted in very slow growth in medium 
without added inositol. The growth was reduced to a level that would not 
allow quantification. Human Ino1 with an RFP at the C-terminus was not able 
to restore the ability of these cells to grow without inositol supplementation, 
even though expression was observed in the ino1- cells by live cell imaging. 
Studies to examine the chemical properties of the Ino1 protein purified from 
human foetal liver showed that the highest activity of the enzyme was 
observed at a temperature of 40°C (Chhetri et al., 2012). cDNA coding for 
the Ino1 derived from a post-mortem human prefrontal cortex was previously 
shown to be functional in yeast, complementing the inositol auxotrophy (Ju et 
al., 2004). Enzyme activity of the purified human Ino1 measured by Ju et al. 
(2004) was reported to be optimal at 37°C (~65 U/mg), reaching ~29 U/mg at 
30°C and ~17U/mg at 20°C. In this study, yeast cells expressing human Ino1 
protein were grown at a temperature of 30°C. It is thus possible that the 22°C 
temperature at which the Dictyostelium ino1- strain was grown was not 
permissive for human Ino1 enzyme activity, thus resulting in an insufficient 
level of inositol production to rescue the inositol auxotrophy of the ino1- 
mutant. Since the optimal temperature for the growth of Dictyostelium is 21-
23°C, and growth is significantly repressed above 25°C, this hypothesis 
could not be tested in vivo in the axenic strains used in this project.  




Dictyostelium and human Ino1 proteins tagged at the N- and C-termini 
had a cytosolic localisation by fluorescence microscopy. In agreement with 
this finding, Ino1 protein was previously reported to be present in the cytosol 
in a soluble form in unicellular and multicellular eukaryotes (Lackey et al., 
2003). However, despite the wide acceptance that inositol phosphate 
biosynthesis is restricted to the cytosol, there is evidence to suggest that Ino1 
can also be localised to membrane-bound organelles, including mitochondria, 
the endoplasmic reticulum, and the nucleus, opening interesting avenues to 
exploration (Kerr and Corbett, 2010; Lackey et al., 2003).  
Growth assays were performed using the wild-type and ino1- cells 
inoculated in liquid media, where ino1- mutant was unable to grow without 
exogenous inositol supplementation (≥ 150 µM). Dictyostelium ino1- mutants 
were previously shown to be unable to grow without inositol supplementation 
in liquid media (Fischbach et al., 2006). Cells utilise pinocytosis to take up 
nutrients when cultured in liquid medium (Clarke and Kayman, 1987). Low 
inositol levels may affect nutrient uptake via a disruption of inositol phosphate 
and phosphoinositide cycle in cells (Bohdanowicz and Grinstein, 2013; 
Rupper et al., 2001; van Haastert and van Dijken, 1997). Previous studies 
have shown, however, that pinocytosis was not affected in Dictyostelium cells 
with a disrupted ino1 gene that were starved of inositol (Fischbach et al., 
2006). This result suggests that fluid internalisation is not disrupted by the 
absence of inositol. 
In contrast to the growth in liquid media, ino1- cells were unable to 
grow with bacteria on agar plates, even with added inositol. However, the 
cells were able to clear away the bacteria when inoculated in liquid (the 
growth rate was not measured). The bacteria were heat-killed before inositol 
was added to ensure that inositol would not be metabolised by the bacteria. 
Dictyostelium inositol-auxotrophic mutants have been previously shown to be 
unable to grow on bacterial lawns or in suspensions of bacteria, and a 
disruption of phagocytosis has been reported in Dictyostelium mutants with 
an inactivated ino1 gene (Fischbach et al., 2006). However, contradictory to 
the findings presented in this thesis, the internalisation of bacteria was 
severely reduced during inositol starvation, and the ability to phagocytose 




was completely lost by the ino1 mutant cells after 24 hours without inositol 
(Fischbach et al., 2006). This discrepancy can result from a difference in 
methods used. Fischbach et al. used FITC-labelled bacteria, while the assay 
described in this thesis involved the use of freshly heat-killed bacteria. FITC-
labelled bacteria are particles that had to be phagocytosed by cells. Indeed, 
ino1- cells were shown to be defective in phagocytosis but not pinocytosis 
(Fischbach et al., 2006). Additionally, the pinocytosis rate of cells cultured on 
bacteria has been shown to be negligible (Clarke and Kayman, 1987). The 
nutrients released from the freshly killed bacteria and dissolved in the liquid 
would therefore not require phagocytosis, because pinocytosis would be 
sufficient for cells to take up the nutrient-containing liquid. Ino1- cells may 
thus be able to internalise smaller particles dissolved in liquid by endocytosis 
or pinocytosis but be unable to do this when grown on a solid substrate. 
These results suggest that the processes of phagocytosis, endocytosis and 
pinocytosis have different dependencies on inositol-derived compounds. 
Phagocytosis and particle digestion occurs over a number of steps that 
include the particle binding to the cell surface, followed by an engulfment of 
the particle by pseudopod extension, and finally the fission and fusion 
reactions to form phagolysosomes (Cardelli, 2001). Phosphoinositides are 
essential in these processes in a number of cell types, including 
Dictyostelium (Botelho et al., 2000).  
During starvation, Dictyostelium cells aggregate and initiate 
multicellular development to undergo a change in morphology and produce 
spore-bearing fruiting bodies. Inositol metabolites are required for cell 
signalling and membrane reorganisation especially, during the initial stages 
of development (cell aggregation) (Cai and Devreotes, 2011). Ino1- cells 
grown in the absence of inositol prior to development initiation were not able 
to form fruiting bodies, and inositol was sufficient to rescue this phenotype. 
Also, overexpressing Ino1-RFP in the ino1- cells restored this developmental 
phenotype. These data suggests that development of Dictyostelium requires 
the presence of inositol.  
 





This chapter described generation of the ino1- mutant and a genetic 
rescue with Dictyostelium and human Ino1 proteins. Both human and 
Dictyostelium Ino1 proteins were shown to localise to the cytosol. The ino1- 
mutant exhibited inositol auxotrophy and an inositol requirement for 
development. Exogenous inositol (500 µM) allowed for growth of these cells 
in liquid medium, and for completion of multicellular development, but was 
not able to rescue the inability of ino1- cells to phagocytose bacteria on agar 
plates.
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Chapter V  
Effects of inositol depletion and 
Ino1 loss on cell function 
5.1 Introduction 
The studies described in the previous chapter showed that loss of Ino1 
in Dictyostelium cells leads to inositol auxotrophy, highlighting the importance 
of inositol in cell growth and development, and reproducing the “inositol-less 
death” phenotype (Culbertson and Henry, 1975; Fischbach et al., 2006). 
Inositol has been shown to be important for a vast number of cellular 
functions, including cell adhesion, cytokinesis, autophagy, and cell movement 
(Criollo et al., 2007; Europe-Finner et al., 1989; Fischbach et al., 2006; Logan 
and Mandato, 2006; Mayer and Tomlinson, 1983; Sarkar and Rubinsztein; 
Sarkar et al., 2005; Schiebler et al., 2015; Steger et al., 2003; Vicencio et al., 
2009; Yorek et al., 1993; Zhang et al., 2012). Indeed, a genome-wide screen 
for non-lethal mutations causing inositol auxotrophy in S.cerevisiae found 
419 genes (Villa-García et al., 2011), whereas the presence of inositol 
repressed the expression of 32 genes and choline repressed the expression 
of 93 genes (Jesch et al., 2005). Thus, inositol depletion can have a variety 
of cellular responses that could arise due to alteration of signalling pathways.  
Analysis of an inositol auxotrophic strain of Dictyostelium during 
inositol starvation revealed a decrease in inositol, a change in 
phosphoinositide levels, and the build-up of a glycolysis metabolite, 2,3-
bisphosphoglycerate (Fischbach et al., 2006). Inositol depletion may also 
disturb the turnover of inositol phosphate to phosphoinositide, which can 
have an impact on vital processes like nutrient consumption (Azab et al., 
2007). Phosphoinositides are synthesised in the endoplasmic reticulum and 
transported to other membranes within the cell, either by vesicular transport 
or via transfer proteins (De Camilli et al., 1996). Phosphoinositides are 
critically involved in a range of cellular functions, including phospholipid 
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synthesis, the UPR (unfolded protein response), protein secretion, signalling 
events in cellular compartments, motility, and intracellular membrane 
trafficking (Balla, 2001; Brill et al., 2011b; Cremona and De Camilli, 2001; 
Peracino et al., 2010; Sbrissa et al., 2007; Walter and Ron, 2011). Since 
inositol is a precursor to a family of phosphoinositides, its removal is 
predicted to have an impact on Dictyostelium cell physiology and 
metabolism, as was previously demonstrated in yeast (Gaspar et al., 2006; 
Villa-García et al., 2011). For example, phosphoinositide 4,5 bisphosphate 
(PIP2), which is associated predominantly with intracellular membranes, 
plays a role in cell substrate adhesion and cytokinesis (Brill et al., 2011b; 
Logan and Mandato, 2006). PIP2 and PIP3 also activate a variety of effector 
proteins by targeting them to specific membrane locations, where they 
activate signal transduction pathways, and have important roles in cell 
movement during development (Dormann et al., 2004; Dowler et al., 2000; 
Nichols et al., 2015; Stephens et al., 2008). 
Inositol is synthesised de novo in cells by the Ino1 enzyme, and thus 
the loss of the protein, which leads to inositol auxotrophy, can have a 
potential effect on cell physiology and metabolism. The current 
understanding of the role of Ino1 is based on its catalytic activity as an 
isomerase that converts glucose 6-phosphate to inositol 3-phosphate 
(Kofman and Belmaker, 1993), and few studies have differentiated between a 
loss of the Ino1 enzyme and inositol depletion. These aspects of inositol 
biology have not been examined in Dictyostelium. This chapter describes an 
investigation of the physiological and metabolic effects of inositol depletion 
and the loss of Ino1 protein in Dictyostelium.  
5.2 Intracellular inositol levels during inositol starvation 
Loss of Ino1 is predicted to block the de novo biosynthesis of inositol, 
and is therefore likely to affect intracellular inositol levels. To test this 
prediction, inositol levels were measured in the ino1- mutant during inositol 
supplementation and starvation. Inositol levels were quantified by NMR in the 
ino1- and wild-type cells, in the presence or absence of exogenous inositol 
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(Dr S. Claus and C. Le Roy, University of Reading) (Figure 5.1). Wild-type 
cells grown without inositol supplementation contained 1.5 ± 0.1 µM inositol, 
which increased significantly to 3.4 ± 0.1 µM following supplementation with 
inositol (500 µM, p < 0.0001), and returned to the baseline level of 1.5 ± 0.1 
µM after 12-hour inositol removal. Ino1- cells grown with inositol 
supplementation had an inositol level of 1.8 ± 0.1 µM, which was slightly 
higher than the 1.6 ± 0.1 µM present in wild-type cells grown without 
exogenous inositol (control); the value for ino1- cells significantly decreased 
to 0.8 ± 0.1 µM following the removal of exogenous inositol for 12 hours (p = 
0.0013). The reduced inositol level was maintained at 24-hour post inositol 
removal at 1.2 ± 0.1 µM, and returned to 2.0 ± 0.1 µM following the re-
introduction of inositol. These data show that, in ino1- cells, inositol was 
depleted following withdrawal of exogenous supply. Additionally, wild-type 
Dictyostelium cells were demonstrated to take up inositol from extracellular 
sources even when inositol is already produced by these cells.  
Figure 5.1 The effect of inositol depletion on intracellular inositol concentration. To 
analyse inositol levels in wild-type and ino1
-
 cells, the cells were grown in the presence of 
inositol (500 µM, denoted ‘+’), the absence of inositol (12h or 24h; denoted ‘+/-‘) or in inositol 
added (500 µM for 12h) after a 24-hour depletion period (denoted ‘+/-/+‘). Inositol levels were 
measured by NMR. The level of inositol was reduced following inositol depletion for 12 or 24 
hours in the ino1
-
 mutant, and restored to basal levels following reintroduction for 12 hours. 
Statistical analysis was carried out between two groups using unpaired two-tailed student’s t-
test; *p < 0;05, **p < 0.01, ***p < 0.001; n = 4 independent technical repeats. The work 
presented here was done in collaboration with Dr S P Claus and C. Le Roy, University of 
Reading.  
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5.3 Cell viability and adhesion 
Dictyostelium cell viability is often assessed by counting plaques 
formed on bacterial lawns. However, this method could not be used since 
ino1- cells were unable to grow on bacteria. As an alternative approach to 
determine cell viability during inositol depletion, experiments were performed 
where the cells were stained with vital dyes. Two dyes were used to analyse 
cell viability: fluorescein diacetate (FDA) and propidium iodide (PI). In these 
experiments, live cells convert the non-fluorescent FDA into a fluorescent 
compound (fluorescein), providing an indication of viability. In an alternative 
approach, PI is added to cells, and enters dying cells that have damaged 
membranes, and stains the cell nucleus with a red fluorescent signal, which 
is a sign of cell death. However, both of these approaches were 
unsuccessful, since FDA was not converted to fluorescein by all the live cells, 
and PI did not appear to stain all the dead cells. Therefore, no direct measure 
of loss of cell viability as a result of deletion of Ino1 was possible. 
Loss of cell adhesion has been previously linked to inositol depletion 
(Fischbach et al., 2006; Zhu et al., 2015). To monitor this effect in 
Dictyostelium, the number of cells that remained attached to culture plates 
following the removal of exogenous inositol was assessed over a period of 72 
hours (Figure 5.2). In the presence of 500 µM inositol, ino1- cells proliferated 
and remained adherent (Figure 5.2). However, the removal of exogenous 
inositol caused a decrease in cell density to 88.5% after 24 hours and to 
33.5% after 72 hours (compared to ino1- + inositol condition). Ino1- cells 
expressing ino1-RFP initially grew to a significantly higher density than the 
ino1- mutant cultured in the presence of exogenous inositol. However, after 
46 hours, cell density started to decrease, reaching a number similar to that 
of ino1- cells grown in the presence of inositol. These experiments showed 
that initially the number of adherent ino1- cells increased, and then after 24 
hours of inositol depletion rapidly started to decrease, suggesting that the 
absence of inositol triggered a loss in substrate adhesion. The 24-hour time 
point was used for analysing the effects of inositol starvation on the ino1- 
cells in subsequent experiments. 




Figure 5.2 The effect of inositol depletion on cell-substrate adhesion in ino1
-
 cells. Cell 
adhesion was monitored in wild-type and ino1
-
 cells, and in ino1
-
 cells expressing ino1-RFP, 
in the presence (500 µM) and absence of inositol for at least 24 hours. The medium was 
gently removed and the cells detached from the surface of the dish by pipetting. The 
detached cells were counted to obtain cell density. Ino1
- 
cells grown in the absence of 
inositol started to lose substrate adhesion after 24 hours following inositol removal. 
Supplementation of growth media with 500 µM inositol or ino1-RFP overexpression resulted 
in cells remaining adherent to the dishes. Statistical significance was determined for each 
individual time point in separate test by an unpaired two-tailed student’s t-test; *p < 0.05, ***p 
< 0.001, ino1
-
::dino1-RFP was compared to ino1
- 





inositol); n = 3 technical repeats; 1 biological replicate. 
5.4 Cytokinesis 
Dictyostelium cells grow by nutrient consumption followed by cell 
division, where during the process of cytokinesis the nuclei and cytoplasm of 
a dividing cell are separated into two daughter cells (Robinson et al., 2002). 
Since ino1- cells grew at a slower rate than the wild-type cells, the effect of 
inositol depletion on cytokinesis was examined. In this experiment, cells were 
grown in shaking suspension with or without inositol (500 µM). Wild-type or 
ino1- cells were stained with DAPI to visualise and count the number of nuclei 
per cell (Figure 5.3) (Pakes et al., 2012). In these experiments, the majority 
of wild-type cells (90%) had one or two nuclei per cell, with 10% of cells 
having ≥3 nuclei. The ino1- cells, however, showed a significant increase (p < 
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0.001) in the nuclei number following inositol depletion compared to the wild-
type strain. In the absence of inositol, 24.7% of the ino1- cells accumulated 
≥3 nuclei, compared to 7.7% for the wild-type cells. This effect was rescued 
by growing cells in the presence of 500 µM inositol (9.7% of the ino1- cells 
accumulated ≥3 nuclei) or by overexpressing ino1-RFP in these cells (10% of 
the ino1-::dino1-RFP cells accumulated ≥3 nuclei) (Figure 5.3 B). These data 
suggest that inositol depletion leads to a reduction in cytokinesis. 




cells were grown in liquid medium +/- exogenous inositol (500 µM). The ino1
-
 cells were kept 
in the medium without inositol for 24 hours prior to image acquisition. Cells were fixed with 





::dino1-RFP cells and (B) quantified in the presence or absence (24 hours) of 
inositol treatment using the ImageJ software. Error bars represent SEM. Statistical 
significance was determined by 2-way ANOVA with Bonferroni post-test, *p < 0.05, ***p < 
0.001 and difference presented to wild-type control; n ≥ 250 cells analysed per condition 
from 3 independent technical repeats, 1 biological replicate. 




Autophagy is a biological process that leads to the degradation and 
recycling of cellular material (Mesquita et al., 2013). During autophagy, 
cellular components are engulfed inside autophagosomes, which then fuse 
with lysosomes to degrade the engulfed cell material. Stress conditions, 
including nutrient depletion, can trigger autophagy (Kosta et al., 2004). For 
this reason, the effect of inositol depletion on the number of autophagosomes 
being formed in the ino1- cells was assessed. 
In Dictyostelium, the formation of autophagosomes can be visualised 
by the incorporation of fluorescently-tagged autophagy-related protein 8 
(Atg8) into autophagosomal membranes (Otto et al., 2003). In the following 
experiment, wild-type and ino1- cells were grown in the presence of 
exogenous inositol (500 µM) or in the absence of inositol (24 hours in the 
case of the ino1- mutant). Live images were acquired using a fluorescence 
microscopy, and the number of autophagosomes per cell was quantified 
(Figure 5.4).  
Autophagosome number per cell was similar between the ino1- cells 
(1.4 autophagosomes per cell) and wild-type cells (1.1 autophagosomes per 
cell) when both strains were grown in the presence of inositol (500 µM) and 
to the wild-type cells grown in the absence of inositol (2.0 autophagosomes 
per cell) (Figure 5.4 A,B). Inositol starvation led to a nearly four–fold increase 
in the autophagosome number per cell in the ino1- cells (7.0 
autophagosomes per cell) as compared to the wild-type (2.0 
autophagosomes per cell) when both strains were grown for 24 hours in the 
absence of inositol, while the cell size of both strains remained comparable 
(average cell area: ino1- = 123 µm2; wild-type = 147 µm2) (Figure 5.3 B,C). 
These data suggest that ino1- cells lacking inositol exhibit an autophagic 
response. 
Interestingly, the growth of both wild-type and the ino1- cells in 
medium containing added inositol (500 µM) led to a decrease in cell area 
(average cell area: ino1- without inositol = 123 µm2, and with inositol = 92 
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µm2; wild-type without inositol = 147 µm2, and with inositol = 107 µm2) 
(Figure 5.4 C). No significant difference was found in the cell area between 
the wild-type and the ino1- cells. 
 
Figure 5.4 The effect of inositol depletion on the accumulation of autophagosomes. 
Wild-type and ino1
- 
cells were grown in liquid medium +/- exogenous inositol (500 µM). The 
medium was changed to LowFlo medium (Formedium) for approximately 16 hours to 
minimise the background fluorescence. The ino1
-
 cells were kept in the medium without 
inositol for 24 hours prior to image acquisition. (A) Autophagosomes were visualised in the 
wild-type and the ino1
-
 cells expressing atg8-GFP and (B) quantified in the presence or 
absence (24 hours) of inositol treatment using the ImageJ software. (C) Cell size was 
quantified by measuring the surface area with the ImageJ software. Error bars represent 
SEM. Statistical significance was determined by a two-tailed student’s t-test; ***p < 0.001; n 
≥ 117 cells analysed per condition from 3 independent technical repeats, 1 biological 
replicate.  
5.6 Chemotaxis towards cAMP 
Cell migration and adhesion play important roles in Dictyostelium 
development, where cells initiate aggregation and form multicellular fruiting 
bodies when the food is depleted (Loomis, 2014). Chemotaxis is the oriented 
movement of cells in response to a chemical gradient. During the early 
stages of development, Dictyostelium cells release a chemoattractant, cAMP, 
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that is sensed by neighbouring cells, prompting these cells to initiate 
movement along the gradient towards the source of the chemical (Schaap 
and Wang, 1986). Since cell adhesion and development were impaired in the 
ino1- mutant deprived of inositol, the ability of these cells to chemotax was 
assessed.  
Chemotaxis towards cAMP was measured in a Dunn Chamber (Zicha 
et al., 1991). Aggregation-competent cells were subjected to a cAMP (5 µM) 
gradient in a Dunn chamber over a 12-minute period, and cell movement was 
analysed with Image Pro 6.3 software to determine the velocity (µm/min), 
aspect (roundness) and persistence (Figure 5.5 & Table 5.1). Aspect refers 
to a ratio between X and Y axes of a cell; an aspect of 1 indicates a perfectly 
round cell and an aspect greater than 1 indicates an elongated (polarised) 
cell. Persistence of a cell is the ratio of the distance between the start and 
endpoints and the total length of the track for the cell, and indicates 
directionality of the movement, 1 being straight. Under these conditions, the 
wild-type chemotaxing cells had a constant velocity (8.73 µm/min), an 
average aspect of 2.96 and persistence of 0.917, indicating that these cells 
moved in a straight line towards the cAMP source (Figure 5.5 & Table 5.1). 
The ino1- mutant cells grown in the presence of inositol (500 µM) were also 
able to move with a similar velocity (6.79 µm/min). In contrast, ino1- cells 
grown in the absence of inositol showed decreased velocity (4.42 µm/min, p 
< 0.001) compared to wild-type cells (Figure 5.5 & Table 5.1). In addition, 
analysis of the aspect of ino1- and wild-type cells suggested that ino1- cells 
were significantly more round. These experiments showed that the addition 
of exogenous inositol corrected the reduced velocity of the ino1- cells; 
however, the less polarised cell shape was not rescued by exogenous 
inositol. 




Figure 5.5 The effect of inositol depletion and Ino1 loss on chemotaxis. The movement 
of aggregation-competent ino1
-
 cells, grown in medium with inositol (500 µM), or without 
inositol for 24 hours, towards cAMP (5 µM) in a Dunn chamber was recorded by time-lapse 
imaging over a 12-minute period (1 image taken every 15 seconds). Image Pro 6.3 software 
was used to capture the recording and to analyse cell movement. (A) Plots showing the 
velocity of the wild-type and ino1
-
 strains. (B) Analysis of the aspect (roundness) of the wild-
type and ino1
-
 cells. n ≥ 20 cells analysed per condition from 3 independent technical 








Table 5.1 Average velocity, aspect and persistence of ino1
-
 cells during chemotaxis 
towards cAMP. Aggregation-competent ino1
-
 cells were grown with or without inositol (500 
M) for 24 hours, and their movement towards cAMP (5 µM) in a Dunn chamber was 
recorded using time-lapse imaging over a 12 minute period (1 image taken every 15 
seconds). Image Pro 6.3 software was used to capture the recording and to analyse cell 
movement. Velocity shows the distance travelled by cells over time. Aspect refers to the 
roundness of cells (1 = perfectly round). Persistence is a measure of distance travelled by a 
cell over the total distance to travel towards the chemoattractant (1 mm bridge distance in a 
Dunn chamber). Statistical significance was determined by an unpaired two-tailed student’s 




p < 0.05, 
++
p < 0.01 for the comparison between ino1
-
 cells +/-inositol; n = 9 cells quantified per 
condition from 3 independent technical repeats, 1 biological replicate.  
5.7 Metabolic profile of the ino1- mutant  
Inositol plays a key role in a range of cellular processes and is a 
necessary constituent of a number of signalling chemicals (Deranieh and 
Greenberg, 2009). Thus, a reduction in the production of inositol would likely 
have a broad impact on cell metabolism. To investigate the potential 
metabolic changes caused by loss of Ino1, the metabolic profile of the wild-
type (Ax2) and ino1- mutant cells was obtained (collaboration with Dr S.P. 
Claus and C. Le Roy, The University of Reading). In these experiments, ino1- 
and wild-type cells were grown in the presence or absence of inositol (500 
µM) for 12 or 24 hours to monitor changes caused by reduced inositol 
availability. In addition, following inositol removal (24 hours), inositol was re-
introduced (500 µM, 12 hours) to the growth medium, in order to assess any 
changes caused by inositol rescue. 
The metabolic consequences of inositol depletion were assessed by 
comparing the metabolic profiles of wild-type and ino1- cells under different 
inositol treatment conditions (Figure 5.6). Both ablation of ino1 and inositol 
Strain Velocity (µm/min) Aspect Persistence 
WT (Ax2) 8.73 2.96 0.917 
ino1- (+inositol) 6.79 1.63 (***) 1.177 
ino1- (-inositol) 4.42 (*** / +) 1.76 (*** / ++) 1.809 (*) 
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treatment induced specific metabolic changes. Principal component analysis 
(PCA) of metabolic profiles indicated that the greatest metabolic change 
between the wild-type and ino1- cells was independent of exogenous inositol 
supplementation. Ino1 ablation accounted for 53% and inositol treatment for 
12% of the total variance as observed in PCA (Figure 5.6 A). Ino1 loss 
resulted in an increase in amino acids and compounds related to amino acid 
breakdown (alanine, aspartate, isoleucine, lysine, methionine, GABA, 
putrescine), in energy-related metabolites (fumarate, lactate), in adenosine 
phosphorylated derivatives (5’-AMP, 3’-AMP, ATP, cAMP), and in sn-glycero-
3-phosphocholine (GPC) (Figure 5.6 B). Inositol treatment resulted in an 
increase in the amino acids phenylalanine, leucine, methionine, and tyrosine 
(Figure 5.6 C). Metabolic profile analysis thus suggested a vital role of the 
Ino1 protein in metabolic regulation in Dictyostelium, with only minor changes 
in metabolite levels associated with inositol depletion.  
The distribution of data points (circles denoting wild-type and triangles 
denoting ino1- mutant) along the X-Y axes on the PC plot shown in figure 
5.8A informs about the similarity between these cell lines under the different 
treatment conditions (the closer the data points are along a given axis, the 
more similar the metabolic profile is under the given conditions). Inositol 
treatment did not have a major metabolic impact on wild-type cells since 
treating wild-type cells (control) with inositol (+inositol) did not increase the 
metabolic distance between these two conditions (Figure 5.6 A). 
Interestingly, re-introduction of inositol for 12 hours after a 24-hour inositol 
depletion period made the metabolic profile of the ino1- cells under the +/-
/+inositol condition more similar to the metabolic profile of the wild-type 
(control) than the metabolic profile of the ino1- cells grown with inositol 
supplementation (+inositol) (Figure 5.6 A). 
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Figure 5.6 Comparison of the metabolic profiles of wild-type and ino1
- 
mutant cells 
during inositol depletion. To monitor the metabolic profiles of the wild-type and ino1
-
 
mutant, the cells were grown in the presence of inositol (500 µM, denoted +inositol), the 
absence of inositol (for 12 or 24h denoted +/-), or in inositol added after 24h depletion period 
(500 µM for 12h denoted +/-/+ 12h). Control, shown in green, refers to the wild-type cells 
grown without inositol. Metabolic analysis was performed with Nuclear Magnetic Resonance 
(NMR). (A) Metabolic variations existing between cell type and inositol exposure were 
assessed by principal component analysis (PCA) generated from the 
1
H-NMR spectra of the 
Dictyostelium metabolic fingerprints. The main source of variation (53%) was driven by the 
mutation while inositol depletion accounted for approximately 12% of the metabolic variation 
in this dataset. (B) Loadings plot associated with PC1 (red peaks pointing upwards are 
positively associated with PC1 while those pointing downwards are negatively associated 
with PC1). (C) Loadings plot associated with PC2. The work presented here was done in 
collaboration with Dr S.P. Claus and Caroline Le Roy, University of Reading. n = 4 
independent technical repeats, 1 biological replicate; samples were prepared with 2 x 10
7 
cells per condition 
Since Ino1 absence resulted in a major change in the metabolic profile 
of Dictyostelium cells, the specific metabolic fluctuations were analysed using 
orthogonal projections to latent structures discriminant analysis (O-PLS DA) 
to provide a statistical method for multivariate data. O-PLS removes variation 
from X (descriptor variables) that is not correlated to Y (property variables). 
Initially, the ino1- (+inositol) metabolic profile was compared against the wild-
type metabolic profile using analysis that took mutation as a predictor of the 
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difference. As seen in plot A, the scores associated with the metabolic 
profiles of the wild-type and ino1- cells group separately, indicating that the 
ino1 ablation caused a significant change in the Dictyostelium metabolic 
profile (R2Y = 0.89, Q2Y = 0.88 and p value for 500 random permutations = 
0.002) (Figure 5.7). No effect on the metabolic profile was seen due to the 
selection antibiotic (blasticidin) for the ino1- cells (O-PLS model parameters: 
R2Y = 0.18 and Q2Y = 0). Analysing the levels of the individual metabolites 
(Figures 5.7 B & 5.8) confirmed that Ino1 loss was associated with a 
significant increase in the amino acids alanine, aspartate, glycine, GABA, 
isoleucine, lysine, and methionine, in metabolites associated with the 
regulation of cell cycle and DNA metabolism, including guanosine, ATP, 
deoxy-ADP, 5’AMP, 3’AMP, UTP, β-alanine (a biomarker of the degradation 
of pyrimidines) (Di Meo et al., 2015) and sn-glycero-3-phosphocholine 
(GPC). Also, the levels of putrescine, lactate, acetate, fumarate and 
succinate were significantly increased. 
The impact of inositol depletion on the metabolic profile of the ino1- 
mutant was also analysed. Ino1- cells grown in the presence of inositol and 
starved of inositol for up to 24 hours were compared for metabolic differences 
(Figures 5.7 C,D). The scores generated by this O-PLS DA model, where 
inositol depletion was used as a predictor of the difference, were seen to 
group separately on the plot presented in Figure 5.7 C, indicating that inositol 
depletion had an impact on the metabolic profile of the ino1- mutant (R2Y= 
0.67, Q2Y=0.51 and p value for 500 permutations = 0.002). However, inositol 
depletion had less of an impact compared to Ino1 loss on Dictyostelium 
metabolic profile, since the distance between the scores representing ino1- 
+/-inositol groups (Figure 5.7 C) is smaller than between the scores 
representing wild-type and ino1- groups (Figure 5.7 A). 
Finally, the effect of a re-introduction of inositol after a 24-hour 
starvation period was assessed in the ino1- mutant (Figure 5.7 E,F). The O-
PLS DA analysis was performed where the metabolic effect of the absence of 
inositol for up to 24 hours was compared against the effect of inositol re-
supplementation. The score grouping on the plot in Figure 5.7 E indicates 
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that inositol re-introduction greatly altered the metabolic profile of the ino1- 
cells (R2Y = 0.90, Q2Y = 0.86 and p value for 500 permutations = 0.002). 
This mirrors the findings presented in Figure 5.6 A, where inositol re-supply 
shifted the ino1- metabolic profile to resemble that of the wild-type. Since 
inositol supplementation after a period of starvation, rather than constant 
growth in inositol supplemented medium, caused the ino1- metabolic profile 
to be closer to that of the wild-type, this result suggests that inositol acted as 
a switch to re-set the metabolic state of the ino1- cells. 
In contrast to the loss of Ino1, inositol depletion caused limited 
changes to the Dictyostelium metabolic profile. Comparing ino1- cells grown 
in the presence or absence of inositol, it was seen that inositol 
supplementation led to an increase of inositol, glycogen, glucose and lipids, 
and a decrease in succinate and lactate (Figure 5.7 D); comparing inositol 
depletion to inositol re-introduction, it was seen that inositol depletion caused 
an increase in amino acids tyrosine, phenylalanine and isoleucine, and the 
compounds sn-glycero-3-phosphocholine, maltose, acetate, formate, lactate 
and putrescine (Figure 5.7 F). Supervised analysis to evaluate the general 
impact of inositol depletion on individual metabolites was conducted (Figure 
5.8), and suggested that inositol depletion resulted in changes in some amino 
acids (increases in alanine, GABA, glycine, valine, and a decrease in 
phenylalanine), an increase in lactate, fumarate, and succinate, and a 
decrease in 3’AMP, guanosine and glycogen (Figure 5.8). Although it was 
observed that the ino1- mutant was already in a catabolic state, the addition 
of inositol lessened this phenotype, since markers of anabolism (glycogen 
and lipids) were higher in cells supplemented with inositol, while those not 
supplemented were associated with  markers of catabolism (lactate and 
succinate). Overall, the metabolic profile analysis suggests that the absence 
of Ino1 rather than inositol depletion triggered broad metabolic changes, 
while inositol supplementation lessened the impact of these changes. 
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Figure 5.7 Comparative analysis of the metabolic profile of the ino1
- 
mutant under 
different inositol treatment conditions. Extended analysis of the metabolic profile was 
performed using NMR. (A,B) Metabolic changes induced by ino1 ablation to determine the 
specific impact of the mutation on cell metabolism. (A) Plot of the scores against the cross 
validated scores generated by the O-PLS DA (R
2
Y = 0.89, Q
2
Y = 0.88 and p value for 500 
random permutations =0.002) using the 
1
H-NMR spectra of the wild-type and ino1
- 
cells 
(except +/-/+inositol condition) as a matrix of independent variables and mutation as a 
predictor. (B) Loadings plot associated with O-PLS DA model. Peaks in red indicate 
increased metabolite levels in response to the mutation. (C,D) Metabolic changes induced by 
inositol treatment in the ino1
- 
mutant. (C) Plot of the scores against the cross validated 
scores generated by the O-PLS DA (R
2
Y = 0.67, Q
2
Y = 0.51 and p value for 500 
permutations = 0.002) using the 
1
H-NMR spectra of the ino1
-
 cells (-12h & -24h inositol vs 
+inositol) as a matrix of independent variables and depletion of inositol as a predictor. (D) 
Loadings plot associated with the O-PLS DA model. Peaks in red indicate increased 
metabolite levels in response to inositol presence. (E,F) Re-introduction of inositol post-
deprivation induces a metabolic shift. (E) Plot of the scores against the cross validated 
scores generated by the O-PLS DA (R
2
Y = 0.90, Q
2
Y = 0.86 and p value for 500 
permutations = 0.002) using the 
1
H-NMR spectra of the ino1
- 
cells (-12h and -24h inositol vs 
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+/-/+inositol) as a matrix of independent variables and inositol re-introduction as a predictor. 
(F) Loadings plot associated with the O-PLS DA model. Peaks in red indicate increased 
metabolite levels in response to the depletion of inositol. The work presented here was done 
in collaboration with Dr S.P. Claus and C. Le Roy, University of Reading. n = 4 independent 






















Figure 5.8 Levels of metabolites in the wild-type and ino1
- 
cells grown under different 
inositol conditions. Metabolite levels were measured by NMR, quantified using MATLAB, 
and plotted using GraphPad Prism 5.02. The changes observed in wild-type and ino1
-
 cells 
were measured for (A) amino acids, (B) cell cycle- and DNA-related metabolites, and (C) 
other metabolites. Control, shown in green, refers to the wild-type cells grown without 
inositol. Statistical analysis was carried out between wild-type (Ax2) (+inositol) and ino1
-
 
(+inositol) by unpaired two-tailed student’s t-test to illustrate the significance of changes due 
to the loss of Ino1 protein, shown as “*”, *p < 0;05, **p < 0;01, ***p < 0;001; A separate 
unpaired two-tailed student’s t- test was used to compare ino1
-
 (+inositol) and ino1
-
 (-inositol 




p < 0.05, 
++
p < 0.01, 
+++
p < 0.001. The work presented here was 
done in collaboration with Dr S.P. Claus and Caroline Le Roy, University of Reading. n = 4 
independent technical repeats, 1 biological replicate; samples were prepared with 2 x 10
7 
cells per condition. 
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5.8 Phosphoinositide levels during inositol depletion 
Inositol is a precursor to a family of membrane phospholipids (Seelan et 
al., 2009b). Thus, the inositol depletion phenotype described here enabled an 
analysis of the effect of reduced inositol levels on phosphoinositide levels (in 
collaboration with Dr J. Clark and Dr P. Hawkins, Babraham Institute, 
Cambridge). Two types of phospholipids are present in Dictyostelium, diacyl 
phospholipids containing two acyl linkages to the glycerol backbone, and the 
recently reported ether/acyl phospholipids containing a glycerol backbone 
linked to a fatty alcohol at position 1 (Clark et al., 2014) (Figure 5.9 A). Both 
types of phospholipids form separate pools of glycerophospholipids, 
synthesised from glucose, as exemplified by the pathway for the diacyl-linked 
species (Figure 5.9 B). Phosphatidic acid (PA) and CDP-DAG are precursors 
of phosphatidylserine (PS), phosphatidylethanolamine (PE), and 
phosphatidylcholine (PC), or phosphatidylinositol (PI) when combined with 
inositol. There are different forms of PIs, depending on the phosphorylation 
state of these molecules: phosphatidylinositol monophosphate (PIP), 
phosphatidylinositol bisphosphate (PIP2) and phosphatidylinositol 
trisphosphate (PIP3) (Figure 5.9 B). Diacyl and ether phospholipid species 
was quantified by mass spectrometry in the wild-type and ino1- cells that had 
been grown in the presence or absence of inositol (500 µM) (Figure 5.9 C-F). 
Separation of distinct phospholipid species was limited to those of different 
molecular weights. Phosphatidic acid (PA), a phospholipid precursor that 
comprises a glycerol backbone and two fatty acid tails, was examined first. 
Both diacyl-linked and ether-linked PA levels decreased during early inositol 
depletion (12 hours) in the ino1- cells (Figure 5.9 C,D). Phosphoinositol (PI) 
(formed by the addition of the inositol head group to PA) decreased following 
inositol depletion (in the ino1- mutant), with a greater reduction in diacyl- than 
ether-linked PI. A similar effect was seen for the diacyl-linked 
phosphatidylinositol monophosphate (PIP). Surprisingly, inositol depletion 
resulted in a reduction in diacyl-linked phosphoinositol bisphosphate (PIP2), 
but not in ether-linked PIP2. For phosphoinositol trisphosphate (PIP3), only 
ether-linked PIP3 was detectable, and was reduced compared to wild-type 
cells, independent of exogenous inositol supply. The reintroduction of inositol 
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for 12 hours after a 24-hour starvation period restored the level of the 
majority of ether-linked and diacyl-linked phospholipids. These data suggest 
that the pool of diacyl-linked phospholipids is more sensitive to inositol 
depletion than ether-linked species, and that cellular ether-linked PIP2 levels 
are maintained during these conditions. 
Since a decrease in inositol levels attenuated the production of 
phosphoinositides, and caused a transient reduction of PA, seen at 12 hours 
of inositol starvation, changes in other glycerophospholipids were also 
examined. No change in phosphatidylserine (PS) was seen in the wild-type 
cells grown in the presence or absence of inositol (500 µM); however, ino1- 
cells depleted of inositol for 24 hours showed a non-significant increase in PS 
that was further elevated following inositol replenishment for both ether-linked 
and diacyl-linked species (Figure 5.9 E,F). Phosphatidylethanolamine and 
phosphatidylcholine did not change in the wild-type or ino1- cells under any 
experimental condition (Figure 5.9 E,F).  
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Figure 5.9 Inositol depletion affects the level of phosphatidylinositol and its 
phosphate derivatives. Wild-type and ino1
-
 cells were grown in the presence of inositol 
(500 µM, denoted ‘+’), the absence of inositol (12 or 24h; denoted ‘+/-‘), or in inositol added 
after 24h depletion period (500 µM for 12h; denoted ‘+/-/+‘). (A) The structure of inositol 
phosphate showing diacyl or ether/acyl fatty acid linkages to a glycerol backbone. (B) 
Metabolic pathway depicting phospholipid production from phosphatidic acid (PA) with 
diacyl-linked species used as an example. The levels of ether/acyl (C34:1ea) or diacyl 
(C36:3aa) phospholipids measured in the ino1
-
 cells are shown as a percentage relative to 
phospholipid levels present in the wild-type strain grown in the absence of inositol. (C-D) 
Inositol depletion reduced the level of diacyl-linked PI, PIP, and PIP2 (PIP3 was 
undetectable), and the levels of ether-linked PI, PIP, and PIP3, in the ino1
-
 cells. (E-F) 
Inositol starvation increased the PS level, while the level of PE and PC remained unchanged 
in the ino1
-
 cells. Error bars represent SEM. Statistical analysis was carried out between 
wild-type (Ax2) (+inositol) and ino1
-
(+inositol) by unpaired two-tailed student’s t-test; *p < 
0;05, **p < 0.01, ***p < 0.001; n = 3 independent technical repeats, 1 biological replicate; 
samples were prepared with 1.7 x 10
6 
cells per condition. The work presented here was 
done in collaboration with Dr J. Clark and Dr P. Hawkins, Babraham Institute, Cambridge.  




In this chapter, the effects of starvation of inositol and the loss of Ino1 
on cell function were investigated. The data presented showed that during 
inositol depletion Dictyostelium cells still maintained inositol, albeit at a 
significantly reduced level (inositol level decreased from 2.0 µM to 0.84 µM 
after 12-hour inositol starvation). The addition of exogenous inositol for 12 
hours after 24-hour depletion restored the level of inositol in the ino1- cells 
(1.96 µM) to the basal concentration (2 µM). This result suggested that 
Dictyostelium cells were able to take up inositol from extracellular sources to 
replenish the intracellular pool, and thus inositol availability was not a major 
contributing factor to the phenotypic consequences of inositol starvation. 
Interestingly, wild-type Dictyostelium cells cultured in the presence of 
exogenous inositol (500 µM) had an increased level of intracellular inositol 
(3.4 µM with inositol supplementation vs 1.5 µM without inositol 
supplementation). This finding is consistent with the growth phenotype in 
liquid medium reported in chapter 4, where the wild-type cells grown in the 
presence of inositol reached a higher cell density compared to the cells 
without inositol supplementation. These findings suggest that even though 
axenic Dictyostelium wild-type cells had inositol levels sufficient for vital cell 
functions, the exposure to exogenous inositol prompts these cells to take up 
more inositol from the growth media. 
Due to a vital role of inositol in cell function, cell-substrate adhesion 
was monitored in the ino1- cells in the absence of inositol. Ino1- cells 
exhibited reduced cell substrate adhesion in the absence of inositol. 
Overexpressing ino1-RFP in the ino1- mutant or provision of exogenous 
inositol rescued the reduction in adhesion. Moreover, ino1-RFP 
overexpression in the ino1- cells resulted in a higher number of cells that 
remained attached to a substratum in the first 46 hours of the experiment.  
Inositol is a precursor for phosphatidylinositol 4,5-bisphosphate (PIP2), which 
as a regulator of actin polymerisation and depolymerisation is critical for cell 
motility, adhesion and cytokinesis (Echard, 2012). Cytokinesis is the final 
step of the cell division process, ensuring the partitioning of the nuclear and 
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cytoplasmic contents into independent daughter cells (D'Avino et al., 2005). It 
consists of three sequentially occurring phases: an assembly of the 
cytokinetic apparatus, furrow progression, and fission (abscission) of the 
daughter cells (Logan and Mandato, 2006). Recent studies showed that 
elevating PIP2 at the cleavage furrow is essential for its stability (Logan and 
Mandato, 2006). Removing inositol from Dictyostelium ino1- cells for 24 hours 
caused over a twofold increase in the percentage of cells having ≥ 3 nuclei 
and a threefold reduction in substrate adhesion. Since inositol is a precursor 
for PIP2, its depletion could cause impaired cytokinesis, possibly through an 
inability of the cleavage furrow to close. Inositol has been previously shown 
to play a role in cell-substrate attachment dynamics (Fischbach et al., 2006; 
Zhu et al., 2015). Inositol depletion thus can impair cytokinesis, likely via a 
PIP2 reduction and a decreased substrate attachment.  
Autophagy plays a major role in the maintenance of cell viability during 
nutrient starvation conditions (Mizushima et al., 2002), and recent studies 
have shown a link between inositol depletion and autophagy. Depleting 
inositol caused a change in the level of phospholipids and inositol-containing 
secondary messengers, like inositol-1,4,5 trisphosphate (InsP3), thus altering 
intracellular signalling (Takeda et al., 2014). Lower levels of InsP3 were 
shown to stimulate autophagy (Vicencio et al., 2009), whereas enhancing 
InsP3 levels inhibits autophagy that is induced by nutrient depletion (Criollo 
et al., 2007). Additionally, the bipolar disorder drugs carbamazepine, VPA, 
and lithium, which were proposed to act via inositol depletion (Berridge et al., 
1989; Williams et al., 2002), were shown to induce autophagy, both in vitro 
and in vivo (Sarkar et al., 2005; Chiu and Chuang, 2011; Toker and Agam, 
2014; Toker et al., 2014; Motoi et al., 2014). Schielber et al., (2015) also 
reported that carbamazepine (50 µM) leads to the death of mycobacteria 
after 24 hours via an autophagy process, triggered by inositol depletion 
alone. Since inositol-starved Dictyostelium ino1- cells exhibited impaired 
growth and a development phenotype, and unbalanced growth has been 
previously suggested in these cells as a result of inositol depletion (see 
chapter 4 Discussion), the potential upregulation of autophagy was 
investigated in these cells. For this purpose, Atg8 protein tagged with GFP 
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was overexpressed in both the ino1- mutant and wild-type cells. Post-
translationally modified Atg8 is present on the autophagosome membranes, 
where the protein stays conjugated to phosphatidylethanolamine (Mizushima 
et al., 2002). The presence of GFP-Atg8 on the autophagosome membranes 
was used as a marker allowing for the quantification of the number of 
autophagosomes. Ino1- cells had nearly four–fold more autophagosomes per 
cell after 24 hours of inositol starvation compared to the either the wild-type 
or ino1- cells grown in the presence of exogenous inositol (500 µM). An 
increased number of autophagosomes suggests an upregulation of 
autophagy in the ino1- cells during inositol depletion. This is supported by the 
metabolic profile of the ino1- mutant, where the accumulation of amino acids 
and their breakdown products, favouring a catabolic state, was observed.  
Autophagosomes require fusion with endosomes, and later with 
lysosomes, to allow for the degradation of their components (Kirisako et al., 
1999; Mizushima et al., 2002). Thus, alternatively, the accumulation of 
autophagosomes in the ino1- mutant could also be due to endosome 
dysfunction (preventing fusion of autophagosomes with late endosomes and 
lysosomes), membrane imbalance (resulting from a reduction of 
phosphatidylinositol and phosphatidylethanolamine), or an impaired 
acidification of lysosomes, which is essential for their fusion with 
autophagosomes (Yamamoto et al., 1998). Indeed, perturbation of endosome 
function in yeast led to an accumulation of autophagosomes that were not 
able to fuse with lysosomes (Fujita et al., 2003; Nara et al., 2002) and a yeast 
mutant with defective vacuole fusion events had a higher number of 
autophagosomes in the cytoplasm compared to the wild-type cells (Kirisako 
et al., 1999). The increased number of autophagosomes in the Dictyostelium 
ino1- mutant during inositol depleting conditions needs to be investigated 
further to confirm whether autophagy is upregulated or the clearance of 
autophagosomes forming at the basal rate is reduced because of defective 
fusion. However, an unbalanced cell growth and an increase in the protein 
degradation products in these cells as a result of inositol starvation support 
an increased autophagic response in these cells. It is perhaps not surprising 
that inositol starvation would trigger autophagy, since this process is 
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responsible for the majority of starvation-induced proteolysis in cells 
(Mortimore and Poso, 1987). To investigate a defect related to 
autophagosome accumulation in the ino1- cells, a difference in the rate of 
autophagosome formation can be monitored in the wild-type and ino1- cells 
during inositol depletion over a few-hour time period.  
Cell migration plays an essential role for Dictyostelium to initiate 
development when nutrients are depleted (King and Insall, 2009). In the 
experiments described in this chapter, the effect of inositol depletion was 
examined in the ino1- cells chemotaxing up a cAMP gradient in a Dunn 
chamber. Regardless of inositol supplementation, the ino1- cells were able to 
migrate towards the cAMP source. However, inositol depletion significantly 
reduced the velocity of the ino1- cells, while Ino1 loss resulted in a 
significantly less polarised cell shape compared to wild-type. Cytoskeleton re-
organisation involving changes in actin polymerisation is an important aspect 
of cell migration, and regulation of cell substrate adhesion can influence the 
speed and directionality of moving cells (King and Insall, 2009; Stephens et 
al., 2008). It is possible that impaired cell substrate adhesion in the ino1- 
mutant caused a reduction in velocity. Similarly, a reduction in speed during 
chemotaxis and random cell movement was observed in a Dictyostelium 
sextuple pi3k- mutant that does not produce PIP3. This result suggests that 
reduced levels of PIP3 in the ino1- cells may have caused a decrease in the 
speed of moving cells. This idea is strengthened by the finding that the ino1- 
cells had lowered PIP3 levels compared to the wild-type cells, regardless of 
inositol supplementation, even though the intracellular inositol level was 
comparable to that observed in the wild-type cells. It additionally suggests 
that the Ino1 protein may be involved in regulating PIP3 levels. It is also 
interesting to observe that the ino1- cells supplied with inositol had reduced 
cell polarity, which suggests a requirement for Ino1 protein in re-arrangement 
of cell shape during cell movement. Phosphatidylinositol 3-kinase (PI3K) is 
responsible for PIP3 production, and since the PI3K inhibitor LY294002 has 
been shown to affect the frequency of pseudopod generation (Andrew and 
Insall, 2007), the reduced levels of PIP3 and altered cell polarity of the ino1- 
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mutant could also suggest a possible impairment in the stability of protrusion 
formation in the migrating ino1- cells. 
Ino1 loss was shown to significantly impact Dictyostelium metabolism. 
To better understand the metabolic role of Ino1 in cells, the metabolic profiles 
of  wild-type and ino1- mutant cells subjected to different inositol conditions 
were analysed. The greatest change in metabolic profile was observed 
between the cells with and without the Ino1 protein. The differences between 
the metabolic profiles of the wild-type Dictyostelium and the ino1- mutant 
were not rescued by the addition of inositol, suggesting that the observed 
metabolic shift was not due to inositol levels per se, but rather an absence of 
the Ino1 protein. Surprisingly, ino1- cells exposed to inositol depletion and 
then rescued by exogenous inositol showed a similar metabolic profile to that 
of the wild-type cells grown without inositol. Individual metabolite analysis 
showed that Ino1 loss was associated with an increase in certain amino 
acids, in metabolites regulating cell cycle and DNA function, and an osmolyte 
sn-glycero-3-phosphocholine (GPC), suggesting that the lack of inositol was 
compensated for by the production of another osmolyte. The level of 
putrescine was significantly increased, indicative of an inhibition of cell 
proliferation (Kumar et al. 2014). Also, higher levels of lactate were observed, 
suggestive of an increase in the NADH to H+/NAD+ ratio and stimulation of 
the lactate dehydrogenase activity. An increase in NADH to H+/NAD+ ratio 
(linked to catabolic reactions) would also inhibit the citrate synthase and slow 
down the Krebs cycle, resulting in an accumulation of some intermediates, 
like acetate (derived from the spontaneous hydrolysis of oxaloacetate), 
fumarate, and succinate. Inositol treatment was seen to have little impact on 
ino1- cells compared to wild-type. Overall, these data indicate that the ino1- 
cells were in a catabolic state and support the potential triggering of 
autophagy in the ino1- mutant during inositol starvation. This is further 
strengthened by research showing that inositol depletion and amino acid 
deprivation led to an autophagic response (Criollo et al., 2007; Sarkar and 
Rubinsztein, 2006; Sarkar et al., 2005; Vicencio et al., 2009). Autophagy is 
regulated by three signalling systems in cells: a Tor-kinase complex, an Atg1-
phosphoprotein kinase complex, and a phosphatidylinositol 3-kinase (PI3K) 
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complex (Glick et al., 2010). Inositol depletion was shown to lead to 
autophagy via an mTOR independent mechanism (Sarkar and Rubinsztein, 
2006; Criollo et al., 2007), while amino acid deprivation was reported to 
cause autophagy via mTOR/raptor signalling through activation of class 3 
phosphatidylinositol 3OH-kinase. Therefore, the potential autophagy 
observed in the ino1- mutant could be a result of varied responses to a global 
scale nutrient deprivation. 
Inositol depletion however still reduced the level of phosphoinositides, 
and caused an increase in the level of phosphatidic acid and 
phosphatidylserine. Similar to our findings, Yamagami et al. (2015) reported 
that inositol depletion caused changes in lipid composition in yeast, including 
a decrease in phosphatidylinositol and an increase in phosphatidylserine. 
Inositol depletion also restored vesicle transport in yeast phospholipid 
flippase mutants (Yamagami et al., 2015). Phospholipid flippases play a role 
in maintaining phospholipid distribution at the plasma membrane and are 
implicated in the formation of transport vesicles (Yamagami et al., 2015). 
Mutations in phospholipid flippases cause defects in growth and endocytic 
recycling in yeast cells (Takeda et al., 2015). The restoration of the function 
of the endocytic recycling pathway and promotion of vesicle production was 
mediated by an increased cellular level of phosphatidylserine, which was 
proposed to actively recruit proteins for vesicle production or by inducing a 
curvature in the cytoplasmic membrane that facilitated vesicle formation 
(Takeda et al., 2014). Phosphatidylserine levels, which increased after 24 
hours of inositol starvation in Dictyostelium ino1- mutant cells, can facilitate 
endocytosis.  
The effect of ino1 deletion and inositol rescue on the level of 
phosphoinositides was also examined. Dictyostelium cells use two distinct 
types of glycerophospholipids: one type of phospholipid contains fatty acid 
tails linked to a glycerol backbone with a double acyl (diacyl) linkage, and the 
second type comprises a fatty alcohol (ether) at the sn-1 position and an acyl 
at the sn-2 position (Clark et al., 2014). Both of these types of phospholipids 
were reduced by inositol depletion, with an enhanced reduction of diacyl 
species. Specifically, inositol depletion led to a rapid reduction in PI and PIP 
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(ether and diacyl species), and diacyl PIP2, but unexpectedly had little effect 
on ether PIP2. Only ether-linked PIP3 could be monitored in samples, and 
this was heavily reduced under all conditions, independent of exogenous 
inositol. Since ether-linked phosphoinositides account for over 95% of 
Dictyostelium inositol phospholipids (Clark et al., 2014), the enhanced 
reduction in diacyl phosphoinositides may be a reflection of their lower 
abundance. Alternatively, diacyl compounds may comprise a more labile pool 
of signalling molecules than ether phosphoinositides.  
Cellular levels of ether PIP2 were maintained during inositol 
starvation. The maintenance of PIP2 levels during inositol depletion was a 
surprising finding, although other phosphoinositides (PI, PIP, PIP3) were 
significantly depleted. This suggests a critical role for PIP2 in cell function, a 
view that is supported by recent studies that demonstrated an essential role 
for PIP2 in cytokinesis (Mitsuhiro et al., 2012), vesicle formation and 
transport (Klopfenstein et al., 2002), and Dictyostelium cell movement during 
chemotaxis. Knock-out of PIP5 kinase (PikI) that produces PIP2 caused a 
90% reduction in PIP2 level, and resulted in a highly disorientated movement 
of the pikI- mutant in cAMP gradients (Fets et al., 2014). These findings have 
relevance to phosphoinositide metabolism in the brain, as a recent study 
suggests that phosphoinositides, and specifically PIP2, play an important role 
in membrane traffic at the synapse (Cremona and De Camilli, 2001). PIP2 
was implicated in neurotransmitter secretion, nucleation of clathrin coats, and 
the formation of a cytoskeletal scaffold to promote endocytosis at the 
synapse area, where PIP2 dephosphorylation accompanies the release of 
newly formed vesicles (Cremona and De Camilli, 2001). The pivotal role of 
PIP2 in these processes and in Dictyostelium cell growth and development 
could therefore explain the requirement for cells to maintain the levels of this 
essential molecule. This assertion is strengthened by the finding that the 
protein complexes involved in exocytosis and endocytosis at the synapse are 
highly conserved throughout evolution, and are similar to protein complexes 
that take part in exocytosis and endocytosis in all eukaryotic cells (Cremona 
and De Camilli, 2001).  
 




Overall, the data presented in this chapter show that the depletion of 
inositol leads to a dramatic change in cell physiology, potentially leading to 
an autophagic response, a reduction in cell division, and a loss of substrate 
adhesion that could be a contributing factor in the velocity reduction of 
chemotaxing ino1- mutant cells. Inositol depletion also led to a decrease in 
the level of inositol phospholipids, and yet the level of PIP2 was maintained 
by cells, indicating an important role of this phospholipid. Removal of Ino1 
protein accounted for a significant change in the Dictyostelium metabolic 
profile when compared to inositol depletion. The Ino1 protein may also be 
involved in maintaining PIP3 levels, and its loss caused a reduction in the 
polarised cell shape during chemotaxis.  
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Chapter VI  
Cellular roles of Ino1 
6.1 Introduction 
The established role for the Ino1 enzyme is de novo inositol 
production (Dean-Johnson and Henry, 1989). In the previous chapters 
however, Ino1 was shown to be involved in cell growth, shape and metabolic 
regulation, regardless of inositol provision. To investigate a role for Ino1 in 
regulating these processes independent of its catalytic activity, the induction 
of Ino1 transcription and the effects of Ino1 mutations on cell growth and 
development were examined.  
Ino1 transcription has been extensively researched, showing that the 
transcription of the gene was tightly regulated by the presence of inositol, 
choline, and Ino1 protein itself, as well as cellular events like the unfolded 
protein response (Brickner and Walter, 2004; Donahue et al., 2010; 
Felberbaum et al., 2012; Ford et al., 2007; Grigat et al., 2012; Kerr and 
Corbett, 2010; Konarzewska et al., 2012; Loewy and Henry, 1984; Shetty 
and Lopes, 2010). Structure and enzyme activity studies showed that the 
Ino1 protein exists as a homotetramer in yeast and as a homotrimer in 
mammals (Klig and Henry, 1984; Majumder et al., 1997; Seelan et al., 2004). 
Each Ino1 monomer has three major domains: a catalytic domain that binds 
the substrate glucose-6-phosphate, an NAD-binding domain, and a central 
domain that consists of the N- and C-termini that functions to stabilise the two 
other domains (Jin et al., 2004; Stein and Geiger, 2002). For Ino1 to 
complete its catalytic cycle, the active site folds to completely encapsulate 
the substrate in an example of induced fit. 
There is little experimental evidence relating to the role of Ino1 post-
translational modification. However, a recent study suggests that Ino1 activity 
is regulated by phosphorylation, where by mass spectrometry analysis five 




phosphosites were identified in yeast Ino1 protein (Deranieh et al., 2013). 
Phosphorylation of rat Ino1 extracted from brain was also demonstrated via 
phosphospecific ProQ-Diamond staining and Western blot analysis 
(Parthasarathy et al., 2013). Three of the identified phosphosites in yeast 
(S184, S296, S374) were conserved in the human Ino1 (S177, S279, S357). 
Phosphorylation was also shown to regulate an activity of human and yeast 
Ino1 (Deranieh et al., 2013). Phosphodeficient (S296A) and phosphomimetic 
(SS296D) mutations in Ino1 from yeast (and a corresponding S279 site in 
human Ino1) decreased the enzymatic activity, suggesting that the position of 
serine at this site was critical for Ino1 enzymatic activity. Similarly, 
phosphomimetic mutations S184D and S374D caused a decrease in Ino1 
activity showing that the phosphorylation of these two sites was inhibitory. 
Additionally, the double mutation S184A/S374A caused an increase in Ino1 
activity to enhance growth rate in yeast (Deranieh et al., 2013).  
Ino1 activity is also affected by therapeutically relevant drugs, where 
the mood stabilising drugs, valproic acid and lithium, were shown to lower 
intracellular inositol and inositol trisphosphate levels (Eickholt et al., 2005; Ju 
and Greenberg, 2003; Vaden et al., 2001; Williams et al., 2002). In yeast and 
Dictyostelium, the resulting inositol depletion caused an increase in 
expression of ino1, which is regulated in response to inositol. In yeast, 
valproic acid and lithium also increased the expression of a regulatory gene, 
ino2, which controls the inositol and phospholipid biosynthetic pathways 
(Vaden et al., 2001). Additionally, valproic acid was shown to inhibit the 
activity of the Ino1 enzyme in vivo, but not in vitro, in yeast and in mouse 
frontal cortex extracts, suggesting an indirect mechanism of action of this 
drug on Ino1 (Ju et al., 2004; Shaltiel et al., 2004).  
To decipher the regulatory roles of proteins in cells, it is useful to 
investigate their binding partners and the processes these proteins are 
involved in. Few studies have identified Ino1 interacting proteins. However, 
Ino1 interactors isolated from yeast and human studies included proteins 
involved in the regulation of DNA transcription and translation, nucleic acid-, 
phospholipid-, nitrogen- and carbohydrate metabolism, intracellular protein 




transport, endocytosis, membrane growth and polarity, electron transport 
chain function, and ubiquitination (Schlecht et al., 2012; Tarassov et al., 
2008; Wan et al., 2015). 
In this chapter, initial experiments that sought to develop an assay for 
monitoring ino1 expression were investigated. In addition, mutations in the 
catalytic core and phosphorylation sites of the enzyme as well as the effects 
of inositol depleting drugs on the development of the ino1 mutants were 
examined. Finally, potential Ino1 binding partners in Dictyostelium were 
identified by a proteomics approach following isolation by protein-protein 
interactions using total cell lysates.  
6.2 Monitoring ino1 gene transcription 
To monitor ino1 transcription in response to changing inositol levels, a 
plasmid construct was created that enabled the -galactosidase gene to be 
expressed under the control of the ino1 promoter (Figure 6.1). Primers for 
PCR amplification were designed to amplify 0.35, 0.7 and 1.0 kb of the 
promoter sequence upstream of the ino1 start codon (Figure 6.1 A) and the 
resultant PCR products were cloned and sequenced. Due to the high AT 
content of this region (Figure 6.1 B), sequence analysis revealed that all 
sequenced clones contained mismatches to the available ino1 sequence 
(DDB_G0285505). The nucleic acid sequence that contained the highest 
number of matched bases, further referred to as the ino1 promoter, was 
cloned into the pDdGal vector (Harwood and Drury, 1990), replacing the 
actin15 promoter to drive the expression of the β-galactosidase gene in 
Dictyostelium ino1- cells (Figure 6.1 C-E). The β-galactosidase enzyme 
activity was detected in the lysates prepared from ino1- cells transformed with 
reporter vectors by an Enzyme Assay System from Promega. Cell lysate was 
prepared from adherent cells using reporter lysis buffer. β-galactosidase 
activity was assayed with a buffer that contained the substrate ONPG (o-
nitrophenyl-β-D-galactopyranoside) (Figure 6.1 F). Ino1- cells expressing β-
galactosidase vectors were deprived of inositol for 16 hours prior to the 
assay. The production of the yellow colour was visible in the Ino1- cells 




transformed with the pDdGal vector only (Act15-lacZ) and quantified by 
absorbance reading at ʎ420 (Figure 6.1 F). Cell lysate from the ino1- control 
not expressing β- galactosidase did not produce a visible colour change and 
the absorbance reading at ʎ420 was similar to the blank control. These data 
suggested that the assay was functioning and that the β-galactosidase 
enzyme was active in the ino1- cells. However, vector containing the 0.7kb 
sequence upstream of the ino1 gene (ino1-lacZ) did not express the β-
galactosidase enzyme at a detectable level under the tested conditions as no 
change was observed for the β-galactosidase activity in the ino1- cells 
transformed with this construct. This was suggestive of the cloned ino1 
promoter fragment to be non-functional, which may be a result of the 
mutations in the promoter sequence or, alternatively, the 700bp of the ino1 
promoter fragment was not sufficient to drive gene expression. Due to time 
restrictions these assays were not developed further. 





Figure 6.1 Monitoring Ino1 levels via ino1 transcription in response to inositol. An 
Ino1-lacZ reporter construct was created to express β-galactosidase in ino1
-
 cells to 
measure the level of gene transcription driven by the ino1 promoter in response to inositol 
treatment. (A) 0.35, 0.7 and 1.0 kb of the nucleic acid sequence upstream of the ino1 start 
codon was amplified by PCR using sequence specific primers. PCR products were then 
subcloned into a TOPO-TA vector for DNA vector amplification in bacteria. (B) Diagram 
showing 1000 base pairs of the AT-rich DNA sequence upstream of the ino1 start codon. 
The sizes of the regions amplified by PCR to clone into the pDdGal vector are marked to the 
right of the sequence. DNA sequence marked in red was confirmed by sequencing to be 
complementary to the 0.7kb promoter fragment subsequently cloned into the pDdGal vector. 
The ino1 start codon is shown in blue font and highlighted by a blue box. (C) A test digest 
was performed to select the clone with the correct size PCR product (marked by an asterisk), 
followed by gene sequencing to confirm the correct sequence. (D) The 0.7kb ino1 promoter 
fragment was cloned into a pDdGal vector to replace the Act15 promoter. The completed 
vector contained the lacZ gene coding for the β-galactosidase enzyme transcribed from the 
putative ino1 promoter (700 bp upstream of the ino1 start codon). (E) The correct cloned 
vector was selected by restriction digest analysis with the enzymes that were used to create 
the construct. The fragment of the correct size (700 bp) is marked by an asterisk. (F) β-
galactosidase enzyme activity was assayed using a colourimetric method, where the rate of 
conversion of a colourless substrate into a coloured product was quantified by absorbance 
measurement. Molecular weight marker sizes are shown in kilo base pairs. 




Figure 6.2 Creating a catalytically-inactive Ino1. (A) Cloning of the ino1-D342A construct 
into the 389-2 vector containing mRFPmars to be expressed as a C-terminal tag. Ino1 
sequence was amplified with sequence-specific primers in two separate PCR steps, where 
two fragments of the ino1 gene were amplified first to introduce a point mutation at the amino 
acid position D342 (GAT to GCA), followed by a PCR amplification with a mixture of the two 
DNA fragments as a template to obtain a full length mutated ino1. (B) Multiple sequence 
alignment of a portion of the Ino1 proteins from various species to show amino acids 
conserved around the catalytic domain region. The highly conserved amino acid signature 




belonging to the putative catalytic site (Majumder et al., 2003) is highlighted in a red box. 
The mutated aspartic acid residue is marked with a red asterisk. (C) 389-2 vector ligated with 
ino1D342A sequence was transformed into bacteria and the independent clones were 
screened using a PCR approach with sequence-specific primers. The clones containing DNA 
that showed the band of a correct size during DNA gel electrophoresis (1.67kb, marked with 
an asterisk) were sequenced to confirm the presence of the introduced mutation. (D) Ax2 
and ino1
-
 cells were transformed with the ino1D342A construct. The expression of the ino1 
gene was confirmed with RTPCR on the colonies resistant to the selection antibiotic (G418). 
Molecular weight marker sizes are shown as kilo base pairs. 
6.3 Investigating a catalytically inactive Ino1 mutation 
To examine a possible non-catalytic function for Ino1, a mutated 
Dictyostelium Ino1 protein was expressed that was likely to have disrupted 
catalytic activity (Figure 6.2). For these experiments, a construct was created 
to express Dictyostelium Ino1 with a point mutation, D342A tagged with a C-
terminal RFP in the 389-2 vector (courtesy of Dr Annette Müller-
Taubenberger) (Figure 6.2 A-C). The construct was created by the overlap 
extension PCR method using sequence-specific primers (Figure 6.2 A). The 
presence of the D342A mutation in the ino1 gene was confirmed by DNA 
sequencing. The expression of Ino1-D342A in wild-type and ino1- cells was 
verified by RTPCR (Figure 6.2 D).  
Ino1-D342A did not rescue the inability of ino1- cells to grow without 
inositol supplementation, both on bacterial lawns or in liquid suspension, 
suggesting that the mutated protein was catalytically inactive (Figure 6.3 A & 
B). Expression of Ino1-D342A in wild-type cells did not hinder the growth of 
these cells on bacterial lawns (Figure 6.3 A). However, Ino1-D342A 
significantly decreased the growth of wild-type cells in liquid media compared 
to an untransformed control; grown without inositol, the doubling time of wild-
type control was 23 hours, wild-type expressing Ino1-D342A 43 hours. 
Inositol supplementation (500 µM) reduced the doubling time of wild-type 
expressing Ino1-D342A to 27 hours but did not rescue the growth of these 
cells to the level of the wild-type control (Figure 6.3 B). Cell density of wild-
type cells expressing Ino1-D342A was lower than the wild-type control, 
regardless of inositol supplementation. Also, addition of 500 µM exogenous 
inositol partially rescued the growth defect of the ino1- mutant expressing 
Ino1-D342A (doubling time of 26 hours). Furthermore, ino1- cells grown in the 




presence of 500 µM inositol had higher cell density than wild-type cells 
expressing the mutated Ino1-D342A protein. 
 
Figure 6.3 Growth of Dictyostelium cells expressing catalytically-inactive Ino1. Ino1-
RFP protein with a point mutation (aspartic acid to alanine substitution, ino1D342A) in a 
highly conserved region of the catalytic domain was expressed in wild-type and ino1
- 
cells. 
(A) Grown in the absence of exogenous inositol, wild-type (Ax2) cells transformed with 
ino1D342A were able to grow on bacterial lawn similar to the untransformed control (growth 
zones are marked in red), while ino1
-
 cells were unable to grow. (B) In wild-type cells, 
overexpression of the mutated Ino1 protein caused a significant decrease in the growth 
compared to untransformed wild-type cells, even with the addition of 500 µM inositol to the 
growth media. Ino1
-
 cells were not able to grow without extracellular inositol supply and the 
overexpression of the Ino1-D342A did not rescue this growth phenotype, indicating that the 
protein was catalytically inactive. Addition of 500 µM inositol to the growth medium partially 
rescued the inositol auxotrophy phenotype of ino1
-
 cells and ino1
-
 cells expressing ino1-
D342A. (+I): +500µM inositol; (-I): no inositol added. Error bars represent SEM. Statistical 
analysis was carried out in separate tests for each individual condition compared to wild-type 
(-I) by unpaired two-tailed t-test, *p < 0.05, ***p < 0.001; n = 3 technical repeats; 1 biological 
replicate. 




6.4 Investigating the effect of Ino1 phosphomutations 
 A multiple sequence alignment confirmed that Dictyostelium Ino1 
contained serine residues at positions cognate to the yeast and human Ino1 
phosphosites at S179, S282, S360 (Figure 6.4 A). To gain more information 
about a potential role of Ino1 phosphorylation in Dictyostelium growth, cell 
lines expressing ino1 with single point mutations corresponding to the 
putative Ino1 phosphorylation sites were created. In order to introduce single 
point mutations in Ino1 S179, S282, and S360, three plasmids were created 
using pTXGFP vector as a backbone (Levi et al., 2000) (Figure 6.4B). 
Mutations (S179A, TCC to GCC; S282A, TCA to GCA; S360A, TCA to GCA) 
were introduced by overlap extension PCR with sequence-specific primers 
(Figure 6.4 B). The presence of the full length (1.67kb) ino1 gene was shown 
by restriction digest analysis (Figure 6.4 C). The correct ino1 sequences 
containing each substitution were confirmed by DNA sequencing and the 
expression of ino1 in ino1- cells was verified by RTPCR (Figure 6.4 D). Ino1- 
cells expressing Ino1 with S179A, S280A, or S360A mutations were able to 
grow in the absence of inositol supplementation (not quantified). These 
results suggest that phosphorylation of Ino1 at these sites is not necessary 
for catalytic activity of the protein.  




Figure 6.4 Creating Ino1 phosphomutations. (A) Multiple sequence alignment of the 
human (hISYNA1) and Dictyostelium (dINO1) Ino1 proteins. Black asterisks indicate identical 
amino acids while red asterisks indicate the putative phosphorylation sites. These three 
serine residues (S179, S282, S360) in the Dictyostelium protein sequence were substituted 
with alanine. (B) Cloning of the ino1-S179A, ino1-S282A, and ino1-S360A constructs into the 
pTXGFP vector containing GFP to be expressed as an N-terminal tag. To introduce each 
mutation separately, ino1 sequence was amplified with sequence-specific primers in two 
separate PCR steps, where the two fragments of the ino1 gene were first amplified to 
introduce a point mutation at the amino acid positions S179 (TCC to GCC), S282 (TCA to 
GCA), or S360 (TCA to GCA), followed by a PCR reaction with a mixture of the two DNA 
amplicons as a template to obtain the full length ino1. (C) pTXGFP vector containing 
ino1S179A, ino1S282A, or ino1S360A sequence was transformed into bacteria and 
independent clones were screened by restriction digest with the enzymes used to clone the 
ino1 gene into pTXGFP. The clones containing a band of the correct size by DNA gel 
electrophoresis (1.67kb, marked with an asterisk) were confirmed to contain the introduced 
mutation by DNA sequencing. (D) Ino1
-
 cells were transformed with ino1S179A, ino1S282A, 
or ino1S360A plasmids. The expression of ino1 was confirmed RTPCR on the colonies 
resistant to the selection antibiotic (G418). (E) Fluorescence images of live ino1
-
 cells 
expressing Ino1 with different phosphomutations. Ino1 proteins with a single mutation at the 
three individual phosphosites localised to the cytosol, like the native Ino1 protein tagged with 
GFP (Ino1
-
::GFP-Ino1). Molecular weight marker sizes are shown as kilo base pairs. Size 
bar represents 10 µm.  




6.5 The effect of inositol-depleting drugs on development of 
ino1 mutants 
 Dictyostelium development, where cells aggregate to form fruiting 
bodies, was shown to be sensitive to inositol-depleting drugs (Eickholt et al., 
2005; Williams et al., 1999, 2002). Since Ino1 is responsible for the 
production of inositol in cells, the effect of the inositol-depleting drugs VPA 
and lithium was investigated during development of cells that either lacked or 
overproduced Ino1 protein (Figure 6.5). In these experiments, wild-type 
Dictyostelium cells (Ax2 strain) formed mature fruiting bodies, containing a 
basal disk, stalk, and round spore head, over a period of 24 hours (Schaap 
and Wang, 1986), while ino1- cells required prior supplementation with 
exogenous inositol (500 µM) to complete this developmental process. 
Overexpressing ino1-RFP in ino1- cells rescued the inability of these cells to 
develop without inositol supplementation. These results were consistent with 
the observation that inositol depletion blocks Dictyostelium development. 
 Analysis of the effect of inositol-depleting drugs on the development of 
wild-type cells showed that VPA (1 mM) treatment led to a complete block in 
development (Figure 6.5). Removing or overproducing the Ino1 protein in 
Dictyostelium did not increase resistance to VPA (1 mM). However, 
decreasing the concentration of VPA (0.5 mM) reduced the inhibitory effect of 
the drug, so that wild-type and ino1- cells were able to form fruiting bodies 
within 24 hours. Treatment of wild-type cells with LiCl (10 mM) also caused a 
block in development, resulting in no fruiting bodies forming (Figure 6.5). 
Removing or overproducing Ino1 protein did not rescue Dictyostelium 
sensitivity to lithium at concentration (10 mM). Although ino1 ablation or 
overproduction of the Ino1 protein did not give rise to major morphological 
changes in development, the ino1- cells were not able to develop without 
prior inositol supplementation, suggesting that the catalytic role of Ino1 in 
inositol biosynthesis is essential for multicellular development. These results 
also suggest that Ino1 protein is not a direct target of VPA and lithium, since 
altering Ino1 protein levels would be predicted to alter sensitivity to these 
drugs if it were the direct target.   





Figure 6.5 Development of the ino1
- 
mutants. Dictyostelium wild-type (Ax2) and ino1
- 
cells were developed on nitrocellulose filters over a period of 24 hours. 
Cells were treated with VPA (0.5 mM or 1 mM) or lithium (10 mM) at the start of the 24-hour development assay period. Ino1
-
 cells were grown in the presence 
of 500 µM inositol or without inositol for 24 hours prior to the development assay. Schematic images of the microscope lens over the filter with fruiting bodies 
represent the angle of the camera used to record development from (A) an aerial and (B) side angle view. Representative of 3 independent technical repeats. 
Size bars represent 0.5 mm.  




6.6 Ino1 binding partners 
6.6.1 Proteomics 
Immunoprecipitation was employed to identify potential Ino1 binding 
partners. Lysates were obtained from wild-type and ino1- cells 
overexpressing Ino1-RFP, and RFP was immunoprecipitated using agarose 
beads coated with an anti-RFP antibody, followed by SDS-PAGE separation 
and mass spectrometry analysis (Figure 6.6 A). This method relied on 
immobilising Ino1 and its binding partners on anti-RFP coated beads via an 
RFP tag present on the Ino1 protein (Figure 6.6 B). Protein complexes were 
visualised by Coomassie stain and western blot (Figure 6.6 A). A band of the 
expected size for the monomeric Ino1-RFP protein (~84 kDa) was visible by 
Coomassie stain and western blot with anti-RFP antibody, confirming that the 
protein was present in the cell lines used for these experiments. A number of 
higher molecular weight bands were also seen in the Coomassie-stained gels 
(Figure 6.6 C); sixteen unique protein bands visible only in the Ino1-RFP 
bound fraction and absent from the equivalent control RFP sample were 
excised, along with the corresponding region from the control (ino1- 
expressing RFP or wild-type cells) and analysed by mass spectrometry (S. 
Lilla and Prof R. Insall, Beatson Institute,Glasgow) to identify interacting 
proteins (Figure 6.6 C).  
6.6.2 Intracellular protein-protein interaction 
The mass spectrometry analysis identified ~300 interactors in three 
independent experiments, of which 104 potential binding partners were 
selected based on two criteria, namely a minimum threshold of peptide hits of 
2 and an absence from the control sample (Table 6.1). Potential binding 
partners were then divided into six major functional groups: actin-related, 
immunity and stress, metabolism, nucleic acid-related (translation, 
transcription, regulation of gene expression and DNA recombination), 
protein-related (catabolism, modification and transport, signal transduction, 
ATP hydrolysis and proton transport (Supplementary Material, Table S2).  




Due to the large number of potential binding partners, further analysis 
focused on three proteins: GpmA, a phosphoglycerate mutase, the product of 
which, 2,3-bisphospho-D-glycerate, was found to accumulate in ino1- cells 
starved of inositol (Fischbach et al., 2006); PefB, a penta-EF-hand containing 
protein linked to neurodegenerative and lysosomal diseases 
(Vergarajauregui et al., 2009; Vito et al., 1996); SecG, a putative Arf-guanine-
nucleotide exchange factor (GEF) involved in development and substrate 
adhesion (Garcia et al., 2013; Shina et al., 2010); and Q54IX5, an 
uncharacterised protein, which was present in all three independent 
immunoprecipitation experiments (Figure 6.7). Expression constructs were 
made for all three proteins initially with a FLAG epitope in ino1- cells and co-
immunoprecipitation was performed with cell lysates incubated with anti-RFP 
coated agarose beads (Figure 6.7 A&B). The bound protein fractions were 
analysed for the presence of a FLAG-tagged protein by western blot analysis 
where FLAG -GpmA was shown to bind weakly, and FLAG-Q54IX5 was 
shown to bind strongly to Ino1-RFP; FLAG-SecG and FLAG-PefB could not 
be detected (Figure 6.7 B). Furthermore, the Q54IX5-Ino1 interaction was 
confirmed using the reverse co-immunoprecipitation. Extracts from ino1- cells 
co-expressing Ino1-RFP and GFP-Q54IX5 were incubated with anti-GFP-
coated agarose beads and the co-precipitation of Ino1-RFP was detected by 
western blot analysis with anti-RFP antibody (Figure 6.7 C). Fluorescence 
microscopy of live cells showed that GFP-Q54IX5 protein localises to the 
cytosol, similar to the Ino1-RFP protein (Figure 6.7 D).  
The outcome of these experiments was the identification of a variety of 
actin and metabolism-associated proteins as potential Ino1 binding partners. 
The binding of Q54IX5, a SEL1 domain-containing protein with an unknown 
function, was confirmed by the reverse-immunoprecipitation approach. The 
weak interaction between FLAG-GpmA and Ino1-RFP detected in the initial 
experiment could not be confirmed by reverse immunoprecipitation using 
GFP-gpmA protein. SecG protein could not be resolved on the SDS-PAGE 
gel, possibly due to the large size of the protein.  





Figure 6.6 Immunoprecipitation of the Ino1 protein. Ino1-RFP protein was 
immunoprecipitated using anti-RFP coated beads. Extracts from ino1
-
 cells expressing ino1-
RFP or RFP only (control) were used to identify specific binding partners. (A) Schematic 
representation of the immunoprecipitation procedure. Dictyostelium ino1
-
 cells expressing 
Ino1-RFP were lysed and incubated with anti-RFP coated beads to bind Ino1-RFP and any 
interacting proteins to the beads. Unbound proteins (NB) were eluted. The beads were then 
washed, boiled to dissociate immunocomplexes, and the Ino1-bound complexes eluted. The 
eluates were subject to SDS-PAGE and Coomassie staining. The bands specific to the ino1-
RFP immunoprecipitate were analysed using mass spectrometry. (B) Schematic of the 
plasmid construct transformed into ino1
-
 cells to express ino1-RFP. (C) Coomassie stain and 
western blot of one of the three immunoprecipitation repeats that was used to identify 
putative Ino1-interacting proteins. Left: the purified Ino1 complexes were separated on an 
SDS-PAGE gel and visualised with Coomassie stain. Right: Western blot analysis to confirm 
the presence of a full-length Ino1-RFP protein in the lysates using an anti-RFP monoclonal 
antibody. (B) bound; (NB) non-bound. 
 
  





Figure 6.7 Ino1 protein interaction analysis. (A) Schematic showing vectors transformed 
into Dictyostelium ino1
-
 cells to co-express Ino1-RFP along with its putative interacting 
protein, with either a FLAG or GFP tag. Hygromycin (50 µg/ml) and neomycin (G418) (20 
µg/ml) were used for a double selection to isolate these cell lines. (B) FLAG-tagged GpmA, 
PefB, SecG and Q54IX5 proteins co-expressed in ino1
-
 cells with Ino1-RFP were 
investigated by co-immunoprecipitation using anti-RFP-coated beads, followed by western 
blot analysis with anti-RFP and anti-FLAG antibodies. Left: first repeat of the 
immunoprecipitation; gel electrophoresis showed the presence of FLAG-GpmA, FLAG-PefB 




and FLAG-Q54IX5 proteins (FLAG-SecG protein was not detected) in the eluate that was not 
bound to the antibody-coated beads. A weak band representing FLAG-GpmA in the bound 
fraction (Ino1-RFP bound proteins) was not confirmed in the second repeat of the 
immunoprecipitation. FLAG-PefB was also not seen in the bound fraction. FLAG-Q54IX5 
was present in both repeats of the immunoprecipitation. The strong band detected for FLAG-
Q54IX5 suggested a strong interaction with Ino1-RFP protein. (C) The Ino1-Q54IX5 
interaction was confirmed by immunoprecipitation of GFP-Q54IX5 with anti-GFP-coated 
beads from ino1
- 
cells co-expressing Ino1-RFP, followed by western blot analysis with anti-
RFP and anti-GFP antibodies. GFP-Q54IX5 protein co-immunoprecipitated Ino1-RFP but not 
RFP, suggesting that the interaction was specific to Ino1. (D) Live cell imaging revealed 
cytosolic localisation of the GFP-Q54IX5 protein. Similarly, Ino1-RFP protein was also 
detected in the cytosol. Size bars represent 10 µm. 
6.7 Discussion 
In the previous chapters, the ino1- mutant cells were shown to be 
dependent on a supply of exogenous inositol in order to grow and develop. 
However, only the presence of the Ino1 protein, and not inositol 
supplementation, led to a full restoration of the growth rate, and rescued the 
inability of the ino1- mutant to consume bacteria (Chapter IV). The loss of the 
Ino1 protein, as opposed to inositol deprivation, also caused major metabolic 
changes in Dictyostelium (Chapter V), suggesting that Ino1 protein itself was 
important in regulating cell function.  
To gain more insight into a cellular role for Ino1, the level of Ino1 
production in response to inositol treatment was investigated by measuring 
the expression of the lacZ gene, which encodes the β-galactosidase enzyme, 
from the inositol-sensitive ino1 promoter. The expression of ino1 is regulated 
by the presence of intracellular inositol, since in yeast a decrease in inositol 
level activates ino1 transcription (Culbertson et al., 1976; Ford et al., 2007; 
Shetty and Lopes, 2010). In Dictyostelium ino1- cells, lowered intracellular 
inositol levels are predicted to activate transcription of the lacZ gene when 
placed under control of the ino1 promoter. β-galactosidase activity was thus 
monitored by measuring colour change in ino1- cells expressing the ino1-lacZ 
construct using colourimetry. 700 bp upstream of the ino1 start codon were 
cloned into a vector containing the lacZ gene, since the identity of the ino1 
promoter is not known in Dictyostelium. However, this AT-rich upstream 
sequence, the presumptive ino1 promoter region, proved to be problematic 
for the generation of a mutation-free construct because of Taq polymerase 




errors or replication within bacteria; a clone with the highest homology to the 
sequence from the annotated Dictyostelium genome of this region was used 
in this experiment. β-galactosidase enzymatic activity was detected in the 
positive control samples, ino1- cells constitutively expressing the lacZ gene 
from an actin15 promoter, but was undetectable in the ino1- cells expressing 
lacZ gene under control of the putative ino1 promoter. This result indicated 
that the ino1 promoter was not functional in these cells, presumably resulting 
either from the nucleotide mismatches in the cloned ino1 promoter sequence 
from the published sequence, or because the region cloned was too small. 
This approach requires further optimisation and was not taken forward in this 
project due to time constraints. 
To study the non-catalytic role of Ino1, a point mutation was 
introduced at the core catalytic site of the protein. The aspartic acid present 
within the Dictyostelium Ino1 catalytic region at position 342 is highly 
conserved in the Ino1 proteins from various biological species (Majumder et 
al., 2003) (Figure 6.2 B), and thus mutation of this residue was expected to 
disturb catalytic function of the Ino1 protein. The aspartic acid was replaced 
with alanine, as it is small, non-polar, hydrophobic and relatively non-
reactive, and thus was unlikely to cause protein missfolding or unwanted 
reactiveness with other molecules. On the other hand, since aspartic acid is 
polar and negatively charged (often found in protein active sites (Betts and 
Russell, 2003)), a substitution with alanine would be predicted to significantly 
compromise the interactions of the Ino1 protein that contribute to its catalytic 
activity. Since the introduced D342A mutation is in the catalytic site of the 
inositol biosynthetic enzyme, it is predicted to disrupt inositol production. 
Ino1- cells producing Ino1-D342A would therefore be predicted to still require 
exogenous inositol to grow. Expression of Ino1-D342A in Dictyostelium ino1- 
cells did not rescue the inositol auxotrophy resulting from ino1 loss, 
suggesting that Ino1 with this mutation could not catalyse inositol 
biosynthesis and hence, ino1- cells producing Ino1-D342A protein were 
unable to grow in the absence of exogenous inositol. Overexpression of the 
mutated protein in wild-type cells reduced their growth, independently of 
exogenous inositol provision even though the cells were able to proliferate. 




Ino1 protein exists as a homotetramer or a trimer in other organisms 
(Majumder et al., 1997). This, it is possible that, by similarity, assembly of 
oligomers in Dictyostelium from the endogenous pool of catalytically 
functional Ino1 monomers and a population of heterologously overexpressed, 
catalytically non-functional, Ino1 monomers would yield oligomers that  were 
catalytically inactive or had a reduced ability to produce inositol, hence, 
leading to a decrease in cell growth. However, the addition of exogenous 
inositol in the media did not fully restore the growth rate of wild-type cells 
expressing Ino1-D342A to the level observed in untransformed wild-type 
cells, potentially suggesting a role for Ino1 in other cellular functions. 
Alternatively, the inactivated protein may bind to an deplete the Ino1 
substrate, glucose 6-phosphate, thereby reducing growth rate. 
Published data relating to an in vivo regulation of Ino1 showed that the 
protein is phosphorylated in yeast at S184, S296, and S374 and these sites 
are also conserved in humans (Deranieh et al., 2013) and rat (Parthasarathy 
et al., 2013). By homology alignment, these phosphorylation sites are also 
predicted in Dictyostelium. Analysis of phosphodeficient and phosphomimetic 
site-mutants in yeast indicated that the three conserved sites in yeast (S184, 
S296, and S374) and human (S177, S279, and S357) affected Ino1 activity 
(Deranieh et al., 2013). Phosphodeficient and phosphomimetic Ino1 
mutations in the amino acid residue S296 in yeast Ino1 (corresponding to 
S279 in human Ino1) were shown to decrease Ino1 activity and cell growth. 
However, phosphomimetic but not phosphodeficient mutations of S184 and 
S374 in yeast (corresponding to S177 and S357 in human Ino1) decreased 
Ino1 activity. These findings indicate that, in yeast, phosphorylation at S296 
(human S279) is crucial for the protein function while phosphorylation of Ino1 
at S184 and S374 (human S177 and S357) is inhibitory (Deranieh et al., 
2013). Dictyostelium Ino1 phosphodeficient mutations (S179A, S282A, and 
S360A) still rescued the growth defect of ino1- cells in the absence of inositol, 
indicating that the absence of phosphorylation at these serines did not block 
Ino1 activity. Since it was shown that phosphorylation of yeast and human 
Ino1 had an inhibitory growth effect, it is possible that creating 
phosphomimetic mutations at S179, S282 and S360 in Dictyostelium Ino1 




protein would also decrease Ino1 activity. Furthermore, as an experimental 
follow-up, the effect of generating double or triple Ino1 phosphomutations 
may further define the role of these amino acids. Similarly, double mutation in 
the yeast Ino1 at S184A/S374A caused an increase in the protein activity, 
gave a growth advantage, and partially rescued sensitivity to VPA in yeast 
cells (Deranieh et al., 2013), and these effects could be examined in 
Dictyostelium.  
When starved of nutrients, Dictyostelium cells initiate a developmental 
program, where single cells aggregate to form a multicellular organism 
(Krichevsky and Wright, 1963). During development, a subset of cells release 
a chemical, cAMP, that is sensed by surrounding cells to activate signalling 
pathways within these cells, allowing for their migration and aggregation 
(Loomis, 2014). Dictyostelium cell migration and differentiation involves cell-
substrate adhesion and constant reorganisation of cell-shape, and thus many 
proteins involved in development are involved in regulation of cytoskeletal 
activity, such as Rac/Cdc42 GTPases, talin, myosin II or the polymorphic 
adhesion proteins TgrB1 and TgrC2 (Devreotes and Horwitz, 2015; 
Dumontier et al., 2000; Hirose et al., 2015; Park et al., 2004; Tarantola et al., 
2014; Wang et al., 2014; Zhu et al., 2015). For example, a myosin II light 
chain gene disruption leads to abnormal development where 50% of cell 
aggregates are arrested at the mound stage and the other 50% form aberrant 
fruiting bodies with short, thickened stalks (Chen et al., 1995). As shown in 
the previous chapter, ino1 disruption caused cell-adhesion and chemotaxis 
defects, and therefore it was useful to analyse development of the ino1- 
mutants. Additionally, as the inositol-depleting drugs VPA and lithium block 
Dictyostelium development (Williams et al., 2002), investigating the effect of 
these drugs on development of the cells lacking or overproducing Ino1 could 
provide insight into the roles of Ino1 in these cells and the specific targets of 
these drugs. Developmental analysis of the ino1- mutants showed no change 
in the formation or morphology of the fruiting body in the cells lacking or 
overproducing Ino1 (provided that the former was cultured in the inositol-
supplemented media). Also, no difference was seen between the 1 mM VPA- 
or 10 mM lithium-treated ino1 mutant cells relative to the wild-type control, 




suggesting that neither of these drugs directly target Ino1 in these cells. This 
finding is corroborated by previous studies where VPA was shown to inhibit 
inositol biosynthetic activity of Ino1 in vivo but not in vitro (Deranieh et al., 
2013; Ju and Greenberg, 2003; Shaltiel et al., 2004). The indirect inhibition of 
Ino1 by VPA suggests that there is another protein or a complex of proteins 
that mediate the action of this drug in vivo.  
To investigate a potential non-catalytic role of Ino1 in Dictyostelium, 
co-immunoprecipitation to identify putative binding partners of the protein 
was performed. Anti-RFP agarose beads were used to immobilise Ino1-RFP 
and any potential interacting proteins. The isolated complexes were then 
separated on by SDS-PAGE, visualised with Coomassie blue stain and 
analysed by mass spectrometry. Coomassie blue was chosen for the stain as 
it has high sensitivity, gives more homogeneity, and does not interfere with 
mass spectrometry (Gauci et al., 2013; Neuhoff et al., 1988). Data for 90 
potential Ino1 interactors was gathered over three independent experiments. 
These proteins were related to the processes of cytoskeletal organisation, 
mitochondrial respiration, proton transport, DNA and protein regulation, 
metabolism, including fatty acid, glycolysis, and purine metabolism. These 
cellular processes were previously linked to proteins reported to be Ino1 
interactors in Saccharomyces cerevisiae (yeast) (Boettner et al., 2011; 
Szappanos et al., 2011; Tarassov et al., 2008) and in humans (Emdal et al., 
2015; Low et al., 2014; Wan et al., 2015). Components of the peripheral V1 
complex of vacuolar ATPase were also identified in the mass spectrometry 
analysis. These complexes are responsible for acidifying intracellular 
compartments in eukaryotic cells (Balakrishna et al., 2015). In yeast, the V-
ATPase complex is dysregulated following ino1 deletion and inositol 
depletion (Deranieh et al., 2015). Thus the roles for putative Ino1 interactors 
are consistent with those found in other organisms. 
Four proteins of interest were chosen for further interaction studies to 
confirm their interaction with Ino1. These include GpmA, a phosphoglycerate 
mutase linked to inositol auxotrophy in yeast via dysregulation of glycolysis 
(Shi et al., 2005), and related to 2,3 bisphosphoglycerate (2,3 BPG) that was 




previously shown to be elevated in a Dictyostelium ino1- mutant (Fischbach 
et al., 2006). FLAG-GpmA was shown to bind Ino1-RFP though the 
interaction may reflect weak in vivo binding within a complex and further 
experiments are needed to verify this. 
A second putative Ino1 interactor that was investigated was PefB, a 
calcium-binding protein similar to the apoptosis-linked gene 2 (ALG-2) protein 
implicated in Alzheimer's disease progression (Lacanà et al., 1997; Vito et 
al., 1996) and an interactor of mucolipin-1 linked to a recessive lysosomal 
storage disease (Vergarajauregui et al., 2009). A protein of the predicted size 
(23.3 kDa) was present in cell extracts, suggesting correct expression of the 
gene. However, a specific Ino1-PefB interaction could not be detected as no 
band was seen in the bound fraction, suggesting that PefB protein did not 
interact with Ino1 in these experiments. 
The third protein of interest was SecG, an ankyrin repeat-, PH- and 
SEC7-domain containing protein belonging to the cytohesin family of 
proteins. This protein is involved in chemotaxis towards cAMP during 
development and substrate adhesion in Dictyostelium (Garcia et al., 2013; 
Shina et al., 2010). This protein was of interest since in the previous 
chapters, the Ino1 protein was shown to be required for cell movement during 
chemotaxis towards cAMP and cell-substrate adhesion. SecG is needed for 
coordination of F-actin organization during development (Garcia et al., 2013) 
and cell-substrate adhesion (though not cell-cell adhesion) (Shina et al., 
2010). The expression of FLAG-SecG however did not enable the detection 
of tagged SecG in either non-bound or bound fractions. It is possible that the 
protein was expressed at a low level or it was degraded since a small 
number of very faint low molecular weight bands were detected with anti-
FLAG antibodies in the western blots, suggesting that protein degradation 
occurred. However, similar bands were present in all the samples, and thus it 
is likely that this degradation is not SecG-specific. During early development 
proteolytic activity is reduced (Fong and Rutherford, 1978), and therefore, a 
further optimisation approach to decrease the possible degradation of SecG 




and enhance its detection would be to pulse Dictyostelium cells with cAMP 
for 5 hours in order to initiate development prior to cell lysis.  
Finally, another protein of interest in the Ino1 interaction studies was 
Q54IX5, an uncharacterised protein with three Sel1-like domains and a 
tetratricopeptide repeat (TPR). The interaction of Q54IX5 with Ino1 was 
confirmed by co-immunoprecipitation of FLAG-Q54IX5 with Ino1-RFP. 
Further analysis by performing a reverse immunoprecipitation indicated that 
Ino-RFP strongly interacted with GFP-Q54IX5 protein. Q54IX5 is predicted to 
belong to the SEL1 subfamily and it contains the tetratricopeptide repeat 
(TPR) structural motif. TPRs often form scaffolds to mediate protein-protein 
interactions during the assembly of multiprotein complexes (Blatch and 
Lässle, 1999). It is therefore possible that the Ino1 interaction with Q54IX5 
facilitates Ino1 binding to other proteins.  
Two potential roles for Ino1-Q54IX5 interaction can be proposed here. 
Firstly, a Ino1-Q54IX5 interaction may be involved in the regulation of the 
Unfolded Protein Response (UPR), a cellular stress response that is 
conserved between mammals, yeast and worms (Walter and Ron, 2011). 
UPR is activated in response to an accumulation of unfolded or misfolded 
proteins in  the endoplasmic reticulum (Walter and Ron, 2011). The human 
SEL1L protein (found to be 37% identical to Q54IX5 via a BLAST search) is 
an important protein involved in homeostatic pathways where it participates 
in a ubiquitin-dependent degradation of misfolded endoplasmic reticulum 
proteins (Cattaneo et al., 2014). UPR is required for sustained high-level ino1 
expression in wild-type S. cerevisiae (Chang et al., 2002). Ino1 transcription 
is regulated by intracellular inositol and choline levels, where the decrease in 
both molecules activates ino1 transcriptional regulators that bind to UASINO 
promoter element to de-repress ino1 transcription (Shetty and Lopes, 2010). 
The UPR effect on ino1 transcription is, however, not via an UASINO1 
promoter element, and is also independent of inositol depletion or changes in 
lipid metabolism (Chang et al., 2002). In the view of these facts, there is a 
possibility that Q54IX5 protein may interact with Ino1 to facilitate ino1 
expression independent of inositol levels in cells. Since Q54IX5 contains a 




number of TPR motifs, which facilitate the formation of protein-protein 
complexes (Blatch and Lässle, 1999), this interaction might allow for Ino1 
binding to other proteins, and potentially those involved in UPR. To 
strengthen this assumption, a number of proteins identified by the 
immunoprecipitation experiments were related to protein ubiquitination and 
UPR (Supplementary material, Table S2). Moreover, VPA has been 
proposed to regulate UPR, and the downregulation of SEL1L protein in 
glioma stem cells sensitised these cells to cytotoxic effects of VPA (Cattaneo 
et al., 2014), which has a potential therapeutic role. The role of Ino1 in its 
own gene upregulation, independent of inositol, remains to be investigated.  
A second possible role for an Ino1-Q54IX5 interaction is the regulation 
of processes like the immune response or phagocytosis in an inositol-
independent manner. This hypothesis is based on the similarities between 
ino1- and Dd5P4- mutants (Loovers et al., 2007). The Dictyostelium Dd5P4 
gene encodes a type II inositol 5-phosphatase that when deleted in 
Dictyostelium causes a similar phenotype to the ino1- mutant described in 
this work, namely, slower growth in axenic media and strongly reduced 
growth on bacteria (shown to be due to an inefficiency in closing the 
phagocytic cup and forming a phagosome) (Loovers et al., 2002, 2007). The 
human homologue of Dd5P4, OCRL1, was shown to functionally replace 
Dictyostelium Dd5P4 (Loovers et al., 2007). When expressed in 
Dictyostelium Dd5P4- cells, OCRL1 was shown to interact with a SEL1-like 
repeat protein, allowing for its binding to phosphatidylinositol 3-phosphate to 
partially rescue the impaired growth phenotype of Dd5P4- cells (Loovers et 
al., 2007). Additionally, during Legionella pneumophila infection, OCRL1 was 
shown in Dictyostelium to localise to the replicative vacuole to suppress the 
infection by binding to a SEL1-like domain-containing protein involved in the 
vacuole formation (Weber et al., 2009). Transcriptional regulation of ino1 and 
phagocytosis-related roles of Ino1-Q54IX5 interaction remain to be examined 
in future studies. 
Finally, the immunoprecipitation approach described here for Ino1-
RFP identified multiple high molecular weight bands in a ladder-like pattern. 
This pattern suggests the presence of ubiquitin-conjugates (S.Lilla, personal 




observation) as a result of Ino1 protein ubiquitination or sumoylation. Small 
ubiquitin-related modifiers (SUMOs) are ubiquitin-like polypeptides that are 
covalently conjugated to cellular proteins as part of the post-translational 
modifications that participate in diverse cellular processes, including 
transcriptional regulation, maintenance of genome integrity, and autophagy 
(Johnson, 2004). SUMO attachment to protein is reversible and controlled by 
enzymes involved in ubiquitin pathways. Additionally, a number of proteins 
conjugated with SUMOs can be recognized by SUMO-targeted ubiquitin 
ligases (STUbLs), and thus marked for a degradation by the proteasome 
(Hemelaar et al., 2004; Schwartz and Hochstrasser, 2003). Several SUMO 
pathway enzymes were previously found to be required for growth under 
inositol depletion conditions (Felberbaum et al., 2012), corroborating the idea 
that Ino1 may be ubiquitinated/sumoylated.  
6.8 Summary 
Studies to identify novel roles of Ino1 in regulating cellular function 
involved introducing single point mutations in the Ino1 protein and co-
immunoprecipitation to identify Ino1 binding partners. Using an 
immunoprecipitation approach, a number of potential Ino1 binding partners 
was identified, including proteins related to cytoskeletal organisation, 
mitochondrial respiration chain, proton transport, DNA and protein regulation, 
and metabolism. The interactions of Ino1 with GpmA, a phosphoglycerate 
mutase and Q54IX5, which belongs to the SEL1 subfamily and contains a 
tetratricopeptide repeat (TPR), were confirmed. Although the Ino1-Q54IX5 
interaction is still to be investigated, it is proposed that Q54IX5 functions in 
mediating protein-protein interaction involving Ino1, potentially during the 
assembly of a multiprotein complex.  
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Chapter VII  
Conclusions 
7.1 Background 
Inositol and inositol-containing compounds are vital cellular 
components, thus it is often difficult to investigate the effects of inositol 
depletion without inducing cell death. Previous studies reported in organisms 
such as the yeast S.cerevisiae, A.thaliana, and Dictyostelium, have shown a 
loss of viability associated with inositol depletion, termed “inositol-less death”. 
Inositol depletion has been also linked to an imbalance in the synthesis of 
cellular components leading to an “unbalanced cell growth” (Culbertson et al., 
1976; Donahue et al., 2010; Fischbach et al., 2006; Ohnishi et al., 2014; 
Ridgway and Douglas, 1958). Inositol is involved in a number of cellular 
events that maintain cell homeostasis and function, including cell movement, 
cytokinesis, protein modification and degradation, and autophagy (Brill et al., 
2011a; Criollo et al., 2007; Deranieh and Greenberg, 2009; Deranieh et al., 
2015; Di Daniel et al., 2006; Europe-Finner et al., 1989; Guérin et al., 2009; 
Jesch et al., 2005; Kim et al., 2013; Kotaria et al., 2013; Michell et al., 1992; 
Straub et al., 2006; Toker and Agam, 2014; Vicencio et al., 2009; Williams et 
al., 2002; Yamagami et al., 2015; Zhang et al., 2012). Additionally, inositol, 
along with choline, is an important osmolyte (Villarreal and Kültz, 2015) that 
plays a role in stress response. 
Inositol dysregulation has been reported in a variety of human health 
disorders. A number of structurally different bipolar disorder treatments, 
carbamazepine, valproic acid (VPA), and lithium, that act via an inositol 
depletion mechanism (Williams et al., 2002), have been shown to induce 
autophagy in vitro and in vivo (Motoi et al., 2014; Toker et al., 2014). 
Similarly, carbamazepine initiated an autophagic response and reduced 
intracellular inositol and phosphoinositide levels in an animal model organism 
and in Dictyostelium (Schiebler et al., 2015). Also, altered inositol levels have 




been reported in the brains of patients suffering from bipolar disorder 
(Shimon et al., 1997), major depressive disorder (Coupland et al., 2005), and 
schizophrenia (Shimon et al., 1998). Following this, inositol has been 
proposed as a therapy in the treatment of bipolar disorder (Chengappa et al., 
2000), depression, and panic disorders (Palatnik et al., 2001). Additionally, 
Ino1 protein levels have been reported to be elevated in post-mortem brains 
of Alzheimer’s patients (Shimohama et al., 1998), although in other studies 
pathologically lowered inositol levels and mitochondrial dysfunction have 
been demonstrated in mouse neurons (Trushina et al., 2012). The roles of 
inositol in the various cellular processes mentioned here and their linked 
diseases are not yet clearly defined. This project aimed at investigating the 
mechanisms of inositol regulation in Dictyostelium cells. 
7.2 The effects of inositol depletion on Dictyostelium ino1- 
cells (Figure 7.1) 
7.2.1 Reduction in the inositol level and inositol auxotrophy 
To examine the role of inositol depletion on cell function and 
metabolism, the Ino1 enzyme, essential for the de novo production of inositol, 
was genetically ablated. The concentration of inositol was measured in the 
ino1- cells exposed to inositol depleting conditions, showing that the levels of 
inositol decreased rapidly in the ino1- mutant by 35% - 60% within 12 to 24 
hours of inositol starvation. This finding confirms the necessary role for Ino1 
in producing inositol. Ablation of ino1 produced an inositol auxotrophic 
phenotype and defective development, which was rescued by treatment with 
exogenous inositol. 
7.2.2 Decrease in the level of phosphoinositides 
Reduced inositol also caused a general decrease in the level of 
phosphoinositides in cells. Understanding the role of inositol-dependent loss 
of phosphoinositides in Dictyostelium is complicated by the presence of novel 
chemical species. Dictyostelium has been reported to contain two types of 
phosphoinositides, varying by the glycerol-fatty acid linkages that comprise 




diacyl (acyl/acyl) containing or an ether (ether/acyl) containing 
phosphoinositides (Clark et al., 2014). Inositol reduction caused a rapid 
decrease in PI and PIP (both diacyl and ether species) and diacyl PIP2, 
however, the level of ether PIP2 was not changed, highlighting the 
importance of this phospholipid for cell function. The ether species of 
phospholipids are more abundant and comprise over 95% of Dictyostelium 
inositol phospholipids (Clark et al., 2014). As a result, diacyl phospholipids 
might be broken down more rapidly, or alternatively, these compounds may 
provide more labile signalling molecules compared to ether phospholipids. 
7.2.3 Reduction in actin-dependent cell functions 
Inositol depletion also reduced cytokinesis, cell substrate adhesion, 
and velocity during chemotaxis in the ino1- mutant. These cellular functions 
are dependent on actin dynamics, where PIP2 plays an important role (Wu et 
al., 2014). PIP2 participates in signalling pathways that regulate actin 
polymerisation and depolymerisation in substrate attachment (Wu et al., 
2014), and is critical for proper scission of the cleavage furrow in cell division 
(Logan and Mandato, 2006). Since cell motility and migration requires a 
controlled attachment and detachment from the substrate, the reduction in 
cell velocity observed in the ino1- mutant may result from an impaired cell-
substrate adhesion. Activation of small GTP-binding proteins regulates actin 
structures in cells, and the generation of contractile forces during cell 
migration, with PIP2 levels being central to these processes (Wu et al., 
2014). PIP2 promotes the initiation of new actin filaments and enables the 
elongation of the existing ones (Insall and Weiner, 2001). Therefore, a 
decreased level of the diacyl PIP2 observed during inositol depletion may 
lead to a reduction of cytokinesis, cell-substrate adhesion and the speed of 
cell movement. Interestingly, ether PIP2 levels were not changed by the 
removal of inositol supplementation. Thus, diacyl PIP2 may be preferentially 
used in the regulation of cell function during cell attachment, division and 
motility events.  
 
 




7.2.4 Autophagosome accumulation 
During inositol starvation, ino1- cells were shown to accumulate over 
three-fold more autophagosomes than wild-type or ino1- cells grown in the 
presence of inositol. Autophagosomes are produced during autophagy to 
clear away non-functional cellular components, for example misfolded 
proteins or damaged organelles during stress responses like nutrient 
starvation (Glick et al., 2010). The phosphoinositides PIP, PIP2, and PIP3, 
and their effectors, play an important role in various aspects of autophagy, 
including the control of autophagosome biogenesis, maturation, and 
intracellular transport (Dall’Armi et al., 2013). For example, the local 
production of PIP on the isolation membrane (one of the initial steps of 
autophagosome formation) promotes the membrane negative curvature and 
controls autophagosome size (Dall’Armi et al., 2013). PIP2 controls late 
stages of autophagy, specifically the maturation and turnover of 
autophagosomes, where it promotes membrane trafficking and fusion events, 
as well as compartment acidification (Dove et al., 2009). Also, the conversion 
of PIP2 to PIP3 is the initial trigger that activates mTOR complex 1 
(mTORC1) and suppresses autophagy (Zoncu et al., 2011). Thus, the 
decreased level of phosphoinositides resulting from inositol depletion may 
lead to an accumulation of not fully formed autophagosomes. 
7.2.5 Increased catabolism supports an induction of autophagy 
Inositol depletion accounted for a minor change in the metabolic 
profile of Dictyostelium ino1- cells, leading to an increase in amino acids and 
products of the Kreb’s cycle, which is suggestive of enhanced catabolism. 
Amino acid deficiency has been shown to activate autophagy by direct 
inhibition of various components of the signalling pathways downstream from 
growth factors (Beugnet et al., 2003; Lynch, 2001; Nobukuni et al., 2005). As 
a result, inositol depletion can potentially initiate a stress response due to 
nutrient deprivation over 24 hours, and thus trigger an autophagic response, 
possibly leading to cell death.  
 





Figure 7.1 The effects of inositol depletion on Dictyostelium ino1
-
 cells. Inositol levels 
were reduced in the ino1
-
 cells in the absence of exogenous inositol, and were rescued by 
the addition of inositol. A number of cellular functions were assessed to investigate this 
relationship. Inositol depletion caused an inability of cells to grow in liquid media and a 
decrease in phosphoinositol production, which in turn reduced cell velocity during 
chemotaxis, cell-substrate attachment, cytokinesis, and likely caused an impairment of 
cellular membrane synthesis. Reduced inositol levels also led to increased catabolism in 
cells, marked by an increase in amino acid levels and compounds related to energy 
metabolism in cells. Ino1
-
 cells starved of inositol were shown to accumulate 
autophagosomes, possibly as a result of increased autophagy linked to a metabolic 
imbalance caused by the nutrient starvation. 
These findings thus confirm an important role for inositol in 
maintaining optimal growth conditions in cells and give a validation for the 
unbalanced growth of inositol auxotrophs. Furthermore, these studies 
suggest a number of phenotypic, but no major metabolic changes, in the cells 
that are exposed to inositol depleting conditions (Figure 7.1). 




7.3 The effects of the Ino1 loss on Dictyostelium ino1- cells 
(Figure 7.2) 
7.3.1 Impaired cell growth and phagocytosis 
Ino1 loss led to inositol depletion in the absence of exogenous inositol, 
but additionally some changes that were not rescued by inositol 
supplementation. Inositol levels in the ino1- cells grown in the presence of 
exogenous inositol were equivalent to the level of inositol in the wild-type 
cells. Hence, the behavioural changes observed in the ino1- mutant in the 
presence of inositol may be due to a loss of the Ino1 protein. Since the 
inositol auxotrophy of the ino1- mutant was only partially rescued by 
exogenous inositol supplied in saturating conditions (300µM and 500µM), this 
suggests a potential role for Ino1 protein outside of inositol biosynthesis to 
promote cell growth. Additionally, Ino1 may be involved in mediating efficient 
phagocytosis, since inositol supplementation in the ino1- cells grown on agar 
plates seeded with bacteria did not rescue the inability of these cells to 
phagocytose. 
7.3.2 Reduced cell polarity and decreased PIP3 levels 
Ino1- cells showed reduced polarity during chemotaxis, regardless of 
the presence of exogenous inositol, thus suggesting that Ino1 protein is 
involved in signalling leading to cell polarisation during chemotaxis or the 
localised production (spatial distribution) of inositol is important in this 
process. Interestingly, ether PIP3 levels were severely reduced in the ino1- 
mutant (diacyl PIP3 levels were too low to allow for quantification), even in 
the conditions where inositol was present, suggesting that the absence of the 
Ino1 protein had an inositol-independent effect on the regulation of PIP3 
levels. Signalling via PIP3 is required for cell polarisation during cell 
movement (Hoeller and Kay, 2007), and since PIP3 levels were reduced in 
the ino1- mutant, the data supports a notion of Ino1 regulating these 
processes independent of inositol biosynthesis. These findings thus suggest 
that the loss of the Ino1 protein may lead to a decrease in PIP3 production, 
which reduces the effective chemotaxis in the ino1- cells. 




Figure 7.2 The effects of the Ino1 loss. Ino1 loss caused a number of cellular effects that 
were not rescued by the addition of exogenous inositol. This includes a major change in the 
metabolic profile of Dictyostelium, specifically observed by an increase in the level of some 
amino acids, break-down products of nucleic acids, energy-related metabolites, and stress-
related molecules. Ino1 loss also caused a reduction in cell polarity, possibly due to a 
decrease in PIP3 production. Ino1
-
 cells, even when grown in the presence of inositol, were 
not able to phagocytose; the growth in liquid media was also not fully restored, suggesting 
that Ino1 protein may be also involved in these biological processes. 
 
7.3.3 Major changes in the metabolic profile 
The general differences in the metabolic profile of Dictyostelium ino1- 
mutant were due to the loss of the Ino1 protein rather than inositol treatment. 
Although inositol depletion accounted for a minor variation in the metabolic 
profile of the ino1- mutant, the removal of the Ino1 protein led to a wide 
metabolic change in these cells. Metabolic profile analysis showed that the 
Ino1 loss caused an increase in amino acids and a build-up of molecules 
related to energy metabolism (fumarate, lactate, acetate and succinate that 
are linked to the Kreb’s cycle), likely via the loss of inositol synthesis in these 
cells. Additionally, Ino1 absence resulted in an increase in metabolites 
related to nucleotide degradation (β-alanine) and stress response 
(glycerophosphocholine), independently of inositol provision. These 
metabolic changes represent differences in protein, energy, and DNA 
regulation, which have major effects on cellular function, and suggest an 




important role for the Ino1 protein in metabolic regulation, independent of 
inositol levels.  
7.4 Relationship between inositol depletion and Ino1 loss 
It is likely that the molecular and metabolic effects of Ino1 presence 
and inositol depletion are interrelated. Decreased intracellular inositol levels 
have been shown to activate ino1 expression in a number of organisms, 
including yeast (Shetty et al., 2013; Vaden et al., 2001), Dictyostelium 
(Williams et al., 2002), and mice (Shamir et al., 2003); therefore, inositol 
depletion is potentially elevating Ino1 levels. Many studies concerning inositol 
depletion have predominately relied on using inositol-depleting drugs that are 
prescribed as bipolar disorder treatments and act via multiple targets (Ju and 
Greenberg, 2003; Shaltiel et al., 2004; Terbach and Williams, 2009). Hence, 
results reported by these studies are likely to be complicated by secondary 
effects.  
The results presented in this thesis suggest that short-term inositol 
depletion does not cause large scale metabolic changes in Dictyostelium. 
Additionally, under normal circumstances, reduced inositol levels increase 
ino1 transcription, thus acting to reverse this deficit (Williams et al., 2002), 
and protecting cells against the effects of inositol imbalance. In contrast, a 
dysregulation of this responsive mode, where Ino1 protein is absent (ino1- 
mutant), is likely to cause greater metabolic effects with possibly enhanced 
phenotypic changes. Indeed, antisense silencing of the Dictyostelium ino1  
expression (Fischbach et al., 2006) resulted in less severe phenotypic effects 
compared to those observed in the ino1 knock-out.  
7.5 Ino1 protein binding partners 
Protein interaction studies were conducted to examine a potential role 
for Ino1 in cell signalling, independent of its ability to synthesise inositol. 
Immunoprecipitation experiments showed that Ino1 interacts with a protein, 
Q54IX5, with an unidentified function that contains SEL1-like domain and 




tetratricopeptide repeats, which are typically present in proteins that 
assemble multi-protein complexes. Ino1 was also shown to weakly bind to 
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (GpmA), 
which catalyses the interconversion of 2-phosphoglycerate and 3-
phosphoglycerate. 2,3-BPG is a product of the glycolysis branch, and has 
been shown in vitro to be a competitive inhibitor of inositol-polyphosphate 5-
phosphatases (Rana et al., 1986), and is elevated in the Dictyostelium ino1- 
mutant (Fischbach et al., 2006). 
7.6 Mutation in the Ino1 catalytic domain 
To investigate a potential non-catalytic role for Ino1 in cell function, an 
Ino1-D342A protein was expressed in the ino1- and wild-type cells, and the 
growth of these cells was assessed. The mutation was introduced to replace 
an amino acid in a conserved catalytic region with one that would likely 
disrupt the catalytic activity of the Ino1 enzyme. Indeed, the presence of the 
Ino1-D342A protein did not rescue the inositol auxotrophy resulting from Ino1 
loss, confirming that this protein did not catalyse inositol biosynthesis. 
Furthermore, the mutated protein reduced cell growth in both ino1- and wild-
type strains, independently of exogenous inositol supplementation. This 
dominant negative effect in wild-type cells may be due to depletion of the 
Ino1 substrate glucose 6-phosphate, with resulting effects on cell energy and 
metabolism, an inactivation of a potential Ino1 multimeric protein complex, or 
by other mechanisms.  
7.7 Ino1 as a target for VPA 
Several studies have suggested VPA may function through an 
inhibition of Ino1 (Agam et al., 2002; Deranieh et al., 2013; Ju et al., 2004; 
Shaltiel et al., 2004). The human Ino1 protein is inhibited in vivo but not in 
vitro by the inositol-depleting drug VPA (0.6 mM), when the protein was 
expressed in yeast cells lacking the endogenous Ino1 (Ju et al., 2004). The 
activity of Ino1 in these cells was decreased by 35%, and the level of inositol 
reduced by 25%, following VPA treatment (Ju et al., 2004). VPA and lithium 




were also previously shown to inhibit Dictyostelium development related to 
inositol depletion (Williams et al., 2002). The VPA-sensitivity of Dictyostelium 
cells lacking or overexpressing Ino1 however did not differ to the VPA-
sensitivity observed in the wild-type cells, suggesting that VPA does not 
directly target Ino1 to cause inositol depletion. 
7.8 Implications of our findings for disease 
The research presented in this thesis shows an importance of inositol 
for a number of cellular functions, including cell attachment and autophagy, 
which have been previously linked to neurodegenerative diseases and 
neuropsychiatric disorders (Corvin, 2010; Lionaki et al., 2015; Nilsson et al., 
2013; O’Dushlaine et al., 2011; Sarkar et al., 2005). Genome-wide 
association studies have identified significant association between the cell 
adhesion molecule (CAM) pathway and susceptibility to schizophrenia and 
bipolar disorder (Corvin, 2010), suggesting a potential role of cell adhesion in 
pathology of these neuropsychiatric disorders. Different signalling molecules 
regulate cell adhesion, among them, phosphatidylinositol-4,5-bisphosphate 
(PIP2) modulates diverse biological processes, including actin cytoskeletal 
dynamics required for cell adhesion. In this thesis, inositol depletion was 
shown to cause the loss of cell substrate adhesion in the ino1- mutant, which 
has been suggested to be a result of the dysregulation of PIP2 in these cells. 
Phospholipids and inositol phosphates have also been linked to autophagy in 
various model organisms (Criollo et al., 2007; Knorr et al., 2014; Nagata et 
al., 2010; Parys et al., 2012; Sarkar et al., 2005). Dysregulation of the inositol 
signalling pathway therefore links to cellular processes previously implicated 
in human disease, and suggests that molecules like PIP2 may be important 
regulators of these processes in the context of a disease. 
 Analysing metabolite changes in patient tissues is informative for 
research into the molecular basis of human diseases (Bracken et al., 2011). 
For example, magnetic resonance spectroscopy has previously reported 
abnormalities in the brain myo-inositol concentrations of bipolar patients 
(Davanzo et al., 2001; Silverstone et al., 2005). The metabolomic study 




presented in this thesis reports specific metabolite changes during inositol 
depletion and Ino1 loss, including increased levels of amino acids, products 
of DNA break-down, stress response molecules, and energy-related 
compounds, which may aid discovery of the details of metabolic 
dysregulation during inositol imbalance in cells. 
Additionally, this study shows that the Ino1 protein has a greater 
impact on the metabolic regulation in Dictyostelium cells than inositol 
depletion, and the loss of this protein causes cellular changes that are not 
rescued by exogenous inositol supplementation. Ino1 protein levels are also 
higher in the brains of Alzheimer’s disease patients (Shimohama et al., 
1998), and patients with family history of a major psychiatric disorder (Shamir 
et al., 2007). Thus, identifying the roles of Ino1 protein is beneficial to 
advance research to understand the molecular mechanisms underlying the 
neurological disorders associated with an inositol imbalance. 
7.9 Summary 
The aim of this study was to examine the effects of inositol depletion 
on cell function and metabolism in Dictyostelium discoideum by removal of a 
highly conserved inositol biosynthetic enzyme, Ino1. The results show that 
Ino1 loss and inositol depletion cause discrete cellular, molecular and 
metabolic changes. Inositol depletion alters cell physiology, likely leading to 
an autophagic response, causing a loss in cell-substrate adhesion, reduction 
in cell division, and a rapid decrease in phospholipids. Inositol depletion does 
not however cause a large change in the Dictyostelium metabolic profile. In 
contrast, the data presented here suggest that the Ino1 protein plays an 
important role in cell growth, cell morphology and metabolic regulation, 
regardless of inositol provision. Ino1 is shown to bind to a putative 
macromolecular complex linker protein, Q54IX5, suggesting further roles for 
Ino1. The findings presented in this thesis are likely informative for research 
into human diseases where inositol involvement has been suggested, and 
thus may be beneficial for the future development of specific therapies that 
are more effective and better tolerated than those currently available.  













Table S1 The list of oligonucleotides used for cloning and screening procedures 
Reference Primer sequence (5’ – 3’) Notes 
ino1 knock-out 3' pLPBLP Forward AAAAGGATCCTGTCAGCACAAATGTTTGAATC Clone 
ino1 knock-out 3' pLPBLP Reverse AAAACTGCAGAGATGGATGGGAGTGGAGTG Clone 
ino1 knock-out 5' pLPBLP Forward ATACCATGGTCCAGCTGTCGTTGATTTAGCC Clone 
ino1 knock-out 5' pLPBLP Reverse ATAGGTACCCTGGATGGAAAGTAGCAAATTGATC Clone 
ino1 knock-out RTPCR Forward GCTGCAAATCAAAAGGATCGTGCC Screen 
ino1 knock-out RTPCR Reverse AAGGTGTTTTGTGGTGAACCATTGATG Screen 
ino1 knock-out Blast Forward AGCTGATGCCATGCAACGTGCTC  Screen 
ino1 knock-out Blast Reverse ACTGACGAGATAATCAGTGAGGACAG Screen 
ino1 knock-out Genomic Control Forward GGCCTTTTCACAGATAAATCAACAAACA Screen 
ino1 knock-out Genomic Control Reverse GGCCCAACCACCGAAAACAATATCG Screen 
ino1 knock-out Genomic Control Forward ATAGCTGAAGTTACTAGTCGTATCAC Screen 
ino1 knock-out Vector Control Reverse GGCCGAGCTAGAAACTTGATAAGAAAGAAAT Screen 
ino1 knock-out Genomic Control Reverse TGGAGAACGATTGTATTGTGACC Screen 
Blastocidin cassette pLPBLP Forward AAAAAGATAAAGCTGACCCGAAAG screen 
Blastocidin cassette pLPBLP Reverse TCAAATAATAATTAACCAACCCAAG screen 
Ino1-RFP (389-2) Forward TATGGATCCTAATCTTTGTTCTAATAACATG Clone 
Ino1-RFP (389-2) Reverse GAGCGAATTCATGTCAGCACAAATGTTTGAATC Clone 
mRFPmars Reverse (389-2) GACCGTTAACTGAACCTTCCA Screen 
D342Adino1 Forward TAGGTAATAACGCAGGTAAGAATCTCTCTGCTC Clone 
D342Adino1 Reverse AATGATTGTATGAAACGATTGAAACTGGTTTAATACC  Clone 
Ig7_Forward ACCTACAAGTCGATCAGAGAC RTPCR control screen 
Ig7_Reverse CACCTCAGTCCTCTCGTAC RTPCR control screen 
hINO1dCB EcoRI Forward GAATTCATGGAAGCAGCAGCAC Clone 
hINO1dCB Forward AGGTGCATTAGAATTAGCTTGGC Clone 
hINO1dCB BglII Forward AGATCTATGGAAGCAGCAGCAC Clone 
hINO1dCB SpeI Reverse ACTAGTTCAAGTAGTTGGCATTGGTGGT Clone 
hINO1dCB_SacI Forward GAGCTCATGGAAGCAGCAGCACA Clone 
pefBFLAG Forward AGATCTATGTACGGATACGGAT Clone 
pefBFLAG Reverse ACTAGTTTAAACTAAAGCAATGAT Clone 
Q54FLAG Forward AGATCTATGGAAAATTTAAAATTATT Clone 
Q54FLAG Reverse ACTAGTTTATTTTTTTAATAAATTTAATTTAG Clone 




secGFLAG Forward AGATCTATGGGATCAACATCAAATTC Clone 
secGFLAG Reverse ACTAGTTTAAGATAATGCAGAAGTTTG Clone 
secGMFLAG Forward GATATGGTAGACCTACTCATTCG Clone 
secGMFLAG Reverse CGAATGAGTAGGTCTACCATATC Clone 
gpmAFLAG Forward AGATCTATGGTTTATAAATTAGT Clone 
gpmAFLAG Reverse ACTAGTTTATTTAGCTTTACCTTGATTGGC Clone 
gpmASacI_FLAG Forward ATAGAGCTCATGGTTTATAAATTAGTTTTAATTAG Clone 
gpmAXhoI_FLAG Reverse ATACTCGAGTTATTTAGCTTTACCTTGATTGG Clone 
dINO1_S179A_Forward CACTCCCAGCCATCTATTTCCCA Clone 
dINO1_S179A_Reverse TGGGAAATAGATGGCTGGGAGTG Clone 
dINO1_S282A_Forward CACATACATCAATGGTGCACCACA Clone 
dINO1_S282A_Reverse TGTGGTGCACCATTGATGTATGTG Clone 
dINO1_S360A_Forward TTACCAAAGCAAATGTTGTCGATGA Clone 
dINO1_S360A_Reverse TCATCGACAACATTTGCTTTGGTAA Clone 
dINO1_S354A_Forward  CAATTCCGTGCCAAAGAAATTACC  Clone 
dINO1_S354A_Reverse GGTAATTTCTTTGGCACGGAATTG  Clone 
secG_screen Forward GAGGTTGCACATTTCCTTTTGACTC  Screen 
secG_screen Reverse CCGAATGACCATTGTAGGCTGC Screen 
seC_screenFCT CTTTGGTTCAAGCAAATCATGCC  Screen 
Q54IX5_screen_Forward GGTATATTACAATGTGATCTC  Screen 
dino1_BglIIF (pDM317) ATAAGATCTATGTCAGCACAAATGTTTG Clone 
dino1_SpeIRSC (pDM317) ATAACTAGTTTATAATCTTTGTTCTAATAACATG Clone 
dino1_SpeIRNSC (pDM317) ATAACTAGTTAATCTTTGTTCTAATAACATG Clone 
dino1 pDXA-3H-Hyg CTTATTTCTTAAAACAAATA Clone 
dino1Bgal_BglIII_R  ATAAGATCTTATTTTTTGTATATATG  ino1 promoter cloning 
1K_dino1Bgal_XbaI_F  ATATCTAGAGGGAAATGCAATGCCATTCGGTG ino1 promoter cloning 
0.35K_dino1Bgal_XbaI_F  ATATCTAGACCAACAAATTACACACACACAAAAATAG ino1 promoter cloning 








Table S2 The list of putative Ino1 interacting proteins 
Actin-related 








When linked to F-actin the actin filaments form preferentially anti-
parallel bundles that associate into meshworks. Plays a major role 
in cytokinesis. Negatively regulates cortical localization of rapgap1. 






Q550R2 10 0 
 Cell-substrate 
adhesion 
Talin A (talA) 
Involved in the control of cell motility and chemotaxis, 
phosphatidylinositol-3,4,5-trisphosphate binding. 
P0CE94 6 0 
 Cell motility Talin B (talB) 
Required for multicellular morphogenesis. Substrate of pkgB and/or 
pkbA. 
Q54K81 7 0 
 Chemotaxis SecG 
Ankyrin repeat, PH and SEC7 domain containing protein that has 
ARF guanyl-nucleotide exchange factor activity. 




May act as an intracellular pH sensor that links chemotactic signals 
to responses in the microfilament system of the cells by nucleating 
actin polymerization or stabilizing the filaments. 
P13231 3 0 
 Phagocytosis Act1 Major actin (cluster) P07830 32 43 
 Response to 
other organisms 





Motor protein, possibly involved in a wide range of motile 
processes, such as cell movement across a surface, and extension 
and retraction of pseudopodia or lamellipodia. 
P22467 2 0 
 









 Fatty-acid beta 
oxidation 
MfeA 
Peroxisomal multifunctional enzyme A. Enzyme acting on the 
peroxisomal beta-oxidation pathway for fatty acids. Protects the 
cells from the increase of the harmful xenobiotic fatty acids 
incorporated from their diets and optimizes cellular lipid composition 
for proper development. 
Q9NKW1 5 0 
 Apoptosis DDB_0187993 
Cysteine-type endopeptidase activator with activity involved in 
apoptotic process. 
Q54IS1 2 0 
 Stress response Prdx5 Oxidoreductase activity. Q54N76 3 0 
  Ddj1 Heat shock protein. Q54VQ1 13 0 
  HspK Small heat shock protein. Q86H60 3 0 
 
Metabolism 














Transaldolase, important for the balance of metabolites in the 
pentose-phosphate pathway. This protein is involved in the second 
step of the subpathway that synthesizes D-glyceraldehyde 3-
phosphate and beta-D-fructose 6-phosphate from D-ribose 5-
phosphate and D-xylulose 5-phosphate (non-oxidative stage). 
Q54UP4 2 0 




 Glycolysis DDB_G0276821 
Putative aldehyde dehydrogenase family 7 member A1 homolog. 
Aldehyde dehydrogenase (NAD) activity. 




NADH-ubiquinone oxidoreductase 49 kDa subunit. Core subunit of 
the mitochondrial membrane respiratory chain NADH 
dehydrogenase (Complex I). 
Q23883 3 0 
 Lipid 
homeostasis 




Pyruvate kinase, involved in step 5 of the subpathway that 
synthesizes pyruvate from D-glyceraldehyde 3-phosphate. 
Q54RF5 6 0 
  PdhX 
Pyruvate dehydrogenase complex subunit homolog. The pyruvate 
dehydrogenase complex catalyzes the overall conversion of 
pyruvate to acetyl-CoA and CO2. It contains multiple copies of 
three enzymatic components: pyruvate dehydrogenase (E1), 
dihydrolipoamide acetyltransferase (E2) and lipoamide 
dehydrogenase (E3). 
Q86AD5 3 0 
  GpmA (PGAM) 
Catalyzes the interconversion of 2-phosphoglycerate and 3-
phosphoglycerate. 
Q54NE6 2 0 
  Ogdh 
2-oxoglutarate dehydrogenase, mitochondrial. The 2-oxoglutarate 
dehydrogenase complex catalyzes the overall conversion of 2-
oxoglutarate to succinyl-CoA and CO2. 
Q54JE4 5 0 
  DDB_G0276065 Acyl-coenzyme A oxidase. Q75JL8 3 0 
  AccA 
Acetyl-CoA carboxylase, catalyzes the rate-limiting reaction in the 
biogenesis of long-chain fatty acids. Carries out three functions: 
biotin carboxyl carrier protein, biotin carboxylase and 
carboxyltransferase. 
Q54J08 8 0 
  Glud2 
Glutamate dehydrogenase 2. Glutamate dehydrogenase (NAD+) 
activity and catabolic process to 2-oxoglutarate. 
Q54VI3 12 0 
 VatA 
V-type proton ATPase catalytic subunit A of the peripheral V1 
complex of vacuolar ATPase. V-ATPase vacuolar ATPase is 
responsible for acidifying a variety of intracellular compartments in 
P54647 11 0 






V-type proton ATPase subunit B. Vacuolar ATPase is responsible 
for acidifying a variety of intracellular compartments in eukaryotic 
cells. The B subunit is non-catalytic but combines with other 
subunits to form the catalytic complex.  
Q76NU1 
 
   22 0 
 
DNA-related 










Eukaryotic translation initiation factor 3 subunit I. Component of the 
eukaryotic translation initiation factor 3 (eIF-3) complex, which is 
involved in protein synthesis and, together with other initiation 
factors, stimulates binding of mRNA and methionyl-tRNAi to the 
40S ribosome. 
Q54MT0 3 0 
 DNA translation 
initiation 
LysS Lysine--tRNA ligase Q54TY4 4 0 
 Regulation of 
gene expression 
ThyA  
Probable thymidylate synthase thy1. Catalyzes the formation of 
dTMP and tetrahydrofolate from dUMP and 
methylenetetrahydrofolate. 
P15808 3 0 




Adenylosuccinate synthetase that plays an important role in the de 
novo pathway and in the salvage pathway of purine nucleotide 
biosynthesis. Catalyzes the first committed step in the biosynthesis 
of AMP from IMP. 
P21900 2 0 
 Ribosome 
biogenesis 
GuaA GMP synthase [glutamine-hydrolyzing].  P32073 5 0 







Dihydropyrimidine dehydrogenase [NADP+]. Catalyzes the 
reduction of uracil and thymine. 
Q55FT1 3 0 
  Pyr56 
Uridine 5'-monophosphate synthase. Involved in step 1 and 2 of the 
subpathway that synthesizes UMP from orotate. 
P09556 6 0 
  UdkC 
Uridine-cytidine kinase C. Catalyzes the conversion of uridine into 
uridine monophosphate and cytidine into cytidine monophosphate in 
the pyrimidine salvage pathway. 
Q54R62 2 0 
      
  Uap56 ATP-dependent RNA helicase activity Q55CR6 4 0 
  Nop56 
Nucleolar protein 56. Required for 60S ribosomal subunit 
biogenesis. 
Q54MT2 3 0 
  Nop10 
H/ACA ribonucleoprotein complex subunit 3. Required for ribosome 
biogenesis. Part of the H/ACA small nucleolar ribonucleoprotein 
(H/ACA snoRNP) complex, which catalyzes pseudouridylation of 
rRNA  
Q54J26 2 0 
  Polr2e 
DNA-directed RNA polymerases I, II, and III subunit rpabc1. DNA-
dependent RNA polymerase catalyzes the transcription of DNA into 
RNA using the four ribonucleoside triphosphates as substrates.  
Q54EH2 3 0 
  Gtf2b 
Transcription initiation factor IIB. General factor that plays a major 
role in the activation of eukaryotic genes transcribed by RNA 
polymerase II. 
Q54FD6 2 0 
  Rpl19 
60S ribosomal protein L19. Ribosomal protein that binds 
calmodulin. 
P14329 6 0 
  Rps2 40S ribosomal protein S2 P27685 4 0 
  Rpl13 60S ribosomal protein L13. Structural constituent of ribosome. Q54E20 3 0 
  DDB_0218525 Structural constituent of ribosome. Q54QM2 2 0 
  Cnrl 
Putative countin receptor Cnr9. Histone methyltransferase activity 
(H3-K36 specific). 
Q55D68 3 0 










 Amino acid 
biosynthesis 
DDB_G0272318  
Importin subunit alpha-B. Functions in nuclear protein import via 
a substrate-importin alpha-beta transport complex that passes 
though the nuclear pore complexes (NPC). Binds specifically 
and directly to substrates containing either a simple or bipartite 
NLS motif. 
Q76P29 3 0 
 Protein folding EmpB 
Transmembrane emp24 domain-containing protein B. Budding 
of coatomer-coated and other species of coated vesicles. 
Q54BN0 4 0 
 Protein transport PefB 
Penta-EF hand domain-containing protein 2, calcium-dependent 
cysteine-type endopeptidase activity. 
Q95YL4 2 0 
 Proteolysis and 
sorocarp development 
Tcp1 
T-complex protein 1 subunit alpha. Molecular chaperone; 
assists the folding of proteins upon ATP hydrolysis. Known to 
play a role, in vitro, in the folding of actin and tubulin. 
Q55BM4 3 0 
 Posttranslational 
protein targeting to 
membrane 
CysB 
Cystathionine beta-synthase involved in the first step of the 
subpathway that synthesizes L-cysteine from L-homocysteine 
and L-serine. 
P46794 7 0 
  Nfs1 
Probable cysteine desulfurase, mitochondrial. Catalyzes the 
removal of elemental sulfur from cysteine to produce alanine. It 
supplies the inorganic sulfur for iron-sulfur (Fe-S) clusters. 
Q54X04 3 0 
  DDB_G0287543 
Endoplasmic reticulum transmembrane protein YET-like. May 
play a role in anterograde transport of membrane proteins from 
the endoplasmic reticulum to the Golgi. 
Q54K74 4 0 
  CrtA 
Calreticulin. Molecular calcium-binding chaperone promoting 
folding, oligomeric assembly and quality control in the ER via 
the calreticulin/calnexin cycle. This lectin may interact 
Q23858 6 0 




transiently with almost all of the monoglucosylated glycoproteins 
that are synthesized in the ER. 
  Ascc3 Activating signal cointegrator 1 complex subunit 3.  Q54G57 4 0 
  Ost1 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 
subunit 1. Essential subunit of the N-oligosaccharyl transferase 
(OST) complex which catalyzes the transfer of a high mannose 
oligosaccharide from a lipid-linked oligosaccharide donor to an 
asparagine residue within an Asn-X-Ser/Thr consensus motif in 
nascent polypeptide chains. 
Q54C27 3 0 
  MppA2 
Mitochondrial-processing peptidase subunit alpha-2. Acts 
cooperatively with the beta subunit of the mitochondrial 
processing protease/peptidase. Alpha subunit participates in 
substrate recognition while beta subunit is the catalytic subunit. 
Q54F93 6 0 
  DDB_G0291650  
Probable importin-5 homolog. Functions in nuclear protein 
import as nuclear transport receptor. Serves as receptor for 
nuclear localization signals (NLS) in cargo substrates. 
Q54EW3 5 0 
  Ap1b1 AP-1 complex subunit beta. Subunit of clathrin-associated 
adaptor protein complex 1 that plays a role in protein sorting in 
the trans-Golgi network (TGN) and endosomes. The AP 
complexes mediate the recruitment of clathrin to membranes 
and the recognition of sorting signals within the cytosolic tails of 
transmembrane cargo molecules. Also involved in early steps of 
phagocytosis and macropinocytosis. 
Q54X82 3 0 
  Apm1 Q54HS9 4 0 
  Spcs3 
Signal peptidase complex subunit 3. Component of the 
microsomal signal peptidase complex which removes signal 
peptides from nascent proteins as they are translocated into the 
lumen of the endoplasmic reticulum. 
B0G180 2 0 
  OatA 
Probable ornithine aminotransferase involved in the first step of 
the subpathway that synthesizes L-glutamate 5-semialdehyde 
Q54JP5 2 0 





  PsmC3 
26S protease regulatory subunit 6A homolog. The 26S protease 
is involved in the ATP-dependent degradation of ubiquitinated 
proteins. The regulatory (or ATPase) complex confers ATP 
dependency and substrate specificity to the 26S complex. 
Q54PN7 7 0 
  Lap 
Cytosol aminopeptidase. Presumably involved in the processing 
and regular turnover of intracellular proteins. Catalyzes the 
removal of unsubstituted N-terminal amino acids from various 
peptides.  
Q5V9F0 3 0 
  PsmD8 
Probable 26S proteasome non-ATPase regulatory subunit 8 
involved in ATP-dependent degradation of ubiquitinated 
proteins. 
P02889 2 0 
  PsmD7 
26S proteasome non-ATPase regulatory subunit 7. Acts as a 
regulatory subunit of the 26S proteasome which is involved in 
the ATP-dependent degradation of ubiquitinated proteins. 
Q54WI8 3 0 
  UbqB Ubiquitin-60S ribosomal protein L40 P14794 11 0 
  UbqC Ubiquitin-40S ribosomal protein S27a (cluster) P14797 10 6 
  Uba1 
Ubiquitin-like modifier-activating enzyme 1. Activates ubiquitin 
by first adenylating with ATP its C-terminal glycine residue and 
thereafter linking this residue to the side chain of a cysteine 
residue in E1, yielding a ubiquitin-E1 thioester and free AMP. 
Q55C16 3 0 
  PsmC2 
26S protease regulatory subunit 7. The 26S protease is involved 
in the ATP-dependent degradation of ubiquitinated proteins. The 
regulatory (or ATPase) complex confers ATP dependency and 
substrate specificity to the 26S complex. 
Q86JA1 4 0 
  PsmB5 
Proteasome subunit beta type-5 that is part of the multicatalytic 
proteinase complex that has an ATP-dependent proteolytic 
activity. Cleaves peptide bonds with very broad specificity.  
Q54BC8 3 0 




  PsmB7 
Proteasome subunit beta type-7 that is part of the multicatalytic 
proteinase complex that has an ATP-dependent proteolytic 
activity. Cleaves peptide bonds with very broad specificity.  
Q54QR2 2 0 
  DDB_0190095 
Ubiquitinyl hydrolase 1. Thiol-dependent hydrolysis of ester, 
thioester, amide, peptide and isopeptide bonds formed by the C-
terminal Gly of ubiquitin (a 76-residue protein attached to 
proteins as an intracellular targeting signal). 
Q55EJ1 2 0 
  PsmB6 
Proteasome subunit beta type-6 that is part of the multicatalytic 
proteinase complex that has an ATP-dependent proteolytic 
activity. Cleaves peptide bonds with very broad specificity. 
Q55GJ6 2 0 
  UbqA Polyubiquitin-A. P0CG76 12 0 
  PsmD4 
26S proteasome non-ATPase regulatory subunit 4. Binds and 
presumably selects ubiquitin-conjugates for destruction. 
Q553E0 2 0 
 
Uncharacterised 
Name Function UniProt ID INO1 Ctrl 
DDB_G0290597  Zinc ion binding. Q54FT8 3 0 
DDB_G0288947 Uncharacterised Q54I73 7 0 
DDB0187985 Uncharacterised Q54IS9 6 0 
DDB_0187949 Putative uncharacterized protein Q54IX5 7 0 
zipA  Zipper-like domain-containing protein Q54L07 2 0 
DDB_0185982 Putative uncharacterized protein Q54PQ6 2 0 




DDB_0205144  Putative uncharacterized protein Q54SZ1 2 0 
DDB_0205702 Hydrolase acitivity Q54X02 3 0 
DDB_0203302 Putative uncharacterized protein Q555X7 2 0 
DDB_0167407  Putative uncharacterized protein Q86I47 2 0 
DDB_G0268034 Rab GDP-dissociation inhibitor activity. Q55FM7 3 0 
 
Table S2 The list of putative Ino1 interactors. Co-immunoprecipitation was conducted using ino1
- 
cells expressing ino1-RFP with anti-RFP coated beads; 
ino1
-
 cells expressing RFP only (two independent repeats) or Ax2 cells expressing RFP only (one repeat) were used as a control (crt). Mass spectrometry was 
used to analyse unique bands from the Ino1 pull down data. The MS/MS protein data was analysed using Scaffold 3 software with the analysis parameters set 
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